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Abstract
Salivary Cortisol as a measure of pain and distress in sick and preterm infants
Background Untreated pain and distress in the newborn infant, particularly the preterm
infant, can affect clinical outcome and have long-term effects on neurological development.
There is currently no reliable tool for assessing sustained pain or distress in sick and preterm
newborn infants. Salivary Cortisol has been used as a tool to assess stress in older infants,
children and adults, but not this population.
Objective To evaluate salivary Cortisol as a potential tool for assessing sustained distress or
pain in sick and preterm infants.
Design
1) Four different saliva collection methods were evaluated for their ease of application in
the population and their effect on Cortisol radioimmunoassay.
2) 50 matched saliva-plasma samples were taken in order to explore the relationship
between salivary and total plasma Cortisol and to estimate the range of values in the
study population.
3) A longitudinal study of weekly, morning and evening salivary Cortisol was undertaken in
11 infants to evaluate the nature of potential circadian rhythm in Cortisol secretion.
4) Saliva samples were taken from infants in 4 'presumed distress' groups:
i) Controls (n=40)
ii) Infants requiring continuous positive airways pressure (CPAP) (n=10)
iii) Infants requiring conventional mechanical ventilation (n=10)
iv) Infants with meningitis or necrotising enterocolitis (n=T0)
Levels from the four groups were compared along with illness severity scores.
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Abstract cont.
Subjects All subjects were in-patients on a neonatal unit in a tertiary referral centre at a
teaching hospital.
Measurements Cortisol was measured in saliva in 100 pi samples by highly specific
radioimmunoassay without prior extraction.
Results
1) Citric acid as a potential sialogogue was found to be distressing to the infants, and cotton
and polyester swabs resulted in Cortisol values significantly higher and more variable
than 'plain' saliva (p=0.01, paired t-test).
2) Total plasma and salivary Cortisol were significantly related using Spearman's
correlation; r = 0.75, p < 0.01
Total plasma Cortisol; median 244.2 nmol L'\ range 37.3-3802 nmol L ,
interquartile range 94.1-418.0 nmol L"1
Salivary Cortisol; median 43.1 nmol L1, range 2.8-3767 nmol L"1 interquartile range
14.0-121.3 nmol L"1
No infant born < 30 weeks gestation, followed till discharge home, had a period of 4
or more weeks of sustained morning > evening salivary Cortisol.
3) Salivary Cortisol levels in infants in 'presumed distress' groups were significantly higher
than in control groups (p < 0.01). Illness severity assessed by SNAP and CRIB scores
did not contribute significantly to salivary Cortisol levels (General linear model, p>0.05).
No difference was found for comparisons between salivary Cortisol in infants who were




1. Salivary Cortisol may be used as a practical tool to assess adrenocortical activity in sick
and preterm infants. Direct suction of 'plain' saliva from an infant's mouth, without
citric acid, was chosen as the most suitable collection method. The effect of cotton and
polyester swabs was presumed to be due to cross-reactivity of swab constituents with the
assay antibody.
2. Salivary levels correlated well with total plasma Cortisol levels and were higher than
previously reported for any population.
3. Classical circadian rhythm in Cortisol secretion is not apparent in very preterm infants
prior to discharge from hospital.
4. Infants with presumably distressing conditions and treatments had significantly higher
salivary Cortisol than controls, and illness severity was not as strongly associated with
salivary Cortisol levels as the degree of presumed distress. Salivary Cortisol levels in
'well' infants do not vary significantly over the first weeks of life, are not significantly
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1 Project Outline
It is now widely accepted that pain and distress exist in newborn infants, both term and
preterm. The effects of such pain and distress on an infant's clinical condition can range
from seconds to days. Longer-term effects on neurological development potentially extend to
weeks, months and years. There is evidence that appropriate treatment of pain and distress
may be advantageous to sick infants. These issues and the relevant literature are discussed in
chapter 2.1.
With such a body of evidence available, it would be advantageous to develop a reliable tool
to measure pain and distress. Only then, will it be possible to detect the problem and monitor
the success of its management. There are behavioural and simple physiological tools for the
assessment of acute pain or distress, but little attention has been paid to the assessment or
measurement of sustained distress. It is unlikely that behavioural assessment alone will be
adequate in this situation. The literature on current pain and distress scores is discussed in
chapter 2.2.
Salivary Cortisol is now widely accepted as a reliable indicator of adrenocortical activity in
healthy term infants, children and adults (chapter 2.4). In these populations, Cortisol levels
are closely associated with negative affect, pain and distress. Salivary Cortisol might thus
mirror distress in preterm and sick newborn infants.
It is relatively simple to ask an adult or school-aged child to spit saliva into a collection pot
but this is impractical in infants. Potential collection methods for use in sick and preterm
infants were therefore evaluated (chapter 4). The selection and development of a suitable
collection method is described.
The relationship between salivary and plasma Cortisol in term infants, children and adults has
been well described, but the physiology of the preterm and sick infants' salivary glands,
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Cortisol metabolism and Cortisol regulation may be different from the more mature infant and
adult. This difference may be so marked that salivary Cortisol is not a reliable indicator of
adrenocortical activity in such infants. To address this issue, the relationship between plasma
and salivary Cortisol in sick and preterm infants is explored (chapter 5).
Circadian rhythm is a feature of a healthy hypothalomo-adrenocortical system in the older
infant, child and adult. Term infants develop circadian rhythm in Cortisol levels at about
three months postnatal age and it has been suggested that preterm infants might develop
circadian rhythms at earlier post menstrual age than term infants. In order to time sampling
and interpret results, the presence of a classical circadian rhythm in Cortisol levels in infants
born <30 weeks GA was sought (chapter 6).
There is no gold standard for pain or distress measurement in sick or preterm infants. It was
therefore assumed that conditions or procedures that adults would find distressing would also
be perceived as distressing to the infants in the study. Infants were grouped by procedure and
condition into 'presumed distress' groups and their salivary Cortisol levels were compared to
each other and controls (chapter 8).
It is possible that sicker infants will be in more pain or require more distressing interventions
than less sick infants. Cortisol may mirror physiological illness severity rather than
psychological distress. An assessment of physiological illness severity (chapter 2.6) was
therefore made for each infant at birth and at the time of the saliva sampling. This was
analysed with the data from 'presumed distress' groups as a potential major confounding
factor in determining Cortisol levels. The results are discussed in light of the literature on the
relationship between illness severity and plasma Cortisol in sick and preterm infants (chapter
2.5 and chapter 8).
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2 Background and review of the literature
2.1 Pain and distress in new-born infants.
2.1.1 Definitions and terminology
'Pain' describes the 'conscious perception of nociception'. It is a subjective experience that
requires truthful self-report for confirmation of its presence. The International Association
for the Study of Pain (IASP) defines pain as an emotional experience based on actual or
potential tissue damage or described in terms of such damage (IASP, 1979). The definition
also states that pain is subjective and learned through experience in later life (Merskey H,
1991). These definitions are extremely difficult to apply to the preverbal newborn infant.
Firstly, newborn infants cannot give the gold standard of self-report, and secondly, they have
no previous experience upon which to base their pain perception. Problems with definition
also extend to philosophical considerations, specifically the nature and emergence of
'consciousness' in the infant.
In infants, it can only be inferred with a high degree of probability that pain is present. This
has led to attempts to define and detect 'apparent probable pain patterns' (Merskey H, 1996).
Most of these have been behavioural measures or patterns, and some have included the
physiological dimension (Table 2.1). Anand and Craig also addressed the above issues by
broadening the definition of pain to include the physiological and behavioural indicators of
pain perception. They put the case that pain occurs early in development and is an inherent
quality of life that serves as a signalling system for tissue damage (Anand and Craig, 1996).
Although most pain scores have been developed and used in the research setting, few have
included the neuroendocrine dimension, with variables such as adrenaline and Cortisol. None
have included Cortisol as part of the 'apparent probable pain pattern' of sustained or
continuing pain or distress. This is the basis of the present study.
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2.1.2 'Pain equivalent experience'
An identical pain experience to that perceived by an adult will not exist in a newborn infant
simply because the newborn infant's neurology and consciousness are different from those
of the adult. It seems logical to accept that a 'pain-equivalent experience' exists in the
following circumstances:





2. The occurrence of these patterns in circumstances that would evoke pain in the adult
i.e. we can infer pain from the circumstances.
3. Therapy that has the primary effect of alleviating pain returns the infant's behaviour
physiology, neuroendocrinology and metabolism to a more 'normal/ pain-free'
pattern.
2.1.3 'Distress'
In a medically sick patient, at some ill-defined point, the 'stress' of illness and therapy may
become 'distress'. The word, 'distress' used in a situation where pain is highly likely
describes associated fear, anxiety, and agitation. Results of a survey of Australian nurses in
1999 revealed that, except for diagnosis, there were no significant differences between the
cues carers used to assess pain and those to assess agitation (Ramelet, 1999). In older
children, distress correlates closely with pain, but may have other causes. It may be just as
important to assess and treat distress, as distress results in physiological instability, reduces
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coping mechanisms, and potentiates the perception and effects of pain (Franck et al., 2000).
In an older child or adult, pain usually results in distress. 'Pain', 'stress' and 'distress' all
describe states that ultimately probably result in suffering and which may have detrimental
effects on the well-being of a sick infant (Anand, 1997; Anand, 1998; Anand and Hickey,
1987; Anand, 1993). The boundaries between these states merge. 'Distress' is a term that
encompasses the negative sensations and effects of pain and stress in the sick newborn
infant. It is used for the purposes of discussion in this project.
2.1.4 Evidence for 'pain' in newborn infants
That both preterm and full-term infants have functioning nociceptive systems was first
drawn together in 1987 (Anand and Hickey, 1987).
2.1.5 Transmission of the pain signal
a) Neuroanatomy and Neurophysiology of pain 'pathways': adults and older children
1. Transduction and transmission from periphery to dorsal horn of spinal cord
a. A-delta fibres: large, myelinated, fast-conducting
b. C fibres: small, unmyelinated, slow-conducting
2. Amplification and attenuation of signal by activation of surrounding neurones in the
spinal chord and periphery, (eg. Stimulation of A-beta fibres that transmit non-
painful touch compete with nociceptive transmission in the dorsal horn of the spinal
cord, reducing pain intensity perception.)
Spinal cord transmitters:
i. Amplification: substance P, calcitonin gene related peptide,
neurokinin A
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ii. Attenuation: endogenous opioids, norepinephrine, serotonin, GABA
(Gamma amino buteric acid), Glycine
3. Second order neurones: spinothalamic, spinoreticular, spinomesoencephalic tracts.
4. Perception. No single 'pain centre' appears to exist. Perception, emotion, and
cognitive meaning occur throughout a 'neuromatrix' (Melzack, 1999).
5. Descending inhibition: by projections from supra-spinal areas eg. peri-aqueductal
grey, raphe nucleus, locus coeruleus. Mediators are: norepinephrine, serotonin,
endogenous opioids, GABA and acetyl choline (Stamford, 1995).
6. Central sensitisation: excitatory amino acids act on NMDA (N-methyl-D-aspartate)
receptors producing prolonged depolarisation and 'windup' (Dickenson, 1995).
2.1.6 Presence of 'pain apparatus' from early gestation
'Characteristics of the immature pain system in preterm neonates predisposes them to greater
clinical and behavioural sequelae from inadequately treated pain than older age groups'
(Anand, 2000a).
The peripheral and central structures required for pain perception are present from between
the first and second trimester (Fitzgerald and Anand, 1993). The newborn infant has as many
sensory receptors or more than are present in adults. Myelination of ascending pathways
(spinal cord, brainstem and thalamus) occurs by 30 weeks, and from thalamus to cortex
occurs by 37 weeks. Spinal cord synapses begin developing before 14 weeks and are
completed by 30 weeks gestation (Anand and Hickey, 1987). Intra-uterine fetal needling of
the abdomen for transfusion results in significant Cortisol and endorphin increases at 23-24
weeks (Giannakoulopoulos et al., 1994).
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The 'natural' painkiller, enkefalin, is known to be present in low concentrations in the CNS
at birth (Rolewicz et al., 1977).
Substance P appears at 12-16 weeks GA, with higher density than adults (Anand and Hickey,
1987).
A developing maturity of the fetal cerebral cortex has been demonstated by Anand and
Hickey (Anand and Hickey, 1987):
1. EEG patterns
2. Cortical evoked potentials elicited before 30 weeks gestation
3. Maximal metabolic rates measured by glucose utilisation in sensory areas of the
brain
4. Regular sleep-wake patterns present from 28 weeks gestation
5. Synaptic connection to afferent nerve axons established at 20-24 weeks
gestation.
2.1.7 Differences between infants and adults in pain transmission
1. Peripheral pain transmission appears to occur mainly along C fibres (non¬
myelinated), rather than A-delta (myelinated) fibres.
2. Spinal cord transmission is less precise.
3. Descending inhibitory neurotransmitters are lacking (Fitzgerald, 1991; Ramsay and
Lewis, 1995).
2.1.8 Developmental neurological processes
2.1.8.1 Programmed neuronal death
Early in development, there is expansion and surplus of neurones and synapses.
Neuronal circuits that are active proliferate, while the inactive will degenerate.
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2.1.8.2 Excitotoxicity
Excessive depolarisation of neurones results in neuronal dysfunction. Small,
inhibitory local circuit neurones are most vulnerable to this process. Thus,
excitotoxicity might result in hyperexcitability, and even greater sensitivity to pain
(Dubner and Ruda, 1992).
2.1.8.3 Hyperalgesia
Tissue injury results in release of inflammatory mediators, eg. potassium,
bradykinin, prostaglandins, cytokines, nerve growth factors, catecholamines,
substance P. These sensitise A-delta and C fibres and recruit 'silent nociceptors',
resulting in hyperalgesia (Dickenson, 1995; Siddall and Cousins, 1995).
2.1.8.4 Sensitisation
Infants have low thresholds to von Frey hair testing (Fitzgerald et al., 1988). They may
perceive pain more intensely because of their limited ability to modulate transmission
(Fitzgerald, 1995; Fitzgerald and Anand, 1993). This appears to result from larger receptive
fields, and prolonged responses to nociceptive stimuli (Fitzgerald, 1991). Specific noxious
stimuli may thus alter the sensitivity of the neonate's nervous system to other inputs, leaving
the infant hyperalgesic (Fitzgerald et al., 1988).
2.1.9 Short term effects of pain.
2.1.9.1 Post-operative stability
Untreated pain results in catabolism and hypermetabolism, resulting in hyperkalemia,
increased susceptibility to infection and slowed healing mechanisms. These consequences
may ultimately lead to poor outcome and morbidity. This was demonstated by Anand, who
found that adequate analgesia for both preterm and term infants undergoing surgery reduced
their stress responses and improved their clinical stability during and after operation (Anand
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et al., 1987; Anand et al., 1990.). Regional anaesthetic techniques have also reduced stress
response in children <4yrs undergoing surgery (Wolf et al., 1993).
2.1.9.2 IVH
Acute physiological changes caused by painful or stressful stimuli have been implicated as
potential factors in the causation or subsequent extension of early intraventricular
hemorrhage (IVH) or the ischemic changes leading to periventricular leukomalacia (PVL)
(Anand, 1998). However, a large subsequent multi-centre randomised trial has showed no
measurable difference in serious brain injury (IVH or PVL) or death in infants treated and
those not treated prophylactically with morphine infusions (NEOPAIN study, 2003,
currently under submission for publication). The data generated by such trials are complex,
and separating the influence that pain and analgesia have on outcome from other factors, as
well as the limitations of the currently used outcome measures, make interpretation
extremely difficult. There remains no consensus on the use of routine prophylactic infusions
of opiates for the treatment of pain and distress (out with the post-operative period) in
newborn infants.
2.1.9.3 Routine treatment procedures
In a randomised placebo-controlled trial of morphine vs saline, physiological, plasma beta-
endorphin, Cortisol, and glucose responses to routine treatment procedures were studied in 84
mechanically ventilated distressed neonates. The duration of hypoxemia and/or arterial blood
oxygen saturation during treatment procedures was significantly longer in the saline group
and distress was much higher. This study suggests that newborns with respiratory difficulties
often suffer from hypoxemia during essential treatment procedures and that the use of opioid
analgesia may reduce the duration of hypoxemia and the associated distress and, therefore,
may improve the long-term results of neonatal intensive care (Pokela, 1994a).
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2.1.9.4 Autonomic resetting and dampened behavioural pain response
Grunau et al described medium term effects on pain response of early exposure to invasive
events. The most significant factors associated with altered behavioural and autonomic pain
reactivity to blood taking at 32 weeks' postconceptional age were a greater number of
previous invasive procedures since birth, and gestational age at birth, both of which were
related to a dampened response. The results of this study suggested that the judicious use of
analgesia may ameliorate these effects on later pain reactivity, as exposure to morphine
seemed to normalise the response. In addition, higher mean heart rate at baseline was
associated with lower gestational age at birth and longer time on mechanical ventilation,
leading to the suggestion that early pain exposure at very low gestational age may alter the
autonomic substrate, resulting in infants who are in a perpetual state of stress (Grunau et al.,
2001).
Preterm infants who spend postmenstrual weeks 28 to 32 in neonatal intensive care are less
mature in their pain response than newborn premature infants of 32 weeks' postmenstrual
age. Greater frequency of invasive procedures is associated with behavioural immaturity,
whereas birth factors are associated with physiological immaturity (Johnston and Stevens,
1996).
2.1.10 Medium term effects of pain
The infant's stress response, measured by salivary Cortisol, and crying duration after
immunisation at 8 weeks was found to be related to mode of delivery, with the greatest
response shown in those bom by assisted delivery and the least response in those bom by
elective caesarean section (Taylor et al., 2000).
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2.1.11 Long term effects of pain
2.1.11.1 Pain responses
Boys who have undergone circumcision without analgesia show increased pain
reactivity (measured by behaviour scores and crying duration) to the pain of
immunisation at 4 and 6 months than those who have not been circumcised (Taddio
etal., 1995).
Subsequent research, however, has raised the question of whether differences in later
pain responses are significant and whether they represent a long-term effect of early
pain experience or a developmental lag in pain response (Oberlander et al., 2000).
These authors detected only subtle bio-behavioural differences in pain response to
heel-stick between pain and non-pain exposed infants at 4 months corrected age.
Children's judgements about pain at age 8-10 years have been compared between
two groups of children with different exposure to nociceptive procedures in the
neonatal period; children born with extremely low birthweight (< 1000 g, n = 47)
rated medical pain intensity significantly higher than psychosocial pain, unlike
children with full birthweight (>2500 g, n = 37). Increased pain affect ratings in
recreational and daily living settings were also related to duration of neonatal
intensive care unit stay for the extremely low birth weight children (Grunau et al.,
1998a).
2.1.11.2 Social, emotional, educational etc.
Exposure to repetitive neonatal pain may cause permanent or long-term changes
because of the developmental plasticity of the immature brain. Decreased pain
thresholds and altered gene expression in the somatosensory cortex were noted in
adult rats that were exposed to repetitive pain in the neonatal period when compared
to those that were not. The same group of rats, as adults, showed an increased
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preference for alcohol; increased latency in exploratory and defensive withdrawal
behaviour; and a prolonged chemosensory memory in a social discrimination test. It
has been hypothesised that the increased plasticity of the neonatal brain may allow
these and other changes in brain development to increase vulnerability to stress
disorders and anxiety-mediated adult behaviour (Anand et al., 1999; Anand, 2000b;
Anand and Scalzo, 2000).
In a prospective study of 36 children who were extremely low birthweight (<1000 g)
preterm infants and 36 matched full-term controls, differences were found in
somatisation at age 4.5 years. Only children who had been extremely premature, and
thereby experienced prolonged hospitalisation and repeated medical intervention in
infancy, had clinically high somatisation scores on the Personality Inventory for
Children (Grunau et al., 1994).
One hundred and thirty-seven very low birthweight children were compared at 12
years with a sample of matched peers. The very low birth weight children were
found to be more likely to have generalised anxiety, more symptoms of depression
and greater than 25% showed a psychiatric disorder of some type, especially ADHD,
compared to 9% of peers (Botting et al., 1997).
Early pain experience has also been implicated in educational, psychological,
behavioural and emotional difficulties in school aged children and adolescents
(Hack et al., 1994; Botting et al., 1997). It is, however, extremely difficult to assess
the affect ofpain specifically on these outcomes as there are multiple factors at play.
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2.1.12 The need for reliable measures of sustained pain.
Accurate pain assessment is essential for effective pain management. Evaluation of therapy
demands specific, sensitive, reliable measures of pain that can be used in both the research
and clinical setting.
2.1.12.1 Prevalence of neonatal pain
The improvement in the survival of premature infants, particularly those weighing
less than lOOOg at birth, means that there are now a significant number of infants,
many of whom require surgery, undergoing frequent and sometimes extensive
traumatic procedures in intensive care units (Barker and Rutter, 1995).
2.1.12.2 Why sustained pain is different from acute pain
A model has been suggested in which acute and sustained pain responses parallel the
infant's response to maternal separation. Thus, acute pain precipitates the
communication of distress, with energy expenditure on body movements, crying,
and changes in facial expression. There are 'fight or flight' type changes in
physiology. With the continuation of pain, decreased body movements,
expressionless face, and passivity predominate. Decreased heart rate, respiratory
variability and 02 consumption suggest a 'shut down' of energy expenditure
(Anand, 1997). While most pain assessment tools are designed to detect and quantify
pain due to acute, isolated, procedural pain, most of these infants are also exposed to
sustained and repeated painful or distressing events. The scores have often been
developed on groups of relatively well and relatively mature infants. There are few
measures to assess chronic pain in infants, and even fewer measures for infants who
are low birth weight, critically ill, or ventilated (Abu-Saad et cil., 1998; Larsson,
1999; Whitfield and Grunau, 2000).
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2.1.12.3 Lack of effective pain management in current clinical practice
A recent study in Sweden showed that few neonatal units attempted to assess pain.
Documentation of pain intensity was 'inadequate' and 'should be improved'
(Gradin, 2000).
A study of the factors influencing individuals making pain assessments in newborn
infants found that there was a tendency to judge early preterm infants to be
experiencing less pain than term infants even though they were subjected to the same
invasive procedure as the more mature infants (Hadjistavropoulos et al., 1997).
A survey in 1997 showed that postoperative pain in neonates in Canadian NICUs
appears to be consistently treated, primarily with opioid analgesics, but analgesia,
opioid or nonopioid, is rarely given for non-surgical invasive procedures (Johnston
et al., 1997a)
2.1.13 Neuroendocrinology and pain in the new-born
The work of Anand that 'set the ball rolling' in the field of neonatal pain research and
the neuroendocrinology associated with medical and surgical pain/stress/distress in the
newborn infant is discussed in detail in chapter 2.3.
2.1.14 Summary
Despite difficulties with nomenclature, there is ample evidence that newborn infants,
including those born prematurely, possess the means to experience pain and distress, exhibit
their effects, benefit from their management in certain situations, and may be adversely
affected if pain or distress are untreated. Sustained or continuing pain is a relevant and
common entity that is at presently poorly understood, assessed and treated.
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2.2 Assessment of pain and distress in the newborn
Table 2.1 (page 52) shows the currently available tools for pain or distress assessment in the
newborn.
2.2.1 Describing vs detecting pain
Most pain assessment tools are based on descriptions of behavioural and physiological pain
reactions to, for example, heel lancing for blood collection. Thus the majority of
observational and descriptive pain research is based on pain of known time, source, nature,
site, intensity and context. An ideal pain assessment tool would allow clinicians to be alerted
to the presence of pain in the 'real' situation, when the onset, nature, source, intensity, etc of
pain are not always obvious. Stevens et al also point out that while 'defining' the premature
infant's behavioural response to pain assists in clarifying the premature infant's reaction to a
tissue damaging stimulus, it does not always guarantee correct 'identification' of pain in
individual infants (Stevens et al., 1994).
The considerable overlap of magnitude of physiological and behavioural pain response with
invasiveness of procedure suggests that there is not a physiological or behavioural threshold
that clearly marks the presence of pain. Inconsistencies in physiological and behavioural
responses make reliance on a pain index difficult. It has been argued that as we have no
adequate pain assessment tool, the best approach may be one of prophylactic provision of
systematic pain management to reduce the acute and long-term impact of early procedural
pain (Porter et al., 1999).
2.2.2 Acute vs continuing pain
There is one tool that has been proposed for clinical assessment of prolonged pain in the
preterm infant; the EDIN score (table 2.1) (Debillon et al., 2001). While this looks
promising, it is not yet in widespread use and has not been extensively appraised. Several of
the parameters used such as 'quality of contact with nurses' and 'consolability' are by their
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nature subjective, so constituting a potential drawback. The scoring system thus presumes
substantial experience and skill on the part of the nurse. Also, no account has been taken of
gestational age, behavioural state, previous pain experience, or illness severity in the
development or application of the score. The authors did not discuss ventilation and the
resultant problems interpreting facial and other behavioural parameters. It is however in the
early stages of development.
As described in chapter 2.1, a model has been suggested in which acute and sustained pain
responses parallel the infant's response to maternal separation. Applying this model,
sustained pain would be associated with decreased body movements, expressionless face,
and passivity (Anand, 1997). The EDIN assessment tool is the only one described that takes
into consideration these potential manifestations of pain or distress.
2.2.3 Clinical application of assessment tools
The CRIES, NIPS, PIPP and NFCS have been shown to be reliable and effective in the
clinical situation. The other tools are research orientated or require further validation in the
clinical setting.
2.2.4 Facial expression
Facial expression has been one of the most studied indicators of pain, and is accepted as one
of the most consistent measures of acute pain for different age groups and situations (Grunau
et al., 1998b; Grunau et al., 1990; Grunau and Craig, 1987). The cluster of facial activity
associated with pain is similar in adults and newborns, both full-term and preterm, providing
construct validity for the proposition that the face 'encodes' painful distress in infants and
adults (Craig et al., 1994).
2.2.5 Body movements
The significance of body movements is still poorly understood (Craig et al., 1984). A recent
study found that some extensor movements seemed to be distress signals, whereas tremors,
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startles, and twitches were not related to discomfort during procedures likely to cause
distress. The point was made that these behaviours may differ qualitatively during longer
lasting tissue invasive events, indicating the need for more in-depth study of patterns of
motor activity in preterm infants over longer observation periods to evaluate potential signs
of stress and pain in babies undergoing intensive medical care (Grunau et al., 2000).
2.2.6 Cry
Some researchers have suggested that crying can be used to measure pain in newborn infants
only when the cause of crying is known (Runefors et al., 2000). This is due to the large
differences between individual cries from a single infant, as well as in the duration of each
cry, total crying time, and fundamental frequencies between infants (Fuller, 1991;Porter et
al., 1986).
One study examining the effect of various comfort measures during heel lance found that
there were proportionately fewer cries in two pacifier groups compared to prone positioning
and standard care groups, and cry duration was positively correlated with PIPP scores.
However, neither cry duration nor fundamental frequency reflected group differences.
Further research is needed to determine if cry is a sensitive and valid indicator of pain in
preterm infants (Johnston et al., 1999a).
Essentially, the problem with 'cry' is that crying is not unique to pain, and pain does not
always illicit cry.
2.2.7 Multidimensional assessment: relationship between behaviour and
physiology
It has been shown that various comfort giving measures can reduce the behavioural response
to pain (Gormally et al., 2001; Gray et al., 2000). However, the aims of pain treatment are to
decrease the distress precipitated by the pain, and not just the expression of that distress, and
to decrease the potentially detrimental effects of the physiological disturbance associated
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with the pain. It is therefore important to understand the extent to which pain behaviour
reflects pain-associated physiological disruption.
An interesting study has shown that while sucrose and rocking can decrease the behavioural
response to pain, heart rate was not decreased by these interventions compared to controls
(Johnston et al., 1997b).
In a study designed to examine the relationship between behavioural and physiological
indices after major surgery, neonates were found to have lower behaviour-physiology
correlations than the older infants, due to low pain scores. Pain characteristics significantly
predicted the COMFORT 'behaviour': heart rate and blood pressure correlations, suggesting
that the behaviour-physiology correlations increase with increasing pain. There were large
inter-individual differences in behaviour-physiology correlations after major surgery (van
Dijk et al., 2001).
2.2.8 Factors that affect pain response and measurement
1. Clinical context/ knowledge of assessors










2.2.8.1 Clinical context/ knowledge of assessors
One study examined the effect that clinical background had on pain scores allocated by
groups of staff to infants on videotape. The group that read clinical background data prior to
scoring gave higher mean levels of assessed pain per videotaped infant than did the group
who only viewed the videotapes (Fuller et al., 1999).
2.2.8.2 Non-pharmacological pain reducing measures
Sweet taste and holding interventions combined in complex ways when acting on different
behavioural and physiological response systems to modify expression of distress during heel
lance procedure (Gormally et al., 2001). Skin to skin contact has been shown to reduce
crying and grimacing by 82% and 65%, respectively, from control infant levels during the
heel lance procedure. Heart rate has also been reduced substantially by contact (Gray et al.,
2000).
2.2.8.3 Sex
While most studies of infant pain have found little difference between the sexes in
behavioural and physiological pain response, some subtle differences have been noted. Sex
differences were apparent in speed of response to heel lance, with boys showing shorter time
to cry and to display facial action (Grunau and Craig, 1987). Recently bom female neonates
of all gestational ages expressed more facial features of pain than male infants during heel
lance and 1 minute afterwards (Guinsburg et al., 2000).
2.2.8.4 Race
Some research has suggested the presence of differences in acute pain response between
Chinese and non-Chinese healthy infants by at least 2 months of age (Rosmus et al., 2000)
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2.2.8.5 Behavioural state
Awake-alert but inactive infants responded to heel lance with the most facial activity,
consistent with current views that infants in this state are most receptive to environmental
stimulation. Infants in quiet sleep showed the least facial reaction and the longest latency to
cry (Grunau and Craig, 1987). Stevens et al also found that facial action in response to heel
lance is lessened in infants in deep sleep states (Stevens et al., 1994).
Handling or immobilisation immediately prior to heel lance results in higher physiological
and behavioural changes (Sparshott M, 1996). Newborns who are younger, asleep, and have
undergone a painful event more recently have been shown to be less likely to demonstrate
behavioural and physiologic indicators of pain (Johnston et al., 1999b). Behavioural state
was found to influence the physiological responses in response to heel lance in premature
infants bom between 32 and 34 weeks gestational age (Stevens and Johnston, 1994).
2.2.8.6 Illness severity
Severity of illness modified the acoustic cry variables in premature infants bom between 32
and 34 weeks gestational age in response to heel lance (Stevens et al., 1994).
2.2.8.7 Gestational age
In a study of infants of gestational ages 26-31 weeks, Johnston et al found that in behavioural
and physiological variables, infants of lower gestational age responded less robustly than
infants of greater gestational age, but were still capable of responding to acute pain in both
behavioural and physiological dimensions (Johnston et al., 1995).
Porter reported similar findings that infants bom at <28 weeks' gestation exhibited increased
increments in response magnitude with increasing postnatal age (Porter et al., 1999).
Neonates with gestational ages as low as 25-27 weeks displayed physiological
responsiveness to heel lance, and the heart rate measure was found to vary with gestational
age (Craig et al., 1993). Dampened behavioural and autonomic pain reactivity at 32 weeks'
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postconceptional age was found in one study to be related to gestational age at birth (Grunau
et al., 2001).
Bodily activity in response to heel lance was found to be diminished in preterm neonates in
general, relative to full-term newborns (Craig et al., 1993). Premature infants also had
shorter, higher-pitched, harsher cries than others in response to acute pain (Johnston et al.,
1993; Johnston et al., 1996).
The same facial responses to acute pain were found to be present in preterm infants, but to a
lesser extent than term infants (Stevens et al., 1994). Craig et al found that facial activity in
response to heel lance increased with the gestational age (25-27 weeks) of the infant.
Specificity of the response to the heel lance was greatest on the facial activity measure
compared to physiological and body movement measures (Craig et al., 1993).
2.2.8.8 Postnatal age
In a study of infants born at 28 weeks gestation and followed for 8 weeks, the magnitude of
physiological (heart rate and oxygen saturations) and behavioural (three upper facial actions)
response to both real and sham heel lance increased with increasing postnatal age. Thus, the
older the infant, the more robust and recognisable the response (Johnston et al., 1996).
2.2.8.9 Pain experience
Newborns who have undergone a painful event recently are less likely to demonstrate
behavioural and physiologic indicators of pain (Johnston et al., 1999b). A significant factor
associated with dampened behavioural and autonomic pain reactivity at 32 weeks'
postconceptional age is a greater number of previous invasive procedures since birth
(Grunau et al., 2001).
2.2.8.10 Drugs
Exogenous steroid exposure has been found to make an independent contribution to both
behavioural and autonomic pain scores, in the direction of dampening the response.
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Conversely, previous exposure to morphine has been associated with "normalized"
increased rather than diminished) behavioural responses to pain (Grunau et al., 2001).
2.2.9 Causes of distress in the newborn infant receiving intensive care.
1. Ventilation;
Presence of endo-tracheal tube and fixation devices
Distress ofmandatory ventilator breathes ('Fighting the ventilator')
Restriction ofmovement and posture required for ventilation
2. Repeated acute invasive procedures;
Endotracheal suction
Arterial/ venous/capillary blood sampling,
Re-siting of drips
3. Repeated relatively non-invasive procedures;
Transcutaneous gas monitoring probe changes
Bolus naso- or oro-gastric feeds
Drug administration
Blood pressure measurement using inflatable cuffs
4. Minor surgical procedures;
Chest drain insertion
Supra-pubic aspiration of urine
Lumbar puncture
Ventricular tap





6. Complications of necessary procedures;
Cellulitis or abscess from infected drip site
Cutaneous probe burns
7. Post operative following major surgery;
Patent ductus arteriosus ligation
Laser therapy for retinopathy of prematurity




General care-giving procedures, e.g. nappy changes
9. Environmental stress
Excessive light, either daylight or from photo-therapy
Excessive and distressing sound from monitor alarms, banging bin lids and
doors




Respiratory insufficiency/ 'air hunger'
Nutritional i.e. hunger
2.2.10 Indices used in pain and distress assessment
1. Behaviour
(a) Cry: spectrographical analysis, latency, duration, and intensity may be used in
pain assessment, but these parameters are not applicable to intubated infants. The
mere presence of attempted crying despite an endo-tracheal tube indicates significant
distress.
(b) Facial expression alteration with brow bulge, eye squint or squeeze, naso-labial
furrowing, mouth or lip purse, tongue tautness and chin quiver.
(c) Tone exaggeration, with startling or twitching.
(d) Changes in tone, with general diffuse increase in activity, flexion of trunk and
extremities, fetal posturing or arching, leg extension, finger splays or fisting
(e) Sleep cycle disruption or sleep accompanied by twitches, sounds, jerks, irregular
respirations, whimpers or grimaces.
(f) Observed self regulatory or comforting behaviour such as lowered state, posture
changes, hand to mouth movements, sucking, grasping or an expression of 'focused
alertness.'
2. Physiological
(a) Heart rate increase
(b) Respiratory rate increases, but decrease in immediate acute pain
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(c) Mean arterial pressure increases
(d) P02 varies
(e) Oxygen saturation decreases
(1) Skin temp fluctuations
(f) Skin colour changes
(g) Galvanic skin response increases
(h) Palmer sweating (after 37 weeks gestation)
(i) Cerebral circulation swings
(j) Intracranial pressure increases
(k) Gastro-intestinal disturbance with hiccups, gagging, grunting or straining
3. Used in research
(a) Neuro-endocrine markers of stress responsive systems, e.g. Cortisol, adrenaline,
endorphins.
(b) Metabolic/ biochemical markers of catabolism, e.g. 3-methyl histidine.
(c) Computerised analysis of physiological data. e.g. vagal tone decreases.
2.2.11 Specific issues regarding the assessment of pain or distress in the ventilated
infant
(a) Cry not possible due to presence of endo-tracheal tube between vocal chords.
(b) Facial expression obscured by endo-tracheal tube and fixing device or phototherapy
goggles.
(c) Posture and movements altered by presence of leads, drips and splints.
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(d) Infants usually preterm so at different stages of maturity of response to pain.
(e) Much of the stress will be subacute and so habituation and withdrawal may occur
making behaviour even more difficult to interpret.
(f) Medical compromise alters or blunts response to distress.
(g) Arousal state modifies responses
(h) Environmental modulators e.g. light, noise, temperature, physical containment
(i) Preterm infants may actually be super-sensitive to pain because of their immature
neurology
(j) Agitation may be due to e.g. respiratory insufficiency or drug withdrawal
Figure 2-1 illustrates some of the above points. In particular, the endotracheal tube and
fixation device obscure the mouth, oedema prevents the eyes from opening and obscures
expression changes, and splints and the use of paralysing agents prevent body movements.
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2.3 Neuroendocrinology and Stress
2.3.1 Stress concepts
Hans Seyle considered 'stress' to be the non-specific response of the body to any demand,
and developed his whole theory of the 'general adaptation syndrome' in the early decades of
the 20th century on the basis of this definition. His original concept of stress was distinct
from that of distress, and he saw stress as a positive experience, as long as the demands
placed on the body could be accommodated and coped with. The popular recent concept of
stress involves a failure of adaptation. More recent research suggests that reactions to stress
are specific, with particular definable patterns and that once a stressor exceeds a certain
threshold, responses may become extreme and generalised. To various degrees, depending
on the nature of the stressor, physiological and psychological compensatory mechanisms,
which ultimately interact, are required to deal with the 'threat to homeostasis' that embodies
'stress'.
At the beginning of the 20"' century, W. B. Cannon first highlighted the role of the
sympathetic nervous system in mediating many of the more obvious physiological changes
characteristic of 'highly stressed' organisms. The classic 'fight or flight' response typified by
sympatho-adrenal activation is instigated by emotions such as fear, rage, and 'mental
challenge' (Baillieres, 1987; Stratakis and Chrousos, 1995).
Besides emotion, physical stress in the form of actual or threatened tissue damage is a potent
activator of the HPA axis and sympatho-adrenal system, as discussed in more detail below.
It is thought that the endogenous opioid system counteracts, buffers and modulates the HPA
and sympathoadrenal systems.
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Central to Seyle's theory of stress was the importance of the hypothalamo-pituitary-
adrenocortical system (see fig 2.2). More recent work has identified the peptide,
corticotrophin releasing hormone or factor (CRH), key to activation of the HPA axis and
produced by the hypothalamus, as a central modulating neurotransmitter (see figs 2.2 and
2.3). In adult psychobiological studies, activation of the adrenocortical system is associated
with negative emotions such as uncertainty, depression, withdrawal, and of being unable to
cope. Chronic activation of the HPA axis has been shown in anorexia nervosa, panic anxiety,
obsessive-compulsive disorder, chronic active alcoholism, excessive exercising,
malnutrition, and sexually abused girls. The function of this adrenal response to emotional
stimuli is thought to be feedback to the hippocampus, which is rich in corticosteroid






Figure 2-2 The Hypothalamo-Pituitary-Adrenal System
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2.3.2 Neurendocrine axis
The 'neuroendocrine axis' comprises the CNS (particularly the limbic system) and its
activation and modulation of the HPA, sympathetic nervous, endogenous opioid, and related
systems. Its role is to act 'in concert' with other physiological systems to maintain the




















• "Fight or flight" response
• Inhibition of growth reproductive and thyroid functions
• Metabolic responses
• Gastric stasis, increased colonic motility
• Immune responses
Figure 2-3: Representation of the 'stress system and neuro-endocrine axis' (Stratakis and Chrousos,
1995)
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The neuroendocrine responses to stress may be considered as adaptive responses on the
rising side of a bell-shaped curve. The fragmenting responses on the down side of the curve
may represent the breakdown of adaptation in the face of excessive demands, with negative
feedback loops disintegrating and damage supervening.
Table 2-2 : Stimuli that have been shown to activate the HPA axis























































Insulin tolerence tests are used widely in both adults and children to assess 'normal' Cortisol
response to hypoglycaemia. The fetus has been shown to mount a significant Cortisol
response to the acute stress of intrauterine transhepatic 'needling' (Giannakoulopoulos et al.,
1999).
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2.3.3 Effects of HPA activation
Metabolic: enhanced hepatic gluconeogenesis, decreased insulin secretion and peripheral
insulin resistance
Electrolyte and fluid balance, particularly sodium and fluid retention
Haemodynamic: increased vascular response to catecholamines
The HPAA also has complex interactions with the Hypothalamo-pituitary-gonadal, thyroid
and growth axes.
2.3.4 HPA response to inflammatory mediators
The inflammatory mediators, TNFa, IL-1 and IL-6 cause activation of the HPA axis alone
and in synergy with each other. IL-6 causes major elevations of ACTH and Cortisol, well
above levels achieved with maximally stimulatory doses of CRH. It appears to act through
stimulation of hypothalamic CRH and AVP secretion, and by direct effects at the pituitary
and adrenocortical levels. Glucocorticoids are thus thought to play a major role in the stress-
induced suppression of immune-inflammatory reaction (Stratakis and Chrousos, 1995).
Extremely high levels of Cortisol have been demonstrated in children with serious bacterial
infections (mean peak Cortisol concentration of 1060 nmol L"1 in bacterial meningitis)
(Nickels and Moore, 1989).
In a study of adults with septic shock, plasma Cortisol concentrations were increased
markedly up to 11,000 (median 1400) nmol L1. Patients with Gram-positive infections had
increased Cortisol levels compared with those who had Gram-negative infections (Schein et
al., 1990)
In a study of 13 neonates (GA 28-40 weeks) with septic shock, endotoxin was recovered
from eight infants. Serum Cortisol concentration from infants with endotoxemia (2500 +/-
1644 nmol L"1) was significantly higher than that from infants without endotoxemia (1097
+/- 659 nmol L"'). The highest single value noted was 6350 nmol L"1 (Togari et al., 1986).
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Herschenfeld & Geffner report a case of an 8 month old infant presenting with staphlococcus
aureus sepsis who had a single sample of plasma with a Cortisol value of 13,500 nmol L"1,
that failed to respond to ACTH and subsequently fell to normal after 5 days of antibiotics
(Herschenfeld and Geffner, 1996).
2.3.5 HPA response to acute procedural pain in the newborn infant
In the newborn infant, significant increases in Cortisol (plasma or saliva) have been
demonstrated following circumcision (Gunnar et al., 1981; Talbert et al., 1976; Williamson
and Evans, 1986), venepuncture (Fiselier et al., 1983; Mantagos et al., 1991) and heel lance
(Kurihara et al., 1996).
2.3.6 Neuroendocrine response to medical illness
Adult ITU patients have higher Cortisol and ACTH than controls, and there is a correlation
between Cortisol levels, severity of illness and mortality. There is also a lack of Cortisol
circadian rhythm in the patients with raised levels. The Cortisol response to ACTH in the
early stages of critical illness is frequently exaggerated, but when levels are extremely high,
the response may be blunted or absent. There is also a shift away from the synthesis of
androgens and mineralocorticoids towards glucocorticoids. There are significant parallels
between the HPA changes in major depression and critical illness. It has been postulated that
peripheral glucocorticoid receptor resistance may underlie exaggerated Cortisol levels. There
is down regulation of the pituitary-gonadal and pituitary-thyroid axes (Reincke et al., 1995).
Endocrine stress responses have been recorded in infants beyond the newborn period with
medical conditions such as bronchiolitis and gastroenteritis that are of a similar magnitude to
post operative stress (Deshpande et al., 1993). The literature on the Cortisol response to
medical illness in the newborn is described in appendix 1. Overall, there seem to be equal
numbers of studies both demonstrating, and failing to demonstrate, a significant rise in
Cortisol in response to medical illness.
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2.3.7 Neuroendocrine response to surgical stress
A great deal of neonatal pain research was inspired by a series of studies by Anand and co¬
workers in the late 1980s and early 1990s. He and colleagues described the metabolic and
endocrine response in preterm and term newborn infants undergoing surgery. The results
showed that newborn infants could mount a substantial endocrine and metabolic stress
response, the main features of which were hyperglycemia and hyperlactataemia associated
with the release of catecholamines and the inhibition of insulin secretion. They described
specific differences between preterm and term neonates (Anand et al., 1985b; Anand et al.,
1985a). The series of studies showed that the degree of anaesthesia/analgesia administered to
newborn infants undergoing surgery had a direct effect on stress hormone levels, markers of
metabolic stress and clinical outcome.
In a randomised controlled trial, preterm babies undergoing ligation of a patent ductus
arteriosus were given nitrous oxide and d-tubocurarine, with (n = 8) or without (n = 8)
fentanyl (an opioid analgesic drug) as part of the anaesthetic regimen. Major hormonal
responses to surgery (changes in levels of plasma adrenaline, noradrenaline, glucagon,
aldosterone, corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, insulin/glucagon
ratio, blood glucose, lactate, and pyruvate) were significantly greater in the non-fentanyl than
in the fentanyl group. The urinary 3-methylhistidine/creatinine ratios were also significantly
greater in the non-fentanyl group on the second and third postoperative days. Compared with
the fentanyl group, the non-fentanyl group had circulatory and metabolic complications
postoperatively. The findings indicate that preterm babies mount a substantial stress response
to surgery under anaesthesia with nitrous oxide and curare and that prevention of this
response by fentanyl administration is associated with an improved postoperative outcome
(Anand et al., 1987).
In a subsequent study, 36 neonates undergoing operations were randomised to two groups:
one group received anaesthesia with nitrous oxide and curare alone, and the other was given
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halothane in addition. Concentrations of metabolites and hormones were measured before
and at the end of operation and at 6, 12, and 24 hours after operation, and the values
compared between the two groups. Neonates given halothane anaesthesia showed decreased
hormonal responses to operation, with significant differences between the two groups in the
changes in adrenaline, noradrenaline, and Cortisol concentrations and the ratio of insulin to
glucagon. Changes in blood concentrations of glucose, total ketone bodies and non-esterified
fatty acids were also decreased in neonates receiving halothane anaesthesia. Neonates given
anaesthesia with unsupplemented nitrous oxide showed significantly greater increases in the
urinary ratio of 3-methylhistidine to creatinine concentration and their clinical condition was
also less stable during and after operation (Anand et al., 1988).
Neonates who received deep anesthesia with sufentanil (an opioid analgesic drug) had
significantly reduced responses of beta-endorphin, norepinephrine, epinephrine, glucagon,
aldosterone, Cortisol, and other steroid hormones; their insulin responses and ratios of insulin
to glucagon were greater during the operation. The neonates who received lighter anesthesia
(with halothane plus morphine) had more severe hyperglycemia and lactic acidemia during
surgery and higher lactate and acetoacetate concentrations postoperatively. The group that
received deep anesthesia had a decreased incidence of sepsis, metabolic acidosis, and
disseminated intravascular coagulation and fewer postoperative deaths (none of 30 given
sufentanil vs. 4 of 15 given halothane plus morphine (Anand and Hickey, 1992).
Graded hormonal and metabolic responses to differing degrees of surgical stress were then
described in neonates in minor (n = 71), moderate (n = 12), and severe (n = 11) stress groups.
Clinical outcome following operation was also significantly different between the three stress
groups (Anand and Aynsley-Green, 1988).
Further study revealed that neonatal stress responses to cardiac surgery are distinct from, and
more extreme than, those seen in adult cardiac surgical patients. In one study, neonates who
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died postoperatively tended to have higher stress responses than survivors (Anand et al.,
1990).
2.3.8 Effects of excessive neuroendocrine stress response
In the medical environment, humans may be subjected to procedures and interventions that
evoke extreme stress responses. As described in the series of studies above, the effects span
every system, and interventions that decrease stress responses and their parallel hormone
levels have been associated with improved clinical outcome.
In animal studies, high levels of glucocorticoids have been found to exacerbate hypoxic-
ischaemic neuronal damage with high levels associated with hipocampal damage (Sapolsky
et al., 1990; Sapolsky and Pulsinelli, 1985). Such observation has led to the proposal that in
adults, pharmacological interventions that diminish the adrenocortical stress response may
improve neurological outcome from stroke or cardiac arrest.
There is evidence that a severe and prolonged catabolic reaction to injury may be associated
with an increased morbidity and mortality in high-risk adult patients. This subject, along
with associated stress hormone responses, is reviewed by Anand (Anand, 1986).
2.3.9 Summary
The neuroendocrine system plays a vital role in preserving the wellbeing of the individual
organism should it be subjected to physical, physiological or psychological 'stress'. The
hypothalamo-pituitary-adrenal axis plays a pivotal role in this system. There is evidence of
the newborn infant's ability to mount an appropriate neuroendocrine response to
inflammatory processes, medical and surgical stress, and pain.
65
2.4 Measurement of salivary Cortisol
2.4.1 Physiological basis
In the late 1950s and 1960s, Katz & Shannon were the first to publish results of the
measurement of steroids in saliva (Katz and Shannon, 1969b; Katz and Shannon, 1969a).
This work was taken further and applied in the clinical setting by the 'Tenovus' group based
in Cardiff (Walker et al., 1978; Walker et al., 1990; Francis et al., 1987; Riad-Fahmy et al.,
1980; Riad-Fahmy et al., 1982; Riad-Fahmy et al., 1983; Walker et al., 1979) and Vining &
McGinley (Vining et al., 1983b; Vining et al., 1983a; Vining and McGinley, 1986;Vining
and McGinley, 1987) in the late 1970s and 1980s.
Salivary Cortisol measurement by radioimmunoassay is now a widely used tool in both the
clinical setting and in psychobiological studies of stress in infants, children and adults.
The easy stress-free, non-invasive nature of saliva collection makes it one of the most
accessible of body fluids and it is of value in studying normal human physiology as well as
pathology (Vining and McGinley, 1986; Vining and McGinley, 1987). Salivary Cortisol
concentration has been found to be directly proportional to the serum unbound Cortisol
concentration (Vining et al., 1983a) both in normal men and women and in women with
elevated cortisol-binding globulin (CBG). The correlation with plasma Cortisol is excellent in
dynamic tests of adrenal function (dexamethasone suppression and ACTH stimulation), in
normal subjects and patients with adrenal insufficiency, in tests of circadian variation and
randomly collected samples. The relationship between salivary and serum total Cortisol
concentration in adults is non-linear with a more rapid increase in salivary concentration
once the serum CBG is saturated. The rate of equilibrium of Cortisol between blood and
saliva is less than 5 minutes. Further work has suggested that unconjugated steroids enter
saliva by diffusing through the cells of the salivary glands and that their concentration in
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saliva does not depend on the rate of saliva production (Vining et al., 1983a). The above
data, combined with the accessibility of saliva, lead researchers to suggest that salivary
Cortisol may be a more appropriate measure for the clinical assessment of adrenocortical
function than serum Cortisol (Vining et al., 1983b).
Walker et al described a direct radioimmunoassay (RIA) for Cortisol in 10-microliter
volumes of parotid or whole saliva. Binding proteins were presumed to be absent from these
fluids, as demonstrated by the excellent correlation between results for samples assayed
directly and by a comparison procedure involving extraction with 1,2-dichloroethane.
Comparison of Cortisol concentrations in plasma, parotid saliva, and whole saliva in subjects
undergoing investigations for assessing adrenal function, including stimulation with ACTH
and suppression with dexamethasone, indicated that changes in plasma Cortisol concentration
were accurately and almost immediately reflected in saliva from either the parotid gland or
whole saliva. A marked circadian rhythm was also demonstrated for Cortisol in parotid-gland
saliva and whole saliva (Riad-Fahmy et al., 1983; Walker et al., 1978). The same team
demonstrated the successful clinical use of salivary hormone measurement in the monitoring
of patients with Congenital Adrenal Hyperplasia (Walker et al., 1979).
Riad-Fahmy et al also found, as above, that Cortisol concentration in saliva was independent
of salivary flow rate. As with Vining & McGinley, they described a disproportionate increase
in salivary Cortisol when plasma levels exceed 500nmol/l as this is the level at which CBG
binding sites are saturated in adults, resulting in rapidly increasing free Cortisol in the
circulation (Riad-Fahmy et al., 1982).
The measurement of free Cortisol in plasma requires sophisticated techniques such as
equilibrium dialysis or ultrafiltration. These techniques are not suitable for routine use. As
salivary Cortisol mirrors levels of free plasma Cortisol, but is technically more accessible, it
offers an attractive means of assessing the biologically relevant product of the HPA axis.
RIA of salivary Cortisol also circumvents the physiological, pathological, and
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pharmacological changes due to corticosteroid-binding globulin alterations (Laudat et al.,
1988).
Adult salivary Cortisol levels range from 1.3 to 27.6% of total plasma levels (Tunn et al.,
1992; Vining et al., 1983b). Vining and McGinlay found that salivary Cortisol was about
30% less than unbound serum Cortisol and presumed the deficit to be due to the partial
conversion of Cortisol to cortisone by 11-P-hydroxysteroid dehydrogenase type2 in the
salivary gland (Vining et al., 1983b). This is discussed further below.
The findings described above have subsequently been reproduced by various authors who
advocate the use of salivary Cortisol measurement in the clinical setting in infants, adults and
children (Bober et al., 1988; Castro et al., 2000; Hiramatsu, 1981; Lo et al., 1992; Peters et
al., 1982; Schmidt, 1998; Tunn et al., 1992; Umeda et al., 1981).
Shimada et al described the adaptation of a commercially available ELISA kit for the
measurement of salivary Cortisol, illustrating the accessibility of the tool to even non-
specialist laboratories. In 35 young children, circadian rhythms of salivary Cortisol levels
were determined by the commercially available kit with a minor modification (Al Ansari et
al., 1982; Shimada etal., 1995).
2.4.2 Cortisol and cortisone
In humans, cortisone derives mainly from the oxidation of the 11 -hydroxyl function of
Cortisol into 11-ketone by 11-P-hydroxysteroid dehydrogenase type 2. In the adult, this
enzyme is located in mineralocorticoid target tissues, principally kidney, colon, and parotid
gland, and most of the conversion takes place in the kidney. The conversion of cortisone to
Cortisol takes place mainly in the liver by the action of 11-p-hydroxysteroid dehydrogenase
type 1. In the adult, Cortisol exceeds cortisone 10 fold. 11-P-hydroxysteroid dehydrogenase
type 2 is present in many tissues in the fetus and in the placenta (Stewart et al., 1994; Stewart
et al., 1995). Thus in the fetus, cortisone is present in concentrations 3 times that of Cortisol
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(Nahoul et al., 1988). The factors that regulate the activity of the enzyme complexes and so
the balance between Cortisol and cortisone are not fully understood. It is known that in
infants born even as prematurely as 24 weeks, following birth, their enzyme activity switches
to a more adult type pattern, with Cortisol predominating in the plasma (Kojima et al., 1981;
Sippell et al., 1978a). Cortisokcortisone ratios take some time to become completely similar
to more mature infants and adults, implying relatively high 11-P-hydroxysteroid
dehydrogenase type 2 activity (Fujitaka et al., 1997).
Brooks and Brooks examined the possibility of conversion of Cortisol to cortisone in the
salivary gland in adults by measuring serum free and salivary Cortisol and cortisone. In
response to ACTH, cortisone in saliva increased to a level twice that of total plasma
cortisone which showed a minimal increase. Basally, salivary cortisone was higher than free
plasma cortisone. Salivary cortisone was more dependent on plasma Cortisol than plasma
cortisone. Salivary flow was also seen to increase the cortisokcortisone ratio ie salivary
cortisone is decreased by increased saliva flow (Brooks FS, 1984). These results suggest
significant 11-P-hydroxysteroid dehydrogenase type 2 activity in the adult salivary gland.
This inference is backed by the work of Meulenberg and Flofman (Meulenberg and Hofrnan,
1990). There appears to be no literature describing the activity of 11-P-hydroxysteroid
dehydrogenase type 2 in the preterm infant's salivary gland.
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2.4.3 Review: Salivary Cortisol data in infants.
Various studies have used salivary Cortisol for the assessment of adrenocortical function in
infants of several months and older. Fewer studies have focused on the newborn population.
The following is a review of the literature containing salivary Cortisol data from the first
month of life. All units have been converted to nmol L"1 for ease of comparison. This
conversion is based on lpg dL"1 of Cortisol being equivalent to 0.03625 nmol L"1. Summary
data are presented in table 2.3.
The literature falls into three main categories:
1. Establishment of normal data including emergence of circadian Cortisol rhythm.
2. Psychobiological studies of new-born infants' stress responses.
3. Studies relating to other clinical areas.
Publications including results from pre-term infants within these categories are:
(Antonini et al., 2000)
(Azcarate et al., 1997)
(Bettendorf et al., 1998)
(Calixto et al., 2002)
(Vaughn et al., 1996)
2.4.3.1 Normal data and circadian rhythm
In 1983, Price et al were among the first to publish salivary Cortisol data from young infants
(Price et al., 1983). Eight infants were followed at monthly intervals for six months, the
primary aim being to establish the age of onset of circadian rhythm in Cortisol secretion. This
was found to be on average the third month of life, and to follow the emergence of a night-
day sleep pattern. It was noted that levels were higher and more variable in the first month of
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life. There were however, no details of results from the very early neonatal period. Saliva
was collected by mucous extractor after stimulation of saliva flow with citric acid and
analysed by radioimmunoassay. Values ranged from 'not detectable' to 50 nmol L 1.
Francis et al studied salivary Cortisol in eight term, two-day-old infants in 1987. Samples
were taken 2 hourly over 24 hours. Two maxima were identified in each day. No correlation
was found between salivary Cortisol level and sleep or wake state, arousal or environment.
There was a good correlation between saliva and plasma levels of Cortisol in a separate group
of 36 normal term babies (r = 0.83). Daily variations were numerous and marked (21-42%).
It was suggested that Cortisol levels were more variable than in adults because saturation of
CBG binding sights impaired the ability of CBG to buffer oscillations of Cortisol in the
circulation. Collection was by De Lee suction catheter over five to ten minutes with citric
acid. Saliva values ranged from 2.5 to 57.4 nmol L"1 Plasma values ranged from 29-507
nmol L"1 (Francis et al., 1987).
In 1991 Spangler et al set out to establish basic information on salivary Cortisol levels and
examine the emergence of Cortisol circadian rhythm. He studied eleven newborn infants and
fourteen 3-7 month olds. Infants were assessed at 2-7 days of age then at 3, 5 and 7 months.
Four samples were taken within each 24-hour period. It was found that adult type circadian
rhythm was established by 3 months and was paralleled by a 24-hour sleep-wake cycle.
Feeds were associated with lower Cortisol levels in infants over three months of age but not
new-borns. In infants greater than 3 months of age, the more sleep in preceding hours, the
higher the Cortisol level, but again no such association was seen in newborns. An interesting
correlation between infant and maternal salivary Cortisol was found, including 10 bottle-fed
babies. There was high intra-subject stability in variations in Cortisol levels, and so the
authors recommend taking into account individual baseline as well as sleeping and feeding
behaviour when interpreting salivary Cortisol results. A range of 0.28-27.6 nmol L"1 was
found for newborns (Spangler, 1991).
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In 1995 Kiess et al sought to describe salivary Cortisol levels throughout childhood. Ten
infants less than one year old were studied. Samples were taken at 0800, 1300 and 1800 in
one day only. It was concluded that there was no evidence of circadian rhythm before nine
months of age. In some samples from young babies, evening samples were found to be as
many as five times higher than the morning samples. Overall, the highest values were found
in those aged cone year. Saliva was collected using a ball and pipette with no citric acid and
analysed by immunofluorescent assay. The range was found to be <2 to > 100 nmol L"1
(Kiess et al., 1995).
Santiago et al sought to establish the time of emergence of circadian rhythm in Cortisol
secretion in nine term infants in 1996. Samples were taken in the morning, afternoon and
evening at 2, 4, 8, 12, 16, 20 and 24 weeks. On average, circadian rhythm took 8 weeks to
emerge. Samples were collected by suction from the floor of the mouth using a tube and
syringe after stimulation with citric acid, and analysed by RIA. The range of values was 'not
detectable' to 28 nmol L"1 (Santiago et al., 1996).
In 1997, Antonini et al investigated the time of emergence of circadian rhythm in Cortisol
secretion in preterm infants and its relationship to sleep pattern. Nine preterm infants,
gestational age 31-34 weeks, were followed from birth to 24 weeks. Samples were collected
twice in the first month, then monthly in the morning and evening, and analysed by RIA.
Circadian rhythm for Cortisol secretion emerged at a median of 8 and a mean of 9.3 weeks.
No numerical results were given in this study (Antonini et al., 2000).
Klug et al established parallel normative data for salivary Cortisol and 17-
hydroxyprogesterone (17-OHP) levels in healthy neonates. Cortisol and 17-OHP levels in
saliva samples from 119 healthy neonates (55 girls, 64 boys) were measured using in-house
time-resolved fluorescent immunoassays. Saliva samples were obtained using a saliva
collecting tube three times a day on the first or second day of life. Gender and gestational age
did not influence salivary Cortisol and 17-OHP levels. No significant circadian rhythm of
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salivary hormone levels was detected in this group of newborns. However, body mass index,
arterial cord blood pH and time of saliva sampling significantly influenced salivary hormone
levels (Klug et al., 2000).
Calixto et al sought to determine correlations between plasma and salivary Cortisol levels in
preterm infants in the basal state and after ACTH stimulation during the first week of life.
Infants (n = 48) were given ACTH and saline solution; each injection was separated by 24
hours. Salivary and plasma Cortisol levels correlated at baseline (r = 0.67) and 1 hour after
ACTH stimulation (r = 0.40). ACTH increased Cortisol levels in plasma from a mean of 340
nmol L"1 to 827 nmol L"1 and in saliva from 27.6 nmol L"1 to 71 nmol L"1 (Calixto et al.,
2002).
2.4.3.2 Psychobiological studies of stress response
In 1993, Spangler examined physiological correlates of behavioural organisation in the
newborn. He measured salivary Cortisol and heart rate parameters in response to the Neonatal
Behavioral Assessment Scale (Brazelton, 1984). 42 babies were assessed between the first
and seventh days of life. A significant Cortisol increase was demonstrated in response to mild
aversive stimulation in a subgroup of babies. Infants with low orientation scores showed
larger increases in Cortisol than the highly orientated babies who showed little or no increase
in Cortisol in response to the assessment. Newborns with high orientation (or behavioural
organisation) had high basal Cortisol levels and vice versa. The range was 15.2-35.8 nmol L"1
(Spangler and Scheubeck, 1993).
Davis and Emory investigated sex differences in neonatal stress reactivity by examining
salivary Cortisol, heart rate parameters, and behaviour assessment. Eighteen males and
eighteen females were examined at about forty hours of age. In response to the mild stress of
the assessment, males had a greater Cortisol increase, and females greater heart rate and
behaviour changes. Saliva was collected by DeLee suction catheter with citric acid solution.
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Values for salivary Cortisol were (mean +/- SD) 29.5 +/- 32.8 nmol L"1 for females and 30.1
+/- 36.4 nmol L"1 for males at baseline (Davis and Emory, 1995a).
In 1992, Magnano et al studied the adrenocortical response to heel-stick and physical
examination of infants born to mothers who abused cocaine during pregnancy compared to
controls (Magnano et al., 1992). The cocaine-exposed infants were reported to have similar
basal salivary Cortisol levels to non-cocaine exposed controls, but a suppressed response to
both heel stick and examination. Saliva was collected be DeLee suction catheter without
citric acid and Cortisol measured by commercial RIA kit. Mean salivary Cortisol levels in
controls were 15.4 nmol L"1 basally, 23.7 nmol L"1 following examination and 35.9 nmol L"1
following heel stick.
In 1995, Gunnar et al described a relationship between response to heel-stick and emotional
temperament at 6 months. Salivary Cortisol (before and 19 minutes after heel-stick) was
measured along with heart rate parameters including vagal tone (calculated from heart rate
changes), and behavioural state. 50 normal term infants were assessed at varying postnatal
ages, averaging about 45 hours. Saliva was collected onto a cotton swab using citric acid and
analysed by commercial RIA kit. Although baseline vagal tone appeared to predict Cortisol
response to heel-stick, no overall relationship was seen between vagal tone and salivary
Cortisol levels. Values were mean (range) for baseline: 11.0 (1.7-24.8) nmol L"1 and for post
heel-stick: 34.2 (4.7-121.4) nmol L"1 (Gunnar et al., 1995).
In 1995, Gunnar reviewed the work of her own group and others in 'The human infant's
adrenocortical response to potentially stressful events.' In this review, she suggested an
approach to differentiating changes in Cortisol levels due to 'stress' as opposed to normal
'non-stressed' fluctuations. She suggested that the ratio of unbound to bound plasma Cortisol
is the key concept. Based on adult data, at a total plasma Cortisol concentration of 440 nmol
L"1 , the ratio of unbound to bound Cortisol suddenly increases, as all the plasma Cortisol
binding sites are saturated. (At this point, any increase in Cortisol is an increase in the
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biologically active and available free hormone.) The free plasma Cortisol in her work was
taken to be equivalent to salivary Cortisol. Therefore, salivary Cortisol values were used in
these calculations. Applying this to a meta-analysis of studies of Cortisol response to stimuli
ranging from undressing and weighing to heel-stick and circumcision, only circumcision and
high-risk delivery clearly and consistently evoked a response of this magnitude. This model
is helpful when considering the wide range of adreno-cortical responses, wide intra-subject
fluctuation and seemingly conflicting data regarding auxologous and behavioural
correlations. Disregarding levels of total equivelent plasma Cortisol below 440 nmol L"1 as
not indicating significant stress, Gunnar re-examined data from a number of studies and
found that differences in behaviour appeared or were most salient when Cortisol exceeded
this level. She also concluded that adrenocortical activity is not merely a reflection of
behavioural distress, and that both withdrawing into quiescent states and crying serve as
coping behaviour (Gunnar, 1989).
In 1996, Kulihara et al examined the adrenocortical and behavioural response to heel-stick,
this time with the aim of describing the stabilising effect of a recording of maternal heart
beat on those responses. As well as salivary Cortisol, salivary DHEA and DHEAS were
measured. 131 normal term infants were examined at 5 days of age, lhr after feeding.
Samples were taken 5-10 mins before, and 20 mins after, heel-stick. Ratio of 'before' to
'after' heel stick salivary Cortisol was used as an index of stress. Samples were analysed by
commercial RIA kit. Saliva was collected using a dental role in all, and citric acid in some
cases. Maternal heartbeat was found to reduce the grade of variation of Cortisol response to
stress, and Japanese drum at the same frequency did not. There was also some decrease in
behavioural response. A sub-group of five infants was studied over 24 hours and no evidence
of circadian rhythm was found. The range of values was 'not detectable' to 69.0 nmol L"1
(from graph) (Kurihara et al., 1996).
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2.4.3.3 Other clinical areas
In 1996 Vaughn et al used salivary Cortisol as a measure of effectiveness of opiate therapy in
post-operative infants. Continuous infusion was compared with intermittent boluses of
fentanyl. Saliva was collected for Cortisol measurement and a pain score carried out at 2, 8
and 24 hours after surgery. Thirty-six infants between 32 and 52 weeks gestation were
studied. There was a good correlation between pain score and salivary Cortisol level. Salivary
Cortisol and pain scores were found to be similar in the two study groups, but the infusion
was found to be clinically safer. Saliva was aspirated from the floor of the mouth after lemon
glycerine on a swab to stimulate flow and analysed by commercial RIA kit. The range of
results, all post operateively, was 50-265 nmol L"1 (Vaughn et al., 1996).
Azcarate et al published an abstract in 1997 with salivary Cortisol results from 18 babies on
the third day of life. The study was designed to establish normal daily variations and the
impact of gestational age and severity of disease. 3 hourly samples were collected over 24
hours using citric acid. Four healthy term, seven healthy pre-term and seven sick preterm
infants were studied. There was found to be great variability of salivary Cortisol levels, with
no fixed pattern. No difference was found between term and preterm infants and no
difference between sick and well infants. Values ranged from medians of 1.1 to 172.1 nmol
L"1 (Azcarate et al., 1997).
In 1989, Magnano et al raised the important issue of milk feeds possibly confounding
Cortisol measurement in salivary Cortisol studies in young infants. Cortisol was measured by
RIA in three common milk formulas and breast milk. Levels ranged from 45.2 to 2284.1
nmol L"1 on straight milk, and 0.6 to 4.1 nmol L"1 after de-fatting and extraction. Thus, many
interfering factors are present in milk as well as Cortisol itself, and this should be taken into
account in planning for and interpreting salivary Cortisol measurement in infants (Magnano
etal., 1989).
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Bettendorph et al set out to test the practicability of sequential Cortisol determinations in
saliva of low birth weight neonates and to evaluate the impact of systemic and inhaled
glucocorticoid therapy on saliva concentrations of Cortisol in preterm neonates with
bronchopulmonary dysplasia (BPD). Salivary Cortisol levels were measured by RIA in saliva
samples from 10 full-term and 10 preterm healthy neonates and from 20 preterm neonates
with BPD during systemic [dexamethasone (DEX); n = 10] or topical steroid therapy
[budesonide (BUD); n = 10]. Saliva samples of each individual were collected on 3
consecutive days at 06.00, 12.00, 18.00 and 24.00 h. Salivary Cortisol levels in preterm
neonates treated with steroids were significantly lower than those measured in healthy
preterm neonates (Bettendorf et al., 1998).
2.4.4 Summary
There exists a considerable amount of data about Cortisol in the saliva of adults, and its
relationship to plasma Cortisol. There is some comparable data from term infants but little
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2.5 Adrenocortical function in the perinatal period.
2.5.1 Ways of assessing adrenocortical function
1) Total plasma Cortisol measured by
a) Radioimmunoassay +/- extraction (Most studies in the past 20 years)
b) Immunofluorescent assay +/- extraction (Economou et al., 1993)
c) Chromatography + UV detection (Fujitaka et al., 1997)
d) Other, infrequently used methods eg MS or protein binding method of Murphy
(Anders et al., 1970)
2) Basal total Cortisol values
a) random (Hanna et al., 1997; Heckmann et al., 2000)
b) morning (Hanna et al., 1997) or timed (Economou et al., 1993)
c) as part of cross sectional study (Heckmann et al., 1999)
d) as part of longitudinal study (Doerr et al., 1988)
3) Response to ACTH
a) High dose ('traditional') (Watterberg and Scott, 1995)
b) low dose ('physiological') (Korte et al., 1996)
4) Response to CRH (Ng et al., 1997b)
5) Metyrapone test (Alkalay et al., 1990)
6) Cortisol production rates (Metzger et al., 1993)
7) Saliva sampling (Bettendorf et al., 1998)
8) Free plasma Cortisol (Rokicki et al., 1990)
9) With or without the measurement of
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a) Steroid precursors (Doerr et al., 1988)
b) Steroid metabolites (Fujitaka et al., 1997)
c) Cortisol binding globulin (Arnold et al., 1998)
2.5.2 Key questions addressed by the literature
1) Are Cortisol levels appropriate for clinical setting?
2) Are Cortisol levels related to long-term clinical outcomes?
3) Are low Cortisol levels related to specific disease processes such as hypotension or
chronic lung disease?
4) Are high levels of Cortisol harmful?
5) What processes underlie adrenocortical insufficiency?
a) Enzyme activity
b) Maturation ofHPA regulation
c) Target tissue responsiveness
6) Can endogenous levels of Cortisol be inappropriately high?
7) In light of all of the above, is exogenous steroid therapy likely to be
a) Required?
b) Effective?
c) How can the subgroup of patients most likely to benefit be identified?
8) How is adrenocortical function affected by
a) Antenatal steroid therapy?
b) Postnatal steroid therapy?
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2.5.3 Possible reasons for disparity of findings in literature regarding Cortisol levels
The literature on Cortisol levels in the newborn infant over the past decades is extensive and
is summarised in table 2-4. The results of the many studies often appear to be conflicting and
difficult to compare. Here is an overview of some of the reasons:
1. The analysis of samples is often from heterogeneous groups of infants, ie a mixture of
well and ill infants, of differing gestational ages, taken from infants on varying postnatal
days. Only more recent publications attempt to the define degree of illness severity, and
more recently still attempt to employ validated illness severity tools. Prior to this, many
studies talked simply of, for example, preterm compared to term neonates.
2. Extraction procedures with variable or low recovery, eg 65-85% in some publications.
This is an issue particularly in earlier studies, when highly specific RIA was not
available and so prior purification or extraction was necessary.
3. Non-specific RIA. RIA performed without prior purification could lead to overestimation
of Cortisol levels due to crossreactivity of the antibody with other steroids present in
plasma. Even relatively recent publications quote high cross-reactivities;
a. 20% cross reactivity with cortisone (Kari et al., 1996)
b. 18-30% cross reactivity with 11DOC, corticosterone, cortisone (Banks et al., 2001a)
c. cross reactivity with cortisone, as 'unknown' (Huysman et al., 2000)
d. no cross reactivities quoted (Hanna et al., 1997)
e. 65% cross reactivity with 21-deoxycortisol (Thomas et al., 1986)
f. 23 % cortisone and 28% 11-deoxycortisol cross reactivities (Hughes et al., 1987)
The point has been made that many Cortisol assays, including commercially available
kits, are validated for adult serum and may give misleading results when applied to
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neonatal serum (Murphy, 1980). Murphy suggests that many published Cortisol values
for newborn infants are too high owing to the use of methods insufficiently specific.
Thus, authors who use methods such as HPLC to purify samples prior to RIA claim that
their values are more representative than those using no extraction or purification
procedures (Nomura, 1997).
4. The existence of a subgroup of infants with very poor capacity to produce Cortisol, eg
enzyme immaturity, may bring down the means/ medians of those infants with
appropriate responses. Some authors have identified such 'outliers'. Korte found, along
with others, a 'bimodal' distribution of Cortisol results, with a subgroup of infants who,
for whatever reason, seemed to have low Cortisol levels. (Korte et al., 1996)
5. Use of opiates or sedation. It is known that opiates can significantly reduce mean plasma
Cortisol levels (Barker and Rutter, 1996; Vaughn et al., 1996). Many studies are carried
out on ventilated infants, but no such studies record whether sedation was used.
6. Small numbers of samples. Recent highly specific yet low-volume RIAs have allowed
'micro' sampling when previously, large volumes of plasma were required for each
measurement, making plasma sampling technically and ethically difficult.
7. Small numbers of subjects. With micro-sampling and salivary sampling, data are
increasingly available from larger numbers of infants. Table 2-4 illustrates that many
studies were carried out on relatively small groups of subjects. Larger numbers appear in
cross sectional and more recent studies.
8. Studies frequently compare 'mean Cortisol' values. The distribution of Cortisol values is
almost always highly skewed or bimodal, however, making this representation
misleading, where medians or log transformation might be more representative
(Heckmann et al., 1999; Watterberg et al., 2000).
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2.5.4 Perinatal adrenal development
2.5.4.1 The fetal adrenal gland
The developmental and functional biology of the primate fetal adrenal cortex have been
reviewed by Mesiano & Jaffe (Mesiano and Jaffe, 1997). The unique characteristics of the
primate (particularly human) fetal adrenal were first realized in the early 1900s. The unusual
architecture of the human fetal adrenal cortex, with its unique and disproportionately
enlarged fetal zone, its compact definitive zone, and its dramatic remodeling soon after birth
captured the interest of developmental anatomists. Many detailed anatomical studies
describing the morphology of the developing human fetal adrenal were reported between
1920 and 1960, and these morphological descriptions have not changed significantly.
Elegant experiments during the 1950s and 1960s demonstrated the central role of the primate
fetal adrenal cortex in establishing the oestrogenic milieu of pregnancy. Those findings were
among the first indications of the function and physiological role of the human fetal adrenal
cortex and led to the proposal of the concept of the 'feto-placental unit', in which DHEAS
produced by the fetal adrenal cortex is used by the placenta for oestrogen synthesis. Tissue
and cell culture techniques, together with improved steroid assays, revealed that the adrenal
fetal zone is the primary source of DE1EA-S. In recent years, the function of the human and
rhesus monkey fetal adrenal cortical zones has been reexamined by assessing the localization
and ontogeny of steroidogenic enzyme expression.
The primate fetal adrenal cortex is composed of two functionally distinct zones:
a. the fetal zone, which throughout gestation expresses little or no 3 PHSD activity
and so primarily produces DHEA-S, with a reduced ability to produce Cortisol. It
constitutes about 80% of the weight of the adrenal gland at birth (Johannisson,
1979; Seron-Ferre and Jaffe, 1981).
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b. the definitive zone, which is the likely site of glucocorticoid synthesis.
Although Cortisol emanating from the fetal adrenal cortex promotes fetal maturation in
primates, its role in the regulation of primate parturition, is unclear (Mesiano and Jaffe,
1997). The fetus contributes significantly to its circulating Cortisol levels and is a net
exporter of Cortisol (Beitins et al., 1973). Data from a study of maternal injection of radio¬
labeled Cortisol and cortisone, showed that in the region of 25% of fetal Cortisol and
approaching 90% of fetal cortisone originate from maternal Cortisol (Beitins et al., 1973).
Another study found that 85% of Cortisol is converted to cortisone in its passage through the
placenta (Campbell and Murphy, 1977). It is thought that this process exists to protect the
fetus from high levels of maternal Cortisol, allowing the fetus to develop its independent
HPA axis (Dancis et al., 1978).
2.5.4.2 Cortisol and cortisone
Two isoforms of 11 P-hydroxysteroid dehydrogenase (1 lp-HSD) catalyse the interconversion
of active Cortisol and inactive cortisone;
Cortisol is converted to Cortisone by lipHydroxysteroid type 2
Cortisone is converted to Cortisol by lipHydroxysteroid type 1
Using a reverse transcriptase, polymerase chain reaction approach, one study group failed to
detect 11 p-HSDl mRNA in any human mid-gestational fetal tissues. In contrast 11 P-HSD2
mRNA was present in fetal lung, adrenal, colon and kidney (Stewart et al., 1995).
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2.5.4.3 Postnatal changes in Cortisol and cortisone
In the fetal circulation, cortisone predominates over Cortisol with a F:E (cortisohcortisone)
ratio of about 0.3 (Nahoul et al., 1988). The F:E ratio rises to >1 in term infants after birth
(Kojima et al., 1981; Sippell et al., 1978a). Levels of cortisone have been found to remain
constant in preterm and term infants after birth, indicating that changes in F:E ratio are
largely due to changes in Cortisol concentration (Nomura, 1997). In a group of preterm
infants born at gestational ages 24-31 weeks, over the first 3 weeks of life, F:E ratios were
also found to be similar to those reported in term infants (Midgley et al., 2001). In a study
following infants beyond the first 2 months of life, a relatively high level of cortisone,
however, has been reported to remain in premature infants for a longer time than in control
term infants. (Fujitaka et al., 1997).
2.5.5 Cord blood Cortisol levels
A review of the data for fetal Cortisol levels at delivery suggested that the mode of delivery
and anaesthetic used influenced levels, as values obtained at elective caesarean section were
lower than those after vaginal delivery. Values in premature infants were only about half
those of mature infants and lower in those who went on to develop respiratory distress
syndrome (Murphy, 1983). In a study of cord serum at birth, there appeared to be a rise in the
fetal level of Cortisol with gestational age in late pregnancy, whether or not labour took
place. This rise was steepest immediately before the normal time of onset of labour and
could not be attributed to the stress associated with labour (Murphy, 1982).
2.5.6 Correlation with clinical state
Cortisol plays a pivotal role in the human body's adaptation to physiological and physical
stress. Absence of a functioning adrenal gland leads to certain death. Adrenal insufficiency in
older adults and children, when compounded by illness also results in severe illness or death.
The issue of adrenocortical function and its relationship to illness severity has been
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addressed in the adult ITU setting. Random serum Cortisol levels have been found to
correlate positively with illness severity. Those with the highest random serum Cortisol levels
(greater than 1655 nmol L"1) had the greatest mortality, while those with lower random
Cortisol levels that stimulated to more than 496 nmol L"1 after ACTH injection had improved
outcomes. The authors suggested that, if adrenocortical insufficiency is suspected, the ACTH
test should be performed since low random Cortisol levels (even to 138 nmol L"1) were not
diagnostic of adrenal insufficiency (Jurney et al., 1987).
There is no consensus about the relationship between illness severity and neonatal Cortisol
levels. The reasons may be several-fold, as outlined at the beginning of this chapter. A
detailed review of the literature regarding illness severity and plasma Cortisol levels can be
found in appendix 1. The studies are summarised in table 2-4. It can be seen that while
numerous studies have failed to demonstrate a positive relationship between illness-severity,
several recent, well designed studies with good subject numbers, have done so.
2.5.7 Variability/ pulsitility
In the healthy HPA system in the adult and child, pulsile Cortisol secretion is characteristic.
To define the pattern of plasma Cortisol levels in 14 ELBW infants, Jett et al obtained blood
specimens every 20 min over a 6-hour period at 4-6 days PNA. Although Cortisol levels in
the 14 infants ranged from 55-1503 nmol L"1 , each infant's Cortisol levels varied little from
his or her own mean Cortisol level. The SDs calculated from each infant's mean Cortisol level
were small. Cluster analysis was applied to the data: only 0.6 Cortisol pulses/infant 6-hour
period were detected. Each infant's plasma Cortisol levels were plotted against time, and
regression analysis was performed. The data indicated that ELBW infants showed little
variability in their plasma Cortisol levels over time. A single random measurement might
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therefore provide an adequate reflection of the adrenal status of the ELBW infant (Jett et al.,
1997). Single random plasma Cortisol levels are used in the adult ITU setting. Hanna et al
also suggests that a single random sample is adequate to indicate adrenal activity (Hanna et
al., 1997). This finding was also found by Doerr et al who described less variation in cortiosl
levels in preterm infants compared to term infants (Doerr et al., 1988).
Metzger found that overall production rates of Cortisol were similar in preterm and term
infants and comparable to those of adults and children, although the amplitude ofpulses were
lower, and length of pulses longer in the preterm infants. Several studies have found that
Cortisol appears to be secreted in pulses every 80 minutes in preterm infants (Arnold et al.,
1998; de Zegher et al., 1994; Metzger et al., 1993), and that pulsitility may be affected by
exposure to antenatal steroids (Arnold et al., 1998). Metzger found the half-life of Cortisol to
be 45-56 mins compared with 63 mins in children, and 73 mins in adults (Metzger et al.,
1993). In a study of infants > 34 weeks GA, on the first day of life, the median serum Cortisol
half-life was found to be 60 minutes (de Zegher et al., 1994).
2.5.8 Free levels and CBG
Rokicki et al estimated that 33% of total plasma Cortisol is free in well preterm infants in the
first week of life (Rokicki et al., 1990). (In healthy adults, free Cortisol is 10-15 % of total
plasma Cortisol). This has been applied by authors such as Hanna et al to estimate free
plasma Cortisol (Hanna et al., 1997). Doing this, however does not take account of the fact
that after saturation of plasma binding sites, the concentration of free Cortisol will rise
steeply, and so represent more than 33%. It also does not account for the variable levels of
CBG in preterm (and sick) infants.
In defining total plasma Cortisol levels that constitute adrenal insufficiency, the CBG should
be considered, as it is the free Cortisol that is biologically active, and involved in feedback
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inhibition. CBG levels have been found to be lower and more variable in preterm infants
than term and adult patients (Hanna et al., 1997).
CBG levels range from 13-26 mg ml"1 in preterm newborn infants (Arnold et al., 1998; Kari
et al., 1996; Metzger et al., 1993; Scott and Watterberg, 1995). Metzger calculated that the
infants had a maximum binding capacity of about 260 nmol L"1 (1:1 binding of Cortisol with
CBG, and MW of 52 000 for CBG (Metzger et al., 1993). Arnold found no difference in
levels between those treated and those not treated with antenatal steroids. Also, there was no
significant correlation between serum total Cortisol and CBG levels, or birth weight, and, in
agreement with other authors (Scott and Watterberg, 1995; Korte et al., 1996), low CBG
levels did not explain low serum total Cortisol levels found in some very sick infants (Hanna
et al., 1997). In another study, 61 infants had samples analysed for CBG. Levels were lower
(16 mg L"1) than for children and adults (19-45 mg L"1), and there was no significant change
with PNA (Scott and Watterberg, 1995). In contrast, Kari et al found that CBG levels did
correlate with PNA, but not GA (Kari et al., 1996). Hanna et al found that CBG levels are
lower in ELBW infants than in term infants (Hanna et al., 1997).
2.5.9 Significance of actual plasma Cortisol values: thresholds and definitions
2.5.9.1 Adults
In acutely ill adults, a single total plasma Cortisol value is thought to be sufficient to make a
(presumptive) diagnosis of adrenal insufficiency:
136-360 nmol L"1 = probable adrenal insufficiency
<136 nmol L"'= definite insufficiency
In well adults, adrenal insufficiency= morning Cortisol <83 nmol L"1 (Grinspoon and
Biller, 1994)
A peak of 550 nmol L"' after ACTH stimulation is the lower limit of normal to describe an
adequate adrenocortical response (Karlsson et al., 1999).
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2.5.9.2 Older children
In older well children, morning total plasma Cortisol levels of about 200 nmol L"1 would be
expected (Sippell et al., 1980)
2.5.9.3 Well preterm infants
Alkalay (Alkalay et al., 1996) performed a meta-analysis of several papers: (Kanarek et al.,
1988; Kuhn et al., 1991; Metzger et al., 1993; Thomas et al., 1986; Wiener et al., 1987) with
128 measures from 86 well preterm infants and concluded that: levels > 138 nmol L"1 were
normal in well preterm infants > 12 days old.
Korte et al gave a definition of 'low' as <414 nmol L"1 on day 2 (Korte et al., 1996).
Merz considered baseline morning total plasma Cortisol values of >138 nmol L"1 to be
normal.
<83 nmol L"1 was considered to be very abnormal. (Merz et al., 1998)
2.5.9.4 Stressed preterm infants
In the same review (Alkalay et al., 1996), the following conclusions were also drawn:
Following dexamethasone therapy, a random sample with Cortisol >360 nmol L"'
indicates adequate HPA activity.
Cortisol 360 nmol L"1 = 3x median Cortisol in well non-stressed preterm infants
Cortisol <360 nmol If' in a stressed infant warrants evaluation of adrenal function.
2.5.9.5 ACTH stimulated values in preterm infants
Hingre (Hingre et al., 1994) and Wilson (Wilson et al., 1988) suggest post ACTH
stimulation, Cortisol lower limit of normal should be 360 nmol L"1
Watterberg and Scott defined adequate response to ACTH as being a rise in Cortisol of >250
nmol If1 (Watterberg and Scott, 1995)
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2.5.10 Papers with total plasma Cortisol levels >1000 nmol L"1
A review of the range of plasma Cortisol levels in the literature reveals that many studies
have produced results with values > 1000 nmol L"'. This suggests that some infants are able
to mount a substantial Cortisol response to some aspect of their clinical condition. See table
2-4 and appendix 2.
2.5.11 Suggested adrenal insufficiency
Despite the papers above that describe some very high Cortisol values, there is a large body
of evidence to suggest that at least a subgroup of preterm and or sick newborn infants
demonstrate a degree of adrenocortical insufficiency. Some very preterm neonates admitted
to the neonatal intensive care unit show circulatory and respiratory problems that improve
after administration of steroids. It is unclear whether these symptoms could be caused by
adrenal insufficiency. A1 Saedi et al found low levels of Cortisol in well infants who did not
show signs of insufficiency (al Saedi et al., 1995) and Futitaka et al argues that low levels of
Cortisol may not indicate adrenal insufficiency but simply the rapid conversion of Cortisol to
cortisone (Fujitaka et al., 1997).
See appendix 3 and table 2-4 for details of the relevant studies.
2.5.12 Possible causes of adrenal insufficiency
During the first two weeks of life rat pups show a markedly reduced adrenocortical response
to stress, and this period of adrenocortical quiescence has been termed the 'stress non-
responsive period' (SNRP). The adaptive value of the SNRP can be understood in terms of
the effects of glucocorticoids on CNS development: excessively high or low corticoid levels
are associated with abnormal neurological and behavioural development. Researchers have
attempted to explain adrenocortical activity during this period in terms of the unique pattern
of glucocorticoid-receptor concentrations that exist in the brain and pituitary of the neonatal
rat. This pattern of receptor concentrations results in a negative-feedback condition at the
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level of the brain and pituitary that ensures the low, stable corticoid levels that appear to be
optimal for neuronal development in glucocorticoid-sensitive brain regions (Sapolsky and
Meaney, 1986)
2.5.12.1 Reduced enzyme activity
Several studies have produced data that suggest, in preterm and sick infants, maturation
dependant reduced activity of 11/3-hydroxylase (Hingre et al., 1994; Korte et al., 1996; Lee
et al., 1989; Nomura, 1997). Reduced activity of 3 /3-hydroxysteroid dehydrogenase may
also be present (Hingre et ah, 1994). The activity of 21-hydroxylase may be reduced; higher
baseline levels of 17-hydroxyprogesterone in preterm sick infants compared to term infants
have been found by several authors (al Saedi et ah, 1995; Huysman et ah, 2000; Murphy et
ah, 1983; Thomas et ah, 1986; Wallace et al., 1987; Murphy et ah, 1983).
Fujitaka, however, argues that the findings of raised steroid precursors may be due to
antibody cross reactivity in immuno-assays leading to falsely elevated levels (Fujitaka et ah,
1997). Using HPLC, he did not reproduce the findings. See appendix 4 for a more detailed
description of the above studies. Fig 2-4 shows the biochemical pathways discussed.
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1. 3/3 Hydroxysteroid dehydrogenase catalyses the conversion of 17a OH Pregnenolone
to 17 a OH Progesterone.
2. 21 hydroxylase catalyses the conversion of 17 a OH Progesterone to 11
deoxycortisol.
3. 11/3 hydroxylase catalyses the conversion of 11 deoxycortisol to Cortisol
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2.5.12.2 Immature HPA regulation
The data in this area are not extensive, and the proposed theories of the nature of a
hyporesponsive HPA axis conflicting:
Hanna et al found a 'normal Cortisol' response to CRH and ACTH (comparable to
older children) in infants born as early as 26 weeks GA (but used high doses of
stimulating hormones) and concluded that either the brain of the preterm sick infant
was unable to recognise stress, or the hypothalamus was unable to secrete CRH
(Hanna et al., 1993).
However, Ng et al showed a high ACTH response to CRH in ventilated preterm
infants, without an increase in Cortisol levels, suggesting that the pituitary is more
mature and functional than the adrenal in preterm infants (Ng et al., 1997c).
Korte et al suggest that there appears to be a dissociation of ACTH and Cortisol
levels in sick preterm infants, which is similar to data from adult ITU patients. They
suggest unresponsiveness at the adrenal level, with many very low birth weight
infants having Tow' Cortisol (<414 nmol L"1) concentrations and unable to mount a
Cortisol response to physiologic doses (0.1 pg kg"1) of 1-24ACTH (Korte et al.,
1996).
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2.5.13 Changes in Cortisol levels with postnatal age.
(see appendix 5)
In general, most studies do not separate sick from well infants in their analysis of trend in
Cortisol levels over time. Preterm infants are usually sickest during the first days or week or
two of life. This is likely to make these earlier values higher compared to later weeks. In both
well and sick infants, the response to the stress of labour and delivery is also evident in
Cortisol levels for the first 48 hours. Neonatal Cortisol values after 48 hours do not show any
correlation with the type of delivery (Kauppila et al., 1978).
In term infants, Cortisol is elevated in comparison with later infancy for about the first week
of life. There may be a "glucocorticoid dip" in Cortisol 2 and 12 h after birth (Kojima et al.,
1981; Sippell et al., 1978b).
In preterm infants, levels are highest in the first 2 days of life (Kraiem et al., 1985;
Watterberg et al., 2000). Several authors have described a decline in Cortisol levels over the
first 2 weeks of life and lower levels appear to be sustained for at least 2 weeks after this
(Metzger et al., 1993; Economou et al., 1993; Kanarek et al., 1988; Kauppila et al., 1978;
Noguchi and Reynolds, 1978; Banks et al., 2001a)
A fall in Cortisol levels over the first 2-3 months of life in preterm and term infants has been
described (Arnold et al., 1997; Noguchi and Reynolds, 1978; Rokicki et al., 1990; Wittekind
et al., 1993).
However, several studies have failed to demonstrated a relationship between postnatal age
and Cortisol levels after the first 48 hours in the first weeks of life, (Arnold et al., 1998;
Kraiem et al., 1985; Lee et al., 1989; Metzger et al., 1993; Ng et al., 1997b; Watterberg et
al., 2000; Bettendorf et al., 1998).
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2.5.14 Changes in Cortisol levels with gestational age
The relevant studies are described in more detail in appendix 6 and summarised in table 2-4.
When examining the effect of gestational age on Cortisol levels, it is logical to account for
the potential effect of illness stress on Cortisol levels. Preterm infants tend to be sicker than
more mature infants. In addressing this question or commenting on this relationship, as with
postnatal age, many authors do not differentiate between sick and well infants, or do not
perform appropriate analysis to account for degree of illness. Most studies have found
preterm infants to have either similar or higher Cortisol levels compared to term infants. As
outlined above, though, there may be a subgroup of preterm infants who manifest a degree of
adrenal insufficiency.
2.5.14.1 Umbilical cord blood levels; 'lower gestation: lower Cortisol'
Maturation dependent Cortisol concentrations without the effects of the stress of neonatal
illness may be indicated by umbilical cord blood levels. In one study, levels of Cortisol were
determined in umbilical cord serum in the presence and absence of labour at various
gestational ages. Without labour, by 35 to 36 weeks, the mean levels had risen from lower
levels in the second trimester and there was a further increase between 37.5 and 40 weeks.
Data obtained at vaginal delivery after the spontaneous onset of labour over the period of 26
to 40 weeks were more variable but showed a similar pattern. Thus, there appears to be a rise
in the fetal level of Cortisol with gestational age in late pregnancy, whether or not labour
takes place. This rise is steepest immediately before the normal time of onset of labour and
cannot be attributed to the stress associated with labour (Murphy, 1982). These findings have
been reproduced by Kari who also found that gestational age correlated with the umbilical
cord concentrations of total Cortisol and free Cortisol (Kari et al., 1996).
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2.5.15 Effect of antenatal steroids on neonatal Cortisol levels
The literature on the effect of antenatal steroid therapy on the HPA axis in the newborn
period is conflicting. Overall, if suppression occurs, it would seem that it is transient,
probably resolving within the first few days of life. See appendix 7 and table 2-4 for more
details of the relevant studies.
2.5.16 Effect of postnatal steroids on neonatal Cortisol levels
ACTH tests have been used widely to attempt to detect adrenal suppression following steroid
treatment. Many of the results are conflicting. This may be because the dose of ACTH differs
from study to study, as does the timing of stimulated samples. Korte et al suggest that many
studies using high doses ofACTH instead of low, physiological doses masks the presence of
functional HPA suppression (Korte et al., 1996). Karlsson found that the peak of plasma
after a low dose ACTH test occurred at 30-40 minutes, while after a standard dose test
occurred after 60-120 minutes (Karlsson et al., 1999).
Most investigators have demonstrated a degree of adrenal suppression in infants with CLD
treated with dexamethasone. Longer courses of dexamethasone tend to induce more
suppression than short (Alkalay et al., 1990; Bettendorf et al., 1998; Bourchier and Weston,
1997; Cronin et al., 1993; Kari et al., 1993; Kari et al., 1996; Merz et al., 1998; Ng et al.,
1989; Rizvi et al., 1992; Scott et al., 1997; Wilson et al., 1988).
Some authors, however have failed to demonstrate evidence of significant suppression
following dexamethasone therapy (Brundage et al., 1992; Cole et al., 1999; Giep et al.,
1996; Rennie et al., 1989; Wittekind et al., 1993).
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2.5.17 Effect of opiates on neonatal Cortisol levels
Baseline median plasma Cortisol in a group of ventilated infants requiring sedation, median
age 15 hours, was 364 nmol L"1. This fell significantly to median 162 nmol L"1, 6 hours after
opiate sedation was commenced (Barker and Rutter, 1996).
Vaughn et al found that Cortisol mirrored the analgesic effects of opiates in term infants in
the post-operative period (Vaughn PR, 1996b).
Pokela studied the effects of analgesia on plasma beta-endorphin, serum Cortisol and blood
glucose responses in 20 distressed, mechanically ventilated neonates during the first 3 days
of life. Cortisol values decreased significantly 2 h after analgesia. The results indicated that
the stress response in the distressed neonates with cardiorespiratory problems, as assessed by
Cortisol, beta-endorphin, and blood glucose, was attenuated by opioid medication (Pokela,
1993).
2.5.18 Association with growth retardation/foetal distress/stress
In a study of infants with GA < 30 weeks during the first two weeks of life, small for
gestational age infants (n = 8) had significantly higher Cortisol values (median 357 nmol If')
than AGA infants (median 199 nmol L"1) (Heckmann et al., 1999).
Increased Cortisol levels in cord plasma have been associated with spontaneous vaginal
delivery but not with chronic fetal distress (Ruth et al., 1993). In agreement, Gutai found no
difference in Cortisol levels between normal infants and infants exposed to antenatal stress in
the form of maternal febrile illness, drug addiction or diabetes (Gutai et al., 1972).
100
2.5.19 Birth Weight
Some authors have found a significant relationship between BW and Cortisol levels:.
In infants with BW <1500, 24-33 weeks, AGA, and ventilated, the Cortisol response
to ACTH increased with increasing birth weight (Watterberg and Scott, 1995).
In a study of 61 infants <32 wks and < 1500g, serum Cortisol concentrations on day
7 were significantly higher in infants of greater birth weight. (Ng et al., 1997c).
Birth weight was required as a cofactor in analysis of Cortisol levels measured on
days 5 and 7 in patients who developed CLD (Watterberg and Scott, 1995).
However, no significant relationship was found between salivary Cortisol levels and
gestational age, postnatal age or birth weight in either full-term or preterm infants, who were
well and stable (Bettendorf et al., 1998). Similarly, Arnold et al have found no association
between mean Cortisol over 6 hours and BW (Arnold et al., 1998).
2.5.20 Hypotension
Dexamethasone has been found to be effective in the management of severe arterial
hypotension in some (5/8) preterm infants not responding to standardized treatment,
implying that adrenal insufficiency may play a role in the aetiology of hypotension
(Gaissmaier and Pohlandt, 1999). Helbock et al have reported a group of hypotensive
preterm infants who had low Cortisol values prior to responding to treatment with
corticosteroids (Helbock et al., 1993). However, in a randomised trial of dopamine or
hydrocortisone for the treatment of hypotension in preterm infants, there was no difference in
pre-treatment basal Cortisol or ACTH stimulated Cortisol in those who did and those who did
not respond to steroids. Dopamine and hydrocortisone were equally effective for the
treatment of hypotension (Bourchier and Weston, 1997).
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2.5.21 Chronic Lung Disease
One study showed that at the end of the first week of life, infants who subsequently
developed BPD and prolonged oxygen dependence had significantly lower Cortisol secretion
in response to ACTH on days 5-7 than infants who recovered without BPD. The authors
speculated that these babies may have been unable to secrete adequate amounts of Cortisol in
a setting of increased stress, leaving them vulnerable to continuing lung injury (Watterberg
and Scott, 1995). These findings were backed by a subsequent study that showed infants with
lower Cortisol values in the first week of life had an increased incidence of PDA, increased
lung inflammation, and an increased incidence of chronic lung disease (Watterberg et al.,
2000). Infants who failed to resolve their lung disease had significantly lower Cortisols than
other infants (Scott and Watterberg, 1995).
Korte et al found an association between CLD outcome and low basal Cortisol (less than 414
nmol L"1), but no association between ACTH stimulated Cortisol and outcome, leading the
authors to suggest that actual and not potential Cortisol levels are significant in these infants
(Korte et al., 1996).
However, in a study of 314 infants GA 24-32 weeks, basal plasma Cortisol concentration
during the first week was found to be only a weak predictor for CLD (Banks et al., 2001a).
Mertz et al found that no association could be found between the synthesis of Cortisol and
ACTH at the end of the first week of life and the development of chronic lung disease (Merz
et al., 1998). Furthermore, neither Ballard et al, nor Doer et al found an association between
early Cortisol levels and the subsequent development of CLD (Ballard et al., 1980; Doerr et
al., 1988)
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2.5.22 Cortisol and pain in infants
In normal term infants <1 month old, after the painful stimulus of a venipuncture, plasma
Cortisol increased significantly, from a mean of 41 nmol L"1 to 458 nmol L"1 at 30-60
minutes. (Mantagos et al., 1991).
Total plasma Cortisol also increases significantly after circumcision in the newborn period:
1. mean 160 nmol L"1 to 406 nmol L"1, 20 minutes post circumcision (Talbert et al.,
1976)
2. mean 221 nmol L"1 to 662 nmol L"1 30 minutes post circumcision (Gunnar et al.,
1984)




While it can be difficult to draw firm conclusions from the literature about neonatal plasma
Cortisol levels and their associations, it seems reasonable to make the following
generalisations:
1. A sizable proportion of preterm and sick infants appear to be capable of
producing high or appropriate concentrations of plasma Cortisol but a sub¬
group may manifest Cortisol insufficiency.
2. Steroid metabolism and HPA axis regulation in the newborn, preterm or sick
infant differ from those of the more mature and less sick infant. The pulsile
nature of Cortisol production, CBG levels and free Cortisol levels are all
affected.
3. Gestational age, postnatal age and illness severity appear to interact in a
complex, currently poorly understood manner that leads to the general
findings of: sicker, younger, less mature infants tending to have higher
Cortisol levels than less sick, older, more mature infants.
4. Antenatal steroid exposure has short-term, rapidly resolving suppressive
effects on neonatal plasma Cortisol levels and postnatal steroid therapy has
mostly been found to induce a significant degree of HPA suppression that
may depend on the length of course of steroid treatment.
5. Newborn infants are capable ofmounting a Cortisol response to acute painful
stimuli and the use of opiates can reduce plasma Cortisol levels.
6. Despite the theoretical potential, there appears to be no strong relationship
between plasma Cortisol levels and hypotension or CLD.
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Future studies of Cortisol levels in sick and preterm newborn infants may be easier to
interpret ifmore rigourous attention is paid to the following areas:
1. Standardisation of subject characteristics, particularly in relation to GA and PNA
2. Use of validated illness severity scores.
3. Incorporation of 'no-handling' periods +/- distress scores




5. Multi-centre studies to increase study numbers
6. Standardisation of sample analysis technique +/- measurement of free or indicator of
free, biologically relevant Cortisol.
Appendices:
Appendix 1 Studies examining the relationship between Cortisol and degree of illness
Appendix 2 Studies with total plasma Cortisol values > 1000 nmolL"1
Appendix 3 Studies with low total plasma Cortisol levels in sick infants
Appendix 4 Studies suggesting reduced enzyme activity as cause for Cortisol insufficiency
Appendix 5 Changes in Cortisol levels with postnatal age
Appendix 6 Changes in Cortisol levels with gestational age
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2.6 Illness Severity Scoring
2.6.1 Background
For the purpose of the present study, an estimate of illness severity is required at the time of
saliva sampling. This is to assess the extent that the acute physiological stress of illness, as
opposed to psychological (//stress, might influence salivary Cortisol.
Table 2.5 gives an overview of illness severity scoring systems.
A widely accepted definition of severity of illness is the probability of mortality (Knaus et
al., 1981; Knaus et al., 1991). Thus most illness severity scores are validated by their ability
to predict mortality.
The assessment of illness severity in patients requiring intensive care was first addressed
scientifically with the development of the APACHE score for use in adult intensive care
units (ITU) (Knaus et al., 1981). This was a score designed for use on admission to ITU. The
score has since been refined and modified to the APACHE III version that is now in
widespread use (Knaus et al., 1991). This scoring system is used to compare the performance
of ITUs, in internal unit audit, as a component of ITU based research and of day-to-day
assessment and charting of an individual patient's progress.
A similar score for use in paediatric ITU was developed, taking account of differences in
physiology between adult and paediatric populations and different likely diagnoses, the PSI
(Yeh et al., 1984), later evolving into the PRISM score (Pollack et al., 1988). This score, like
the APACHE score was validated by its relationship to mortality rates. The PRISM III score
is now widely used in a similar way to the APACHE III score (Pollack et al., 1996;Pollack et
al., 1997).
122
Traditional risk factors for mortality in infants receiving intensive care are BW, GA, sex,
race and Apgar scores. These parameters alone, however, do not account for differences in
outcome between neonatal units. With the motivation to find a grading system that would
account for such differences, the SNAP score was developed (Richardson et al., 1993a)
(Table 2.6.2) (Richardson et al., 1993b). The elements of the score and the mechanism of
scoring were based on those of the APACHE and PSI scores. The physiological parameters
were adjusted so that they were appropriate for the newborn. The score was validated against
mortality, nursing intensity, length of hospital stay and physician estimate of illness severity.
SNAP scores have also been found to correlate with the risk of intraventricular haemorrhage
(GrayJE etal., 1992).
There is no 'diagnosis' element within the SNAP score. While diagnostic classifications have
\
been shown to be important in APACHE III and PRISM III scores, it has been argued by
Richardson (Richardson et al., 1993b) that the 'diagnostic homogeneity of the very low birth
weight population' make it unlikely that diagnosis will play an important role in a scoring
system.
The SNAP-II score was developed as a shorter, 6 element, easier to use version of the SNAP
score that had as good a correlation with mortality as the original SNAP score. It represents
illness severity. Richardson points out that the SNAP score remains a better tool than SNAP-
II for studies including mild and moderately ill infants (Richardson et al., 2001). This is
because the SNAP-II score retains only severely deranged physiology for scoring, thus
giving the strong association with mortality.
The SNAPPE-II score is the SNAP-II score plus weighted scores for birth weight, Apgar
score and being small for gestational age. Richardson states that neither the SNAP-II nor
SNAPPE-II are designed for sequential use but are admission scores.
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The 6 element CRIB score (Table 2.6.3) was designed to be carried out in the first 12 hours
after birth on infants with birth weight <1500gr or born <31 weeks gestation and related to
mortality (The International Neonatal Network, 1993). It combines 3 physiological
parameters with birth weight, gestational age and presence of congenital malformations.
Until recently it was only used as the SNAP score had been ie primarily as a tool in ITU
performance assessment. A recent study however has shown that the CRIB score is suitable
for extended application as an illness severity score rather like the APACHE and PRISM
scores. The CRIB score was examined for reliability and validity beyond the first 12 hours,
and responsiveness over 7 days (Fowlie et al., 1998). The authors examined the score and
'changes in score' over 7 days for relationships with mortality, prolonged 02
supplementation and disability at 2 years. CRIB scores taken throughout the first week
correlated with all three outcomes. The study showed that a change in CRIB score is
associated with mortality risk independent of CRIB score of the first 12 hours. It should,
however, be noted that the CRIB score is heavily weighted for GA and BW which remain
constant when the score is used longitudinally over time.
Various neonatal illness severity scores and their relationship to mortality have been
compared. The variables in the best model to predict mortality were birth weight, birth
weight squared, low 5-minute Apgar score, and the SNAP score. The SNAP score was more
accurate than the other scores, including CRIB and SNAP-PE-II in predicting mortality
(Pollack et al., 2000). However, other researchers have found CRIB scores to be more
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.2 SNAP score sheet
lpt 3pt 5pt 12 pre act
PH 5^.3 7.2-7.3 7.10-7.19 <7.10
pC02 >50 50-65 66-90 >90
p02 <65 50-65 30-50 <30
Fi02 • • •
p02/Fi02<3.5 2.5-3.5 0.3-2.49 <0.3
Max Fi02 >40 0.41-0.6(1) 0.61-0.9(3) 0.91-1.0(5) • • •
Min Fi02 >40 0.41-0.6(2) 0.61-0.9(3) 0.91-1.0(4) • • •
Bicarb hi >33 >33
Bicarb lo <15 11-15 <10
Min BE <-7.0 >-7.0 -7.01to-10. -10.1 to-15. • • •
MAP • • •
Fi02 • • •
p02 • • •
02 index >7 7-20 21-40 >40
RR>60 60-100 >100
BM hi>8.3 8.3-12.9 >12.9
BM lo<2.2 1.7-2.2 <1.7
BP max>66 66-80 81-100 >100
BP min<35 30-35 20-29 <20
HR max>180 180-200 201-250 >250
HR min<90 80-90 40-79 <40
Temp>35.6=n 35-35.6 33.3-35 <33.3
UOP<l/kg/hr 0.5-0.9 0.1-0.49 <0.1
Hct high>66 66-70 >70
Hct low<30 30-35 20-29 <20
Wcc<5 2.0-5.0 <2.0
neuts% • • •
acuual n<l 500-999 <500
Pl<100 30-100 0-29
SBR >2 kg>256 256.5-342 >342
SBR<2kg/kg 85.5-171 >171
Conj SBR>34 >34.2
Urea n=<14.3 14.3-28.6 >28.6
Na high>l50 150-160 161-180 >180
Na low<130 120-130 <120
K high>6.6 6.6-7.5 7.6-9.0 >9.0
K low<3.0 2.0-2.9 <2.0
Ca tot hi>3.0 >3.0
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Ca tot low<l .7 1.2-1.7 <1.2
Cr>106 106-217 217-354 >354
Seizure single multiple
Apnea responsive unresp complete
TOTAL
Table 2-6 SNAP score sheet
2.6.3 CRIB score sheet
lstl2hr Score Actual
BW >1350(0) 850-1350(1) 700-850(4) <700(7)
GA >24(0) <24(1)
Malform.? none(O) non-threat( 1) life threat(3)
Worst BE >7(0) -7.1-10.0(1) -10.1-15.0(2) >-15.0(3)
Min 02 <0.4(0) 0.41-0.6(2) 0.61-0.9(3) 0.91-1.0(4)
Max 02 sfi.4(0) 0.41-0.6(1) 0.61-0.9(3) 0.91-1.0(5)
TOTAL
Table 2-7 CRIB score sheet







2.6.5 SNAP Perinatal extension:
BW <750, 750-999
Small for gestational age
Apgar scor at 5 minutes <7
2.6.6 Oxygenation Index
01 = MAP(cmPTO) X fiQ2(%)
Pa02(mmHg)
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2.7 Circadian rhythm in Cortisol levels in infants.
2.7.1 Studies with data on Cortisol circadian rhythm
Circadian rhythm in Cortisol secretion is a characteristic feature of a healthy hypothalamo-
pituitary-adrenal (HPA) axis in the child and adult. Sick adults in ITU with high Cortisol
levels lack circadian rhythm (Reincke et al., 1995). In infants born at term, a Cortisol
circadian rhythm emerges at 8-12 weeks (literature summary Table 2-8).
There is one longitudinal study of circadian rhythm in Cortisol secretion in preterm infants
(Antonini et al., 2000). Saliva samples were collected from 9 infants born at 31-34 weeks
gestation and continued at home. Circadian rhythm developed at a mean of 9.3 weeks
(median 8) and was associated with the development of a circadian rhythm in sleep pattern.
There are no similar studies of infants born before 30 weeks gestation.
A cross-sectional study of plasma Cortisol levels in 20 infants born at 28-37 weeks gestation
made measurements at 0930 and 1530hrs on days 3-4 of life. In that study, afternoon values
were significantly lower than morning values for grouped data, but there was a wide
variation in Cortisol levels, and only 4 out of 20 infants had a 30-50% drop in plasma Cortisol
in the afternoon (Hindmarsh et al., 1989).
Several studies have suggested that circadian rhythms emerge in preterm infants as a result
of environmental cues and are therefore a function of post-natal age rather than maturation
dependent post-conceptional age (Antonini et al., 2000; McMillen et al., 1991; Mirmiran and
Kok, 1991; Shimada et al, 1993).
2.7.2 Potential for circadian rhythm in pre-term infants:
There is neurological and physiological evidence that preterm infants have the potential to
generate circadian rhythms (Rivkees, 1997). The human circadian timing system is believed
to arise from the hypothalamus, in particular the paired suprachiasmatic nuclei (SCN). When
mature, the SCN exhibit endogenous rhythms based loosely on a 24 hour cycle. Radio-
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labelled melatonin has been used to detect the presence of the human SCN at 18 weeks
gestation (Reppert et al., 1988). There is also evidence that in some species of mammals,
oscillation of the circadian clock begins in utero (Reppert, 1992). Transplanted cells from the
SCN of animal newborns have been shown to restore circadian rhythm to adults in whom it
had been abolished by ablation of the SCN (Hastings, 1998). Maturation of the SCN
continues after birth at term, with neuronal cell numbers increasing so that for some cell
types, numbers comparable to the adult are not reached until the age of one year (Swaab,
1995). The retinohypothalamic tract has been identified in a human newborn infant at 36
weeks gestation (Glotzbach et al., 1992). This is the neurological pathway by which photic
information is relayed from the retina to the hypothalamus in order to keep 24-hour
physiological cycles in tune with the environment (Moore, 1983; Morin, 1994). In human
fetuses, day-night rhythms can be detected for heart rate, respiratory rate, and
adrenosteroidogenesis (Rivkees and Reppert, 1992; Seron-Ferre et al., 1993; Seron-Ferre et
al., 2001). Because these rhythms are not detected after birth, however, it has been presumed
that they are maternally derived. It may be, though, that postnatal environmental and
physiological stimuli manifest as stress, overwhelming and distorting for a while a true
endogenous rhythm present in the fetus.
2.7.3 Relevance of circadian rhythm in preterm infants:
It has been suggested that preterm infants who are exposed to day-night cycles in the nursery
are less ill and grow faster than those without such a light cycle (Mann et al., 1986; Miller et
al., 1995). It is conceivable that providing a 'night' enables infants to cope with the 'stress'
of daytime stimuli, and that reduction in stress enhances physical and emotional well-being.
Thus in this population, circadian rhythm may be an important aspect of health and well-
being. Gotzbach et al proposed that an understanding of all aspects of the circadian system
may facilitate evaluation of factors that improve therapeutic responses, recovery and
outcome ofpreterm infants (Glotzbach et al., 1995).
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Knowledge of the presence and development of circadian rhythm in Cortisol secretion in
preterm infants may shed light on the degree of organisation and maturity of Cortisol
sectretion and the nature of its central control. It would also be useful for the interpretation of
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3.1 Use of different assays for plasma and saliva.
Two different radioimmunoassays were used to measure Cortisol in the course of this project;
one for saliva, and one for plasma. It would have been ideal to use the same antibody for the
correlation of plasma and salivary Cortisol, but for practical reasons, this was not done. The
reason for this was that it is generally expected that salivary Cortisol is present in low
concentrations. The salivary Cortisol assay that was used was developed specifically to be
accurate at these low concentrations. The encapsulated antibody that was key to this feature,
was highly specific, but was unfortunately of limited supply and not available for use in the
plasma assay, in its 'un-encapsulated' form. The plasma assay was developed and validated
for the small volumes of plasma encountered in neonatal research.
3.2 Salivary Cortisol assay
The assay used for the measurement of Cortisol in saliva was an in-house radioimmunoassay.
It was performed by the staff of the department of Child Life and Health, University of
Edinburgh, with the candidate observing. The assay was originally developed by Dr Mike
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Wallace, who is based at the Department of Biochemistry, Glasgow Royal Infirmary. Dr
Wallace kindly manufactured and donated the encapsulated antibody required for the assay.
The assay was carried out without prior extraction.
3.2.1 Principle of the function of the 'encapsulated' antibody:
Separation of antibody-bound, labelled Cortisol and non-antibody-bound, labelled Cortisol
was carried out by centrifugation without the need for a second antibody or other separation
technique (eg Charcoal). Antibody was encapsulated in a semipermeable nylon membrane
containing magnetic dextran (Wallace AM Wood DA, 1984). During centrifugation, the
capsules aggregate and accumulate in a 'pellet' at the bottom of the tube.
3.2.2 Reagents
Antiserum: The antibody was raised in sheep injected with the immunogen Cortisol 3 -
carboxymethyloxime ovalbumen and was purchased from Guildhay Ltd.
125l-Radioiigand: The radioligand used in the assay was cortisol-3-(0-carboxymethyl)
oximo-(2-[I125] iodohistamine) methanol:water (9:1) and was purchased from Amersham
Life Sciences.
Cortisol standards: Cortisol standards were prepared in assay buffer from hydrocortisone
purchased from Sigma. Standards were prepared to cover the range 0-32 nmol L"1 from an
initial ethanolic solution of hydrocortisone (0.5mM). The eight point standard curve included
the following concentrations: 32, 16, 8, 4, 2, 1, 0.25 and 0 nmol L"1.
Buffer, The buffer used throughout the assay was phosphate buffered saline with 0.5%
sodium azide and 1% gelatine. Phosphate buffered saline (0.05M) pH 7.4 was prepared from
concentrated stocks and combined according to Sorensen's recipe to obtain the correct pH.
Wash buffer was 0.9% sodium chloride (saline) containing 0.1% gelatine. The wash buffer
was prepared fresh for each assay. Sodium citrate, sodium dihydrogen orthophosphate,
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disodium hydrogen orthophosophate, sodium chloride and gelatine were purchased from
BDH.
3.2.3 Freeze-thawing
Four cycles of freeze-thaw for each sample were performed in order to reduce salivary
viscosity.
7.25 % difference was apparent after the freeze thaw cycles. This was based on results from
10 samples, each separated into two; one that was freeze-thawed 4 times, and one that was
not. This difference is equivalent to the intra-assay coefficient of variation (7.4%).
3.2.4 Assay procedure:
1) Polystyrene 'ependorph' tubes and precise automatic pipettes were used. All standards
and samples were assayed in duplicate.
2) The standards and quality controls were prepared in bulk beforehand and stored at
-20°C. For each assay, samples, quality controls and standards were thawed and the
assay was set up in Starstedt tubes (3ml, 10x75mm).
3) Stock antibody was diluted (1:200) with salivary assay buffer to give the optimum
antibody titre for the assay. 200 pi of the antibody solution was added to the tubes
containing the standards, quality controls and samples.
4) Label was freshly prepared for each assay; 10,000 cpm in 100 pi. It was added to all
tubes including the 'totals' and non-specific binding tubes that contained no antibody.
5) The assay tubes were mixed by vortex and allowed to incubate at room temperature for
90 minutes.
6) All assay tubes except the 'totals' were then washed with a wash buffer (saline + 0.1%
gelatine) three times. The antibody formed a pellet when centrifuged (3000G, 5 minutes
at 4°C) between each wash.
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7) After the third wash, the pellet was counted on the Packard Cobra autogamma counter.
The standard curve was plotted and the unknown sample concentrations were calculated
from the standard curve.
3.2.5 Assay performance
Sensitivity: The lower limit of detection for the assay was 0.25 nmol L"1
Precision: The intra-assay co-efficient of variation was 7.4% (Calculated from 10 x single
sample in one assay.)
The inter-assay coefficient of variation was 12.78 %, 14.07% and 7.37 % at 2 nmol L"1, 6
nmol L"1 and 16 nmol L"1. This figure was obtained from the low, medium and high quality
control (QC) included on each assay run.



















Table 3-1 Cross reactivities of antibody used in salivary Cortisol assay
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3.2.7 Standard curve for Salivary Cortisol RIA
.3 .5 2 4 10 30
Cortisol standard concentration (nmolL-1)
Figure 3-1 Standard curve for Salivary Cortisol RIA
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3.3 Plasma Cortisol assay
Plasma Cortisol was measured by an in house 'micro' radioimmunoassay, specifically
developed for the small volumes encountered in neonatal research. The assay measured total
Cortisol in 10 pi of plasma (i.e. 5 pi in duplicate). It was a competitive radioimmunoassay
with separation of bound and free label by second antibody precipitation. No prior extraction
was performed. The pH was kept less than 4 during the assay to ensure that Cortisol was
detached from Cortisol binding globulin, in order to be detected by the assay.
3.3.1 Reagents
Antisera: The primary antibody was provided by the Scottish Antibody Production Unit
(SAPU), now Diagnostics Scotland. It was raised in sheep immunised with cortisol-3-0
(carboxymethyl) oxime-bovine albumin conjugate.
Double antibody precipitation utilised donkey anti-sheep sera and non-immune sheep serum,
obtained from SAPU.
125l-Radioligand The radioligand used in the assay was cortisol-3-(0-carboxymethyl)
oximo-(2-[I123] iodohistamine) methanol:water (9:1) and was purchased from Amersham
Life Sciences.
Cortisol Standards: Cortisol standards were prepared in assay buffer from hydrocortisone
purchased from Sigma. Standards were prepared to cover the range 0-500 nmolL"1 from an
initial ethanolic solution of Cortisol (O.lmM). The thirteen point standard curve included the
following concentrations: 500, 200, 100, 50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1 and 0 nmol L"1
Buffer: The buffer used throughout the assay was citrate phosphate buffer with 0.1%
gelatine, 0.1M, pH 4.00. Sodium citrate, sodium dihydrogen orthophosphate, disodium
hydrogen orthophosophate, sodium chloride and gelatine were purchased from BDH.
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3.3.2 Assay procedure
1. Blood samples were collected into lithium heparin tubes, centrifuged and the plasma
pipetted into eppendorf tubes. The samples were stored at -20°C until analysis.
2. Polystyrene 'ependorph' tubes and precise automatic pipettes were used. All
standards and samples were assayed in duplicate.
3. The standards and quality controls were prepared in bulk beforehand and stored at
-20°C and were diluted (1:60) prior to use. For each assay, they and the samples
were thawed and added to Starstedt tubes (3ml, 10x75mm).
4. The primary antibody was diluted 1:4000 in assay buffer from a 1:100 stock
antibody to give a final dilution of 1:32 000 in the assay. Antibody (50pl) was added
to all tubes except totals, and NSBs.
5. Label was freshly prepared for each assay; 10,000 cpm in 50 pi. The label was added
to all tubes including the totals and NSB tubes.
6. The assay tubes were mixed by vortex and allowed to incubate at room temperature
for 4 hours.
7. Before the incubation was complete, the second antibody precipitate was prepared.
Donkey anti-sheep/goat sera (DAGS) in a final dilution 1:28, non-immune sheep
sera (NISS) in a final dilution 1:400 were combined.
8. At the end of the incubation lOOpl of this DAGS/NISS was added to all tubes except
the totals. The assay tubes were vortexed and incubated at 4°C for 18 hours.
9. The bound fraction was obtained after centrifugation at 4°C for 45 minutes at
3000G.
10. The supernatant was aspirated.
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11. The precipitate was counted on the Packard Cobra autogamma counter. The
standard curve was plotted and the unknown sample concentrations were calculated
from the standard curve.
3.3.3 Assay performance
Sensitivity: The minimum detection of the assay was 29 nmol L 1
Precision
The intra-assay coefficient of variation was 8.42 % this figure was obtained from a
sample run ten times in one assay.
The inter-assay coefficient of variation for the assay was 11.2 %, 12.9% and 11.2 %
at 77, 280 and 765 nmol L"1 This figure was obtained from the low, medium and
high quality control (QC) included on each assay run.
3.3.4 Standard curve for Plasma Cortisol assay
Cortisol standard concentration (nmolL-1)
Figure 3-2 Standard curve for plasma Cortisol assay
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Table 3-2 Cross reactivities of antibody used in plasma Cortisol assay
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3.4 HPLC
3.4.1 Reagents and Equipment
The HPLC equipment comprised a Waters Quarternary pump, Waters 600E System
controller, linked to a computer running Millenium v2.0 software and a Waters 486 tunable
Absorbance detector. The column was a C-18 pbondapak column and the mobile phase was
methanol:water (1:1). Fraction collection was carried out manually, and the pumps were
calibrated to deliver 1.0 ml min"1. Ethyl acetate, methanol and sodium hydroxide were
obtained from BDH.
3.4.2 Sample Extraction
A small volume of saliva was diluted in distilled water so that the final working volume was
500 pi. The diluted sample was added to glass conical extraction tubes (Quickfit). The
steroids were extracted into 2 mis of ethyl acetate. Extraction was achieved by vigorous
inversion. The aqueous layer was separated by centrifugation at 2000 G for 10 minutes. The
extract was washed firstly with 500 pi 0.1M sodium hydroxide and secondly with 500 pi
distilled water. A known volume (750 pi) of the ethyl acetate extract was transferred to two
glass tubes and evaporated to dryness under nitrogen. The extract was then re-suspended in
100 pi of the mobile phase (methanol:water (1:1)).
3.4.3 HPLC purification
The HPLC column was prepared by equilibrating with the methanol:water (1:1) running
through the system at least an hour before the first run. The first run was always to check the
separation of Cortisol and cortisone. A cortisokcortisone mixture was injected on to the
column. The absorbance was monitored and the retention time for both Cortisol and cortisone
was noted. Forty 'one minute' fractions were collected for each sample injection.
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The sample was injected on to the column (80 p.1) and the timer started, 'one minute'
fractions were collected. At the end of collection, another injection of cortisohcortisone was
prepared and loaded on to the column to verify that there was no drift in the retention times
of both Cortisol and cortisone.
The fractions were then back extracted into ethyl acetate. The methanol was evaporated off
under a stream of nitrogen and the remaining aqueous volume (50%) was extracted with into
5 mis of ethyl acetate. A known volume of the ethyl acetate extract (1ml) was then
evaporated to dryness under a stream ofnitrogen and resuspended in assay buffer.
The fractions were then assayed for Cortisol using the plasma Cortisol assay.
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Figure 3-3 Chromatogram from saliva sample showing peak of Cortisol
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3.5 Mass Spectrometry
This is a highly accurate means of identifying the nature and abundance of a substance at a
molecular level. Mass spectrometry was kindly carried out by associates at the Western
General Hospital, Edinburgh.
3.5.1 Principle
The sample is first injected into a gas chromatograph column. This then directs the vaporised
sample to the ionisation chamber. Molecules are converted by the impact of the high-energy
electrons into positive ions. An excess of energy remains in the molecular ion causing
rupture of one or more bonds. Depending on the amount of energy, some molecular ions may
dissociate into fragment ions. A 'repeller' voltage followed by accelerating potential are then
applied to the ions so that they may be injected next into the mass analyser. This separates
ions according to their mass: charge ratio. This is done by a quadripole, consisting of 4
parallel conducting rods. Depending on the degree of rod separation and amplitude and
frequency of the fields, the ions will follow a predictable trajectory between the rods prior to
exiting the quadripole mass filter. The ions then hit the detector. The detector consists of
resolving slit, plate collector and amplifier (electron multiplyer).
The equipment is set to scan for set mass ranges. The mass spectrum of a compound contains
the masses of the ion fragments and the relative abundance of these ions compared to the
parent ion. These occur in the same relative abundance for each ion. A 'Total ion
Chromatogram' is reconstructed from the data. It looks similar to a gas chromatogram, and




Advice for all statistical analysis was obtained from a medical statistician. Data was stored
and all analysis carried out using the statistics software package, 'SPSS' version 10.0. All
data handling, analysis and presentation were carried out by the candidate. This was with the
exception of the 'mixed model' analysis and multiple subject characteristic correlations
(chapter 7), which were carried out by the previously mentioned statistician.
3.6.2 Ethical approval
Ethical approval for all parts of the study was obtained from the Lothian Region Ethics
Committee.
3.6.3 Informed parental consent
Consent for all subjects taking part in the study was obtained from at least one of his or her
parents following provision of a verbal explanation and a written information sheet. All
consent was written, and witnessed by a member of the neonatal unit staff.
3.6.4 Setting
All subjects were in-patients at the Simpson Memorial Maternity Pavilion, Royal Infirmary
of Edinburgh. All except the term controls described in chapter 7 were being cared for on the
neonatal unit. The neonatal unit is a tertiary referral centre with 12 intensive care cots, 8
'second level' nursery cots, and 24 'special care' cots. There are 6 500 deliveries per annum
in the hospital, and 477 infants cared for each year in the neonatal unit.
3.6.5 Gestational age
GA was based on first trimester ultrasound scan data from the maternal obstetric notes
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4 Effect of saliva collection method on Cortisol radioimmunoassay
and subsequent selection of collection method for use in new-born
infants.
4.1 OVERVIEW
Background: Various collection methods can make saliva collection from infants
technically easy but may affect Cortisol radioimmunoassay performance.
Objective: To assess 3 potential saliva collection methods for the neonatal population.
Method: Cortisol was measured in saliva collected from 16 adults using;
cotton swabs, polyester swabs and citric acid
and compared to saliva dribbled directly into a pot (plain saliva).
In infants, aspiration of saliva was piloted using citric acid as a sialogogue.
Results: Cortisol in saliva collected using cotton and polyester swabs was significantly
higher than Cortisol measured in plain saliva (p<0.01). Cortisol in saliva collected using citric
acid was not significantly different from plain saliva (p=0.997). Infants appeared to find the
use of citric acid distressing.
Conclusions:
1. The use of cotton or polyester swabs for collection of saliva from infants for Cortisol
measurement using the radioimmunoassay in this study would be inappropriate.
2. Citric acid stimulation was not adopted in the standard method because of associated
infants' distress.
3. The method selected as most appropriate was gentle suction of 'plain' saliva from an
infant's mouth using wall mounted electrical suction. The saliva accumulated in the
suction trap and was drained into a sample tube.
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4.2 BACKGROUND
As described in chapter 2.5, the results from different studies of plasma Cortisol in preterm
and sick infants are often conflicting, and the number of infants studied is relatively small.
The requirement for repeated blood sampling has been a major factor influencing the
quantity, quality and conclusiveness of Cortisol data from these infants. Salivary Cortisol
measurement is now technically accessible to non-specialist laboratories (A1 Ansari et al.,
1982) and is widely accepted as a reliable indicator of adrenocortical activity in children and
adults (Bober et al., 1988; Laudat et al., 1988; Riad-Fahmy et al., 1982; Vining et al.,
1983b) There are many studies examining salivary Cortisol in term and well infants (Klug et
al., 1997; Francis et al., 1987; Spangler and Scheubeck, 1993; Davis and Emory, 1995a;
Lewis and Thomas, 1990; Gunnar et al., 1995; Kurihara et al., 1996) but relatively few with
data from sick and preterm infants (Antonini et al., 2000; Bettendorf et al., 1998; Azcarate et
al., 1997; Calixto et al., 2000; Vaughn PR, 1996a). Salivary Cortisol has the potential to
expand the knowledge of adrenocortical activity in sick and preterm infants. Repeated, non¬
invasive, low volume saliva samples would allow more infants to be studied more frequently
over longer periods of time than opportunistic or infrequent blood sampling regimes.
In the neonatal population, direct aspiration of saliva can be difficult. Infants in the first few
days of life are relatively water depleted, and so their mouths may be too dry to allow
suction of collections of saliva directly. Direct suction also requires specialist equipment.
Citric acid is widely used as a sialogogue in studies of infant salivary Cortisol (Chang et al.,
1995; Davis and Emory, 1995a; Francis et al., 1987; Grauer, 1989; Gunnar et al., 1995;
Kurihara et al., 1996; Price et al., 1983; Santiago et al., 1996).
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Cotton swabs may be placed in an infant's mouth to absorb saliva. These may then be
squeezed in a syringe by the syringe plunger so that saliva drips into a collection pot, or
centrifuged into the bottom of a collection chamber in a purpose made device, eg the
'Salivette' device (Sarstedt, Numbrucht, FRG).
Figure 4-1 Photograph of a 'Salivette' with cotton swab insert
Polyester swabs were introduced for use in the same way as cotton swabs because the
constituents of cotton swabs were found to affect the results in some salivary chemical
measurements. It was thought that the polyester swabs were likely to have less 'interfering
substances' that might affect the measurements (Lenander-Lumikari et al., 1995). An
advantage of swab-collected saliva is that the process of extracting the saliva essentially
filters it, giving a non-viscous, clear sample that is free of cellular and other oral debris. This
is more pleasant and technically easier to handle in the laboratory.
Also, the use of either cotton or polyester swabs avoids the use of suction equipment. This
equipment may be in the form of a traditional 'mucous extractor' with the operator sucking
by mouth on one end of the device, but the potential for the transmission of infection such a
HIV or Hepititis B makes this unethical and impractical. Electrical suction devices with
sterile, flexible, disposable catheters, of the kind routinely used to clear endotracheal tubes
and nasal or nasophryngeal airways, are an alternative. The devices are usually wall-
mounted, as at each cot space in the neonatal unit, but may be portable, like those used by
ambulatory resuscitation staff. Both are specialised and relatively expensive. The advantage
152
of electrical suction is that there is a constant, easily controlled negative pressure that can be
set at any level. A thumb over the hole at the 'trap' ofthe suction catheter completes the seal
required for suction, and with small movements of the thumb, the operator can obtain instant
and subtle changes in suction.
Figure 4-2 Wall-mounted suction device
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Figure 4-3 Disposable suction catheter
In this study, adults were used for practical and ethical reasons. It takes up to 5 minutes to
aspirate sufficient saliva for assay from an infant's mouth and seconds for an adult to spit
into a pot. It is difficult to place both a cotton and polyester swab simultaneously in an
infant's small mouth. This may be distressing and if so the adrenocortical response to this
distress could increase salivary Cortisol over the collection time. It is also possible that the
infant handling required to collect several consecutive samples may elicit a Cortisol response
(Davis and Emory, 1995a). Simultaneous, non-stressed samples would thus be unobtainable.
For the radioimmunoassay in this study, lOOpl of saliva are required for each assay tube.
Therefore 200pl are required for the assay to run in duplicate. Ideally, a minimum of 250pl
are collected to allow for viscosity and practical handling of small samples. More is collected
if possible to allow further aliquots to be diluted and re-assayed if the initial salivary Cortisol
measurement is higher than the accurate part of the RIA curve.
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4.3 OBJECTIVES
To assess 3 saliva collection methods, in adults, potentially useful in the neonatal population.
With the data produced, to select a collection method appropriate for use in the newborn
population of the present study.
4.4 METHODS
4.4.1 Subjects
16 healthy adults. Volunteers from the neonatal unit staff without endocrine disorders or
steroid therapy. Fasted for 1 hour prior to saliva sampling.
10 preterm infants in the neonatal unit. Any infant in the intensive care section of the unit
who was not receiving exogenous steroid therapy was recruited for the collection of a single
saliva sample.
4.4.2 Saliva collection
Adult subjects had a cotton swab placed in one cheek, and a polyester swab in the other.
The subject dribbled simultaneously into a 'universal container'. The swabs were removed
after one minute, and a few grains of citric acid were placed on the tongue to stimulate the
next sample. The citric acid was obtained from the hospital pharmacy department and was
prepared to BP standards and purity. The citric acid stimulated sample was dribbled into a
second 'universal container'.
4.4.3 Sample handling and storage.
The swabs were centrifuged at 2000 rpm for 2 minutes within an hour of collection to give




Cortisol was measured by in-house direct RIA in duplicate 100 pi aliquots using the method
described in chapter 3. All samples were analysed in a single assay run.
4.5 RESULTS:
4.5.1 Salivary Cortisol levels
Figure 4-4 Salivary Cortisol following different collection methods (nmol L"1)
Subject
Table 4-1 Results of salivary Cortisol radioimmunoassay following different collection methods
n=16 Mean nmol L" Standard deviation
Plain saliva 10.9 3.8
Citric Acid stimulated 10.4 4.8
Cotton Swab 25.3* 5.5
Polyester swab 27.9* 9.2
ANOVA: * = significantly higher than plain saliva p<0.01.
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4.5.2 Suction of saliva from infants using citric acid as a sialogogue
Most infants screwed up their faces and wriggled when citric acid was placed on the tongue
seeming to find the experience distressing. The citric acid increased saliva flow.
4.6 DISCUSSION
4.6.1 Effect of swab-collection on Radioimmunoassay
Saliva collected using cotton and polyester swabs resulted in variable and significant over-
estimation of Cortisol when compared to plain saliva. This was presumed to be due to cross
reactivity of swab constituents with the assay antibody. A similar effect was noted with
variable over-estimation of testosterone (Walker et al., 1990), and 170HP (Kruger et al.,
1996) by radioimmunoassay after Salivette saliva collection. Constituents of cotton swabs
have also been found to affect the measurement of various non-steroid saliva components
(Arglebe, 1989). While the effect we found was that of pseudo-activity in the
radioimmunoassay, others have found that absorption of the steroid by swab fibers has led to
unacceptably low recovery from polyester swabs (Walker et al., 1990).
It is unlikely that the high "swab-collected" Cortisol is a genuine stress response. The
collection was not perceived to be distressing by the adult volunteers and the 'citric acid'
samples did not differ significantly from the plain saliva and were collected after the swab
samples. The magnitude of the difference between the 'swab' and plain saliva samples and
the degree of variation, however, could be interpreted under study conditions as an
appreciable stress response in infants (Lewis and Thomas, 1990). The described effect will
vary from assay to assay as described by Shirtcliff et al (Shirtcliff et al., 2001). Cotton swab
saliva collection has been widely used in infant salivary Cortisol studies (Gunnar et al., 1995;
Kurihara et al., 1996; Lewis and Thomas, 1990) and may account for some of the conflicting
results in the literature. The use of different collection methods and the effect described here
also make the comparison of salivary Cortisol levels from different publications more
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difficult. These results highlight the need for authors of infant salivary Cortisol studies to
publish careful validation of their collection methods in relation to their radioimmunoassays.
4.6.2 Citric acid and apparent infant distress
Citric acid stimulated samples were not significantly different from the plain saliva. After
describing the effect of cotton and polyester swabs on Cortisol results, and concluding that
swabs were not suitable, collection of saliva from infants using citric acid and direct
aspiration using electrical suction was commenced. There was an appreciable effect on infant
behaviour. Most infants screwed up their faces and wriggled when citric acid was placed on
the tongue seeming to find the experience distressing. Because the use of citric acid in
infants had been widely described (Chang et al., 1995; Davis and Emory, 1995a; Francis et
al., 1987; Grauer, 1989; Gunnar et al., 1995; Kurihara et al., 1996; Price et al., 1983;
Santiago et al., 1996) and the issue of distress had not been identified as a significant factor
in those papers, this finding was unexpected. There was therefore no plan for formal
definition or assessment of the degree of distress or the recording of the precise number of
infants displaying distress. The effect, however, was of a magnitude such that the candidate
decided that it was unethical to continue its use after 10 samples were collected from 10
infants. Citric acid is a potent, rapidly-acting sialogogue. It is a main ingredient, along with
sugar, in sherbet. The sensation of its presence in the mouth can be intense, with tingling and
'fizzing'. The interpretation of these sensations is subjective. For children with sherbet dips,
the association is with fun and other confectionary, and so distress is not usually a feature.
Several adults in this study commented that the sensation of citric acid alone was unpleasant.
4.6.3 Description of collection technique selected.
Saliva sampling from infants took from a few seconds to five minutes to perform. Some
constituents of milk are known to cross react with Cortisol radioimmunoassays (Magnano et
al., 1989), so at least 40 minutes was allowed to pass after the last feed to minimise the risk
of milk contamination. The negative pressure on the wall-mounted suction device was set to
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40 mm Hg. The tip of a size 8 sterile disposable suction catheter was gently introduced to the
mouth of the infant, with the operator's thumb off the trap, ie with no suction applied. Often
the infant would start to suck on the tube. In this case, the tube was held so that the tip was
about 1 -1.5cm from the lips and directed to the roof of the mouth so that it lay between the
infant's tongue and palate. With each movement of the infant's tongue on the palate and
tube, once the suction was commenced, a small amount of saliva travelled back down the
tube towards the suction trap. If the infant did not suck on the tip of the suction catheter, the
tip was placed in the dependant parts of the mouth and gently moved around. As relatively
low pressures were used, only when there was copious saliva did any leave the trap and
travel further back down the collecting system. Because of the ease of control of the suction
with the thumb cover on the trap, it was possible to place the tube in position before gently
and intermittently at first commencing suction, to minimise any disturbance to the infant.
Saliva collection was not considered by parents or nursing staff to be distressing to the
infant. Many infants stayed asleep while collection took place. Those who were alert to start
with responded with movement +/- vocalisation in the way they would respond to any other
handling or stimulation.
Once there appeared to be sufficient saliva in the suction trap, the catheter was removed
from the rest of the collecting system, the empty flexible tube cut off, and the trap tipped into
and taped to an ependorph tube.
159
Figure 4-5 Collection trap taped to ependorf tube
To ensure that the maximum volume of saliva was transferred from the trap to the tube, the
tube and trap together were then centrifuged for 1 min at 2000rpm. The trap was then
removed, the ependorph tube sealed and transferred to the -20°C freezer until analysis.
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The advantages of the technique described above are:
1. Avoiding the introduction of error due to interfering substances in cotton and polyester
swabs.
2. Avoiding possible distress caused to infants due to citric acid, so making the technique
ethical and more acceptable to staff and parents.
The disadvantages of the technique described above are:
1. It takes practice and patience. Non-researchers would require training.
2. Some infants simply will not have sufficient saliva to collect, and so failure to obtain a
sample must be accepted as part of any study or clinical programme.
3. Specialist equipment, i.e. electrical suction pump, suction catheters and a centrifuge are
required. This makes it less portable, economical and accessible than, for example cotton
swab use.
In light of the above, this technique as it stands is most suited to the research setting.
Changes in RIA procedure, with thorough assessment of the effects of swab constituents,
and/or experimentation with different swab materials might allow a swab technique to be
used in this population in the future. Before the technique is used clinically across centers,
standardization, simplification and validation of collection method in conjunction with
radioimmunoassay should be performed. This should also take into account the practicalities
and potential difficulties of reagent supply for extended time periods. The amount of work
involved would be appreciable, both in clinical and laboratory terms.
4.7 CONCLUSIONS
Cotton and polyester swabs may lead to variable overestimation of salivary Cortisol, while
citric acid does not appear to affect the RIA in this study. Citric acid caused distress to
infants. For use in the specialised research setting of a neonatal unit, direct aspiration of
saliva by electrical suction without the use of citric acid was selected as the most suitable
method of saliva collection.
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5 Correlation of Salivary and Plasma Cortisol in Sick and Pre-term
Infants.
5.1 OVERVIEW
Background Salivary Cortisol is a potentially useful tool for assessing adrenocortical
function in sick and pre-term infants.
Objectives In this population;
1) To establish the range of salivary Cortisol levels.
2) To correlate salivary and total plasma Cortisol.
Design Cross-sectional observational study.
Subjects 32 infants on the neonatal unit in a tertiary referral center. Median gestational age;
30 weeks, median post-natal age; 0.57 weeks (4 days).
Measurements Cortisol was measured by radioimmunoassay in 50 simultaneously gathered
saliva-plasma pairs.
Results
Total plasma Cortisol; median 244.2 nmol L"1, range 37.3-3802 nmol L"1, interquartile range
94.1-418.0 nmol L"1
Salivary Cortisol; median 43.1 nmol L"1, range 2.8-3767 nmol L"1 interquartile range 14.0-
121.3 nmol L"1
Total plasma and salivary Cortisol were significantly correlated, p<0.01 (r= 0.75)
Conclusions
1. Salivary Cortisol levels were wide-ranging and higher than previously reported for any
population.
2. Salivary and total plasma Cortisol levels were closely and significantly correlated.
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5.2 BACKGROUND
The levels and dynamics of salivary Cortisol in sick and pre-term infants are potentially
different from those of term and well infants. There are many publications with salivary
Cortisol data from term and well infants (Davis and Emory, 1995a; Francis et al., 1987;
Gunnar et al., 1995; Kiess et al., 1995; Klug et al., 1997; Klug et al., 2000; Kurihara et al.,
1996; Price et al., 1983; Spangler and Scheubeck, 1993) and few with data from pre-term
infants (Antonini et al., 2000; Azcarate et al., 1997; Bettendorf et al., 1998; Calixto et al.,
2000; Vaughn PR, 1996a). These studies are reviewed in chapter 2d.
5.3 METHODS
5.3.1 Subjects
A 'convenience sample' was recruited over several days. The aim was to include a cross-
section of infants typically resident in a tertiary referral neonatal unit.
5.3.2 Inclusion criteriae
Any infant on the neonatal unit who required blood-sampling for clinical reasons.
Parent available for consent.





5.3.4 Sample collection and analysis
Saliva was collected immediately prior to blood sampling as described in chapter 4. Blood
sampling was by venepuncture or from indwelling arterial catheters.
Cortisol was measured in saliva and plasma as described in chapter 3.
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HPLC: 2 samples of saliva from 2 infants with Cortisol levels >1000 nmol L"1 by
radioimmunoassay were purified by high performance liquid chromatography as described in
chapter 3.
MASS SPECTROMETRY: The samples analysed by HPLC were then analysed by Mass
Spectrometry, also described in chapter 3.
5.3.5 Statistics
Spearman's rho correlation was used to analyse the relationship between saliva and Cortisol
because of the skewed distribution of results.
5.4 RESULTS
5.4.1 Subjects
The details of the study infants are summarised in table 5-1. 32 infants were recruited; 50
pairs of saliva and plasma were collected. 25 samples were from infants whose mothers had
been treated with a full course of antenatal steroids to prevent respiratory distress syndrome.
18 samples were from infants of mothers who received a partial course of antenatal steroids
before giving birth.
Table 5-1 Characteristics of the 19 male and 13 female infants studied
Mean Median Range
Birth weight (kg) 1.455 1.338 0.595-3.79
GA (weeks) 29.7 30 24-41 weeks
Postnatal age (weeks) 1.74 0.57 0-9
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5.4.2 Cortisol
Both total plasma and salivary Cortisol had a skewed distribution (figs 5-1 and 5-2).
Figure 5-1 Histogram of total plasma Cortisol (nmol L"1)
0 1000 2000 3000
500 1500 2500 3500
Total plasma Cortisol (nmol/L)
Plasma Cortisol: Median 244.2 nmol L"1, range 37.3-3802 nmol L"1
Figure 5-2 Histogram of salivary Cortisol (nmol L"1)
0 1000 2000 3000
500 1500 2500 3500
Salivary Cortisol (nmol/L)
Salivary Cortisol: Median 43.1 nmol L"1, range 2.8-3767.4 nmol L"'
5.4.3 Saliva and Plasma pairs
A Scatter Plot of saliva and plasma pairs is shown in fig 5-3. LoglO values are used to
separate the cluster of values at the lower end of the scales.
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Log10 Total plasma Cortisol (nmol/L)
Overall Spearman's rho correlation between total plasma and salivary Cortisol was
significant at p=0.0l level, r= 0.75.
Overall regression equation: salivary Cortisol = 0.87 x plasma Cortisol - 186.4
Spearman's rho correlation coefficient for the relationship between plasma and saliva
Cortisol when total plasma cortiol <200 nmol L"1 was 0.67 (n=20) and when >200 nmol L"1
was 0.8 (n=30) (each significant p=0.01)
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5.4.4 HPLC
Values within 10% of the original assay measurement were obtained after purification.
Dilutions of the fraction gave predicted values in both salivary and plasma assays, producing
straight-line plots of dilution against Cortisol, parallel to the plot of dilutions of a
commercially obtained Cortisol standard (fig 5.4).
Figure 5-4 Plot of serial dilutions of salivary Cortisol measured by radioimmunoassay after HPLC
purification (nmol L~1). Series 2=standard, series 3=saliva.
Figure 5-5 HPLC Chromatogram obtained from a saliva sample with a Cortisol concentration >1000
nmol L"1
Saliva Co rtiso I fo r LL
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39
Fraction Number
5.4.5 Mass Spectrometry
The method is described in chapter 3, and confirmed that the molecule present in the sample
was Cortisol and that it was present in high concentrations.
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5.5 DISCUSSION
The subjects in this part of the study are representative of sick and pre-term infants in many
neonatal units. Most samples were from infants <32 weeks gestational age (mean 28 weeks);
4 samples were from two infants >36 weeks who had infections. Most samples were taken
from infants <2 weeks old (mean 4.2 days), with the exception of 8 samples from 8 infants
who had BPD (bronchopulmonary dysplasia) who were studied when several weeks old.
The correlation between salivary and total plasma Cortisol was good (r=0.75) and
comparable to those in the literature (Bettendorf et al., 1998; Bober et al., 1988; Francis et
al., 1987; Kurihara etal., 1996; Lo etal., 1992; Vining et al., 1983b; Woolston et al., 1983).
Routine clinical laboratories and research laboratories usually measure total plasma Cortisol.
It is thus relevant to compare salivary Cortisol measurements to total plasma Cortisol.
Salivary Cortisol closely follows total plasma Cortisol in normal episodic variation, after
ACTH and Dexamethasone administration (Laudat et al., 1988; Riad-Fahmy et al., 1983;
Walker et al., 1978) and after administration of increasing doses of oral Cortisol (Brooks FS,
1984). However, as changes in plasma cortisol-binding capacity can mask either high or low
free Cortisol levels, the relationship between salivary and total plasma Cortisol is less direct
than the relationship between salivary and free plasma Cortisol. For example, in normal adult
subjects total plasma levels up to 1000 nmol L"1 are associated with normal saliva levels (5-
20 nmol L"1) implying increased Cortisol binding capacity as a cause for their high total
plasma Cortisol (Lo et al., 1992).
From adult data, there is generally a good correlation between salivary and total plasma
Cortisol until all the Cortisol binding sites in plasma have been saturated. This occurs at a
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total plasma level of about 500 nmol L'1. Thereafter, an increase in total plasma Cortisol
leads to a more rapid increase in free Cortisol. The slope of the regression line between
salivary and total plasma Cortisol becomes steeper after this point but the correlation remains
close. Thus, instead of a simple straight-line correlation, there are two intersecting lines
(Vining et al., 1983b).
The total Cortisol binding capacity for plasma in preterm infants is thought to be about 200
nmolL"1 (Hanna et al., 1997). In this study, saliva-plasma pairs were thus divided into 2
groups, those with total plasma Cortisol <200 nmol L"1 (n=20), and those with total plasma
Cortisol >200 nmol L"1 (n=30). The higher levels of salivary and plasma Cortisol correlate
more closely (r=0.8) than the lower levels (r=0.67). This is consistent with the fact that it is
at high levels that the free plasma Cortisol predominates, and should relate more directly to
the salivary Cortisol.
The poorer correlation at values <200 nmol L"1 total plasma Cortisol may be due to
inaccurate salivary Cortisol estimation. Salivary proteins and enzyme conversion, as
discussed below, in conjunction with the inevitable error introduced when working with
small volumes of viscous fluid, often diluted and re-analysed, may all have contributed to
this. As preterm and sick infants' Cortisol binding capacity is often lower but more variable
than that of adults (Hanna et al., 1997), it is possible that the total plasma Cortisol is a
misleading measurement.
There are several potential problems with Cortisol measurement in the saliva of preterm and
sick infants. While the binding effect of proteins in the saliva of healthy adults is negligible
(Walker et al., 1978), it might be greater in preterm and sick infants. Salivary Cortisol
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binding globulin production may be increased as part of a generalised stress response (Chu
and Ekins, 1988; Gabay and Kushner, 1999). Binding proteins may leak into saliva from the
plasma through damaged or immature capillary membranes. A resulting increased salivary
binding capacity might 'pool' Cortisol in the saliva making it disproportionately high. If one
or other of these processes were present in the subjects in this study, the effects do not
appear to influence the validity of the measure overall. It would be interesting to measure the
Cortisol binding capacity of the saliva in this population.
Salivary alpha-amylase, mucins and potentially IgA can affect radioimmunoassay accuracy
(Fulton et al., 1989; Lantto et al., 1980). Salivary Cortisol in infants has been noted to be
extremely variable (Francis et al., 1987; Bettendorf et al., 1998). Spurious salivary Cortisol
levels in preterm and sick infants may be due to high levels of interfering saliva constituents.
In this study, it was observed that preterm and sick infants' saliva was often much more
viscid than adult saliva. Further studies of the amylase, mucins and IgA in the saliva of pre¬
term and sick infants would be interesting.
In adult saliva, there is evidence of significant lip hydroxysteroid dehydrogenase type 2
activity (Morineau et al., 1997; Vining and McGinley, 1986; Brooks FS, 1984; Katz and
Shannon, 1969a; Meulenberg and Hofman, 1990; Vining and McGinley, 1987). This enzyme
converts Cortisol to cortisone. The activity of this enzyme is very much higher in many
organs in the fetus and preterm infant (Stewart et al., 1994; Fujitaka et al., 1997). Poor
correlation of salivary and plasma Cortisol could result from high activity of lip
hydroxysteroid dehydrogenase type 2. The close correlation of salivary and plasma Cortisol
described in this study implies that this process does not markedly affect the relationship.
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The total plasma Cortisol levels are in keeping with those in the literature (Barker and Rutter,
1996; Heckmann et al., 1999; Pokela, 1994b). Many studies of preterm or sick infants have
found some total plasma Cortisol levels > lOOOnmol L"1 (Bourchier and Weston, 1997;
Cronin et al., 1993; Economou et al., 1993; Heckmann et al., 1999; Jett et al., 1997; Kari et
al., 1996) and some authors have found levels several thousand fold (Barker and Rutter,
1996; Hughes et al., 1987; Pokela, 1994b; Rizvi et al., 1992). Six infants in this study had
one sample of total plasma Cortisol >lOOOnmol L"1, with the upper end of the range, 3802
nmol L"1.
The salivary Cortisol levels are much higher than those in the literature. Normal adults have
morning salivary Cortisol means between 8.7 nmol L~' and 15.5nmol L"1 (Brooks FS, 1984;
Hiramatsu, 1981; Laudat et al., 1988; Lo et al., 1992). Tunn found that after intravenous
hydrocortisone, the highest total plasma levels of about 1800nmol L"1 were matched with
saliva levels of 482 nmol L'1, 414 nmol L"1 and 137 nmol L"1 (Tunn et al., 1992). ACTH
administration has led to saliva levels up to lOOnmol L"1 (Laudat et al., 1988)and 120 nmol
L~' (Vining et al., 1983b). Studies of well term infants in the first days of life have found
mean salivary Cortisol levels of 20-30 nmolL"1 (Davis and Emory, 1995a; Magnano et al.,
1992; Price et al., 1983; Spangler and Scheubeck, 1993; Klug et al., 2000; Klug et al., 1997).
The range in these infants is 2.5nmol L"'/below detectable range to between 70 nmol L"1 and
166 nmol L"1 (Francis et al., 1987; .Gunnar et al., 1995; Kiess et al., 1995; Klug et al., 1997;
Kurihara et al., 1996). Levels of salivary Cortisol up to 260 nmol L"1 were found in post
operative term neonates (Vaughn PR, 1996a).
There are relatively few studies of salivary Cortisol in preterm infants. Bettendorph studied
pre-term and term infants finding a range of 0.6-52.1 nmol L"', and a mean of 5.5 nmol L"1
with considerable variation (Bettendorf et al., 1998). All, including the 10 preterm infants
studied were 'well' and older than the infants in the present study. The authors concluded
that salivary Cortisol measurement in low birth weight infants was practical and appropriate,
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but did not include the assessment of sick or stressed infants. Antonini et al published no
absolute values in their study of preterm infants' (>34 weeks gestation) circadian rhythm
(Antonini et al., 2000). One publication describes for day 3-7, infants of 26-33 weeks
gestational age, a mean salivary Cortisol of 30.2 nmol L"1 paired with mean plasma Cortisol
of 372 nmol L"1 (Calixto et al., 2002). An abstract described means of 5-54 nmol L"1
depending on whether preterm infants were sick or well. The highest levels quoted are
'median ofmaximum Cortisols' of 172 nmol L"1 in a group of sick preterm infants (Azcarate
et al., 1997).
5 of the 32 infants in the present study had salivary Cortisol values > 500 nmol L"1. Their
details are displayed in table 5-2. These data illustrate that salivary Cortisol measurement
identifies those infants who produce extremely high adrenocortical activity in response to
significant systemic illness. As seen in the table, gestational age, sex and birth weight do not
appear to have influenced the ability to mount this response. These levels of salivary Cortisol
appear to be higher than those reported for any population.





















Sepsis 1118 >540* F 26 0.595 3
Pneumothorax 1972 >560* M 28 1.345 2
Meningitis 1386 1159 M 41 3.790 3
Necrotising
enterocolitis
2513 2500 M 28 1.210 7
Meningitis 3802 3767 F 36 2.190 2
* Insufficient volume of sample to re-di ute and re-assay.
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As can be seen from table 5-2, a final value was not available for 2 of the samples. This is
because despite analysis ofmore dilute aliquots from the original sample, the value remained
above the straight, accurate part of the RIA curve. This highlights one of the technical
difficulties with using salivary Cortisol as a tool to this population. While some infants,
notably those receiving continuous positive airways pressure, had copious saliva, small
sample volumes were frequent. In approximately 10 % cases, a final high value for salivary
Cortisol could not be generated because the value was 'off the curve' and the sample was
insufficient for further dilution and analysis. Similarly, difficulty in obtaining a saliva sample
from an individual infant in the first place was encountered in approximately 10% of cases.
These factors are relevant when considering potential applications of salivary Cortisol in sick
and preterm newborn infants.
Despite very high salivary Cortisol levels, there were many levels at the lower end of the
range. 'Well' babies had a tendency to have lower levels than 'sick babies'. It was not the
purpose of this study to examine the relationship between severity of illness and Cortisol
response, but no infant who was regarded as 'sick' had a 'low' Cortisol level. Infants who
had one or more salivary Cortisol level >500 nmol L"1 at one time were seen to vary their
levels markedly over time depending on clinical condition, so that when they were well, their
levels were appropriately lower (fig 5-6).
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Figure 5-6 Box plot showing median and range of Iog10 salivary Cortisol (nmol L"1). Samples are from a
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The results show that salivary Cortisol continues to reflect plasma concentrations even at
very high levels and all very high total plasma Cortisol levels are paired with very high
salivary Cortisol levels. Thus salivary Cortisol appears to be a useful measure even in stressed
infants. The salivary Cortisol medians and upper end of range are higher than any from
studies of pre-term infants, or other populations. There does not appear to be a plateau effect
with the transfer of Cortisol from plasma limiting the concentration obtainable in saliva
-■ ■ ' 1 ■
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It is theoretically possible that cross reactivity of the assay antibodies may have led to falsely
high estimates of both plasma and saliva Cortisol. See section 3.2.6 and 3.3.4 for cross
reactivities.
The only known cross reactivity >5% for a naturally occurring steroid for the saliva Cortisol
RIA antibody is corticosterone. It has a cross reactivity of 18.6%. (The plasma Cortisol RIA
antibody had 0.18% cross reactivity with corticosterone.)
Plasma corticosterone levels in newborn infants towards the end of the first week of life are
about 8.3+/-1.8 nmolL"1 in term infants (Anand 1992), and 10 nmolL"1 in preterm infants
(estimated from graph) (Doerr et al 1988). Thus, theoretically, the presence of corticosterone
in saliva may have led to the overestimation of Cortisol in the salivary assay. Only a small
percentage of plasma corticosterone (proportional to non-plasma protein bound hormone)
would be represented in saliva. There appears to be no literature on salivary corticosterone
levels in the neonatal population. Relative to the high concentrations of Cortisol measured in
sick infants, its expected concentration is not likely to contribute significantly to the final
value. In infants with lower Cortisol levels, it is possible that its presence contributed more
substantially to the final value. This may be a factor explaining the less tight correlation
between plasma and salivary Cortisol at lower concentrations of both.
The only known cross reactivity >5% for a naturally occurring steroid for the plasma Cortisol
RIA antibody is 21-deoxycortisol. It has a cross reactivity of 34%. (Unfortunately, there is
no data on the cross reactivity with 21-deoxycortisol of the saliva Cortisol RIA antibody.) 21-
deoxycortisol is formed by the 11-hydroxylation of 17-hydroxyprogesterone. This metabolic
pathway is minor in 'normal' steroid metabolism, and basal plasma concentrations range
from 0.03 to 0.63 nmol/L in older children and adults. Even after adrenocorticotrophic
hormone stimulation, levels are extremely low (0.865 to 1.50 nmolL"1) relative to Cortisol. It
is classically significantly elevated in cases of 21 hydroxylase deficiency (14.5-297 nmolL"
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'). As some authors have described raised levels of 17-hydroxyprogesterone in preterm and
sick neonates (see appendix 4), it would be logical to expect that these same infants may
have elevated levels of 21-deoxycortisol. It is thus theoretically possible that the presence of
21 -deoxycortisol in plasma contributed to an overestimation of total plasma Cortisol. It is
also likely that the sicker or more preterm the infant, the higher the 21-deoxycortisol, and the
greater the over-estimation.
Two factors back the conclusion that the cross reactivities did not have a detrimental effect
on the functionally accurate estimation of Cortisol concentration:
1. Cortisol measurements before and after HPLC gave results within 10% of each
other, ie., when the steroids with which the antibodies cross react were removed, the
difference was comparable to inter/ intra-assay variation. HPLC and mass
spectrometry on 2 samples from 2 infants with high radioimmunoassay-measured
levels confirmed that Cortisol was demonstrated at high concentrations. It would be
ideal to perform HPLC and mass spectrometry on larger numbers of samples in a
future study, to strengthen the validation process. The resources required were
unfortunately unavailable for this study.
2. Correlation data between salivary and plasma Cortisol concentratons were in keeping
with those in the literature.
5.6 CONCLUSIONS
1) Salivary Cortisol levels were wide-ranging and higher than previously reported for any
population.
2) Saliva and total plasma Cortisol levels were closely and significantly correlated.
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6 Classical circadian rhythm for salivary Cortisol in preterm infants.
6.1 OVERVIEW
Background Circadian Cortisol rhythm emerges between 2 and 3 months postnatal age in
term infants. It is absent in sick adults. Little is known about its emergence in very preterm
infants. This part of the study examines circadian rhythm in Cortisol secretion in hospitalised
infants born before 30 weeks gestation.
Design Prospective longitudinal observational study.
Patients 11 infants born before 30 completed weeks of gestation admitted consecutively to
the neonatal unit.
Measurements Salivary Cortisol was measured by highly specific radio-immunoassay on
morning and evening samples gathered at weekly intervals until discharge home.
Results All values: median 10.0 nmol L range <0.5 to 373 nmol L interquartile range
4.4-18.0 nmol L No infants displayed classical circadian rhythm for 4 weeks or more prior
to discharge from hospital. 4 infants displayed a trend towards what may be a 'reverse'
circadian pattern. 5 infants >39 weeks post-menstrual age still had no classical circadian
rhythm. Taken collectively all values: evening levels were significantly higher than morning
(p=0.05).
Conclusion In hospitalised infants bom <30 weeks gestation, adult-type circadian rhythm in
salivary cortisolis absent, and in some there may be periods of 'reverse' circadian rhythm.
The task of collecting the samples for this part of the study was shared with a colleague who
collected approximately 50% of the samples.
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6.2 BACKGROUND
Literature summary and background: See chapter 2.7
6.3 METHODS
6.3.1 Subjects
Consecutive infants born before 30 completed weeks gestation and admitted to the neonatal
unit were recruited. For 9 of the infants sampling was commenced before 2 weeks post natal
age, and 2 infants were recruited at 6 and 9 postnatal weeks. Details of the 11 infants studied
are summarised in Table 6-1. None of the infants received postnatal exogenous steroids. All
but two of the infants were exposed to antenatal steroids.
6.3.2 Sample collection and analysis
Saliva was collected as described in chapter 4 and analysed by RIA as described in chapter 3
6.3.3 Environment
In the nursery, lights were dimmed and noise reduced from 2000hrs until 0700hrs. Paired
saliva samples were taken at 0900-1000hrs and 2200-2400hrs. The infants had samples taken
weekly until they were discharged home.
6.3.4 Statistical analysis
Wilcoxon signed rank test for related samples was used for all analyses on the collective
data.
A pattern of salivary Cortisol values in circadian rhythm was sought in the subjects'
individual graphs as follows:
1. Morning > evening value.
2. A drop of >40% from morning to evening.




There were results for 210 samples comprising 105 pairs of morning and evening samples.
For 17 pairs, one or other sample was insufficient or unsuitable for analysis, and therefore
the pair was regarded as 'missing data'. The data were positively skewed, and so non-
parametric tests were used for collective analyses. The median was 10.0 nmol L with the
range <0.5 to 373 nmol L"1.












































































































































































Graphs ofmorning and evening salivary Cortisol for individual babies are shown in Figure 6-
2.
No pattern of higher morning levels consistently for 4 weeks was found in any infant,
regardless of percentage drop. The closest to the criteria defined for the study was found in
infant 4. Morning higher than evening values were sustained for the three consecutive weeks
leading up to discharge home, with evening values 63%, 57% and 85% lower than morning
values. 5 infants were followed until or past term (>39 completed weeks postmenstrual age)
yet still failed to show sustained circadian rhythm.
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Figure 6-2 Morning and evening salivary
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Of the 105 pairs of results, 41 had morning higher than evening, and 64 evening higher than
morning values. Comparing all the morning samples to all the evening samples, evening
samples were found to be higher, p=0.025 using the Wilcoxon signed rank test for related
samples. Morning samples: median 9.3 nmol L (range: 0-178 nmol L "'), evening samples
median 10.6 nmol L (range: 0-373 nmol L
For each infant, the median Cortisol value for each three-week postnatal time period was
calculated. These values were then grouped with median values from the other infants of the
same postnatal age (Figure 6-3). The salivary Cortisol in the first 3 weeks of life was found to
be significantly higher than in the second, third and fourth 3-week periods (p=0.01, 0.01 and
0.03 respectively).
Figure 6-3 Boxplot of median salivary Cortisol values in relation to postnatal age (nmol L"1)
0-3 weeks 3.1-6 weeks i. 1 -9 weeks 9 weeks onwards
Post natal time period
Median salivary Cortisol
24.0 11.0 5.0 6.5 (nmol L"1)
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There was no significant change in amplitude (i.e. the difference between the two results in
each day) with advancing age (Kruskall-Wallis test on the difference, p=0.14). See figure 6-
4.
Figure 6-4 Amplitude of variation: the difference between the highest and lowest levels of salivary
Cortisol in each day in relation to postnatal age
0-3 weeks 3.1-6 weeks 6.1-9 weeks 9 weeks onwards
Post natal time period
6.5 Discussion
6.5.1 Characterising circadian rhythm
In studies examining circadian rhythm, where multiple samples have been taken over a 24
hour period, mainly in cross sectional studies, ANOVA, conisor analysis, Students t- tests,
Goodness of fit and randomness tests have been used (Azcarate AB, 2001; Hindmarsh et al.,
1989; Klug et al., 1997; Mantagos et al., 1998), but the data from this study, with paired
morning and evening samples, were not suitable for such analysis. Other researchers have
used Wilcoxan signed rank or Mann Whitney U tests to compare evening with morning
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values (Santiago et al., 1996; Spangler, 1991). Some authors have simply 'looked for1 the
'adult type' pattern and amplitude in circadian rhythm. Data from pooled saliva from 8
healthy adult volunteers during the course of this study revealed an evening value 66% less
than the morning value, a greater magnitude drop than any published criteria used to detect
the presence of circadian rhythm.
Krieger developed a method for characterising circadian rhythm in plasma Cortisol in
individuals such that the drop from morning to evening value should be at least 35% giving a
14% false positive rate, or 25% drop giving a 22% false positive rate (Krieger et al., 1971).
Santiago and Antonini based their analyses of salivary Cortisol levels on the coefficient of
variation (CV) for the Cortisol assay (Antonini et al., 2000; Santiago et al., 1996). For
circadian rhythm to be present, the evening level was required to be less than the morning
level by three times their intra-assay CV in individuals (22% drop). Applying this method to
the present study would also mean that a drop of approximately 22% would be sought in
individual infants in this study. Following consultation with a clinical statistician and in light
of the above, it was decided that in preference to applying complex statistical analytical tests
for longitudinal data, as there were 11 subjects, observation of each infant's individual graph
for the following criteria would be used to define the presence of circadian rhythm:
Morning > evening value.
A drop of >40% from morning to evening.
The above sustained for >4 weeks.
6.5.2 Why there was a lack of adult-type rhythm
A. Immature circadian clock.
Despite their presence (Rivkees, 1997), the number or maturation of the cells in the SCN
may be inadequate at early gestation to generate and send organised messages to the
endocrine systems.
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B. Immature HPA feedback regulation.
The salivary Cortisol values are in keeping with Cortisol levels published for infants
elsewhere (Table 2-1). Presumably because infants were included when they were unwell in
the immediate postnatal period, the levels found in the first three weeks of life were
significantly higher than in subsequent three-week periods. As illustrated by the charts, there
were marked differences in Cortisol levels both from week to week, and between the paired
samples collected on single days. For the collective data, there was no change in amplitude
with advancing postnatal age, whereas term infants are reported to have higher amplitude in
Cortisol secretion in the first four weeks than beyond (Price et al., 1983). The lack of change
in amplitude with postnatal age in this study is consistent with control of Cortisol secretion
remaining immature in preterm infants even when they are past term for corrected
gestational age.
In utero, circulating levels of Cortisol are low due to inactivation by lip hydroxysteroid
dehydrogenase type 2 in the feto-placental unit. Thus, in the fetus, there is no requirement
for inhibition of Cortisol secretion by a classical HPA feedback loop. The placental
contribution to deactivation of Cortisol, however, is removed following birth. Thus the
preterm infant is exposed to high levels of Cortisol that its system may not be mature enough
to regulate. This may leave the infant with exaggerated, labile Cortisol secretion, possibly
hyper-responsive to stress. This is in keeping with the higher and more variable levels of
salivary Cortisol than those reported in older infants, children and adults. This degree of
variability would mask circadian variation.
C. Antenatal steroid administration.
Most infants in this study were exposed to antenatal steroids(Table 6-1). Some fetal rhythms
(movement, heart rate and breathing) are abolished by maternal glucocorticoids (Arduini et
al., 1986). It is possible that exposure to large amounts of glucocorticoid at a vulnerable
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period might influence the development of circadian rhythm of Cortisol secretion. None of
the infants received postnatal steroids.
D. Lack of circadian 'coaching'.
Instead of circadian rhythms in preterm infants developing at a similar or earlier post-
conceptional age than term infants as suggested by Antonini et al (Antonini et al., 2000) they
might develop rhythms at a later postconceptional age. Preterm infants have a delay in the
appearance of rhythmic 6-sulphatoxymelatonin production compared with term infants, even
after correcting for gestational age and length of time at home (Kennaway et al., 1992).
Maternal melatonin crosses the placenta freely and there is circadian rhythm in amniotic
fluid melatonin (Rivkees and Reppert, 1992). Infants who progress to term are exposed to
their mothers' circadian rhythms but preterm infants are denied this input. In theory, then, it
might take them longer, i.e. until a greater postconceptional age, to 'organise' their own
rhythms.
E. Race.
The only infant who came close to displaying circadian rhythm in this study was of Asian
origin. Although this is almost certainly due to chance, there are racial differences in other
areas ofmaturation in preterm physiology (Berman et al., 1996). It is interesting to note that
Antonini et al (Antonini et al., 2000) who found 'early' circadian rhythm in preterm infants
carried out their study in South America. However, these infants were also studied in their
home environment, which may have been more conducive to the development of circadian
rhythm, and they did not receive antenatal steroids.
F. Clinical events reflected by Cortisol levels;
Essentially there are no 'preterm controls'. Birth before 37 weeks gestation is abnormal and
results in a physiology adapted for intrauterine life being forced to function in an extra¬
uterine environment. The consequences of prematurity are numerous and include respiratory
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insufficiency, vulnerability to infection, hypothermia, hypoglycaemia, and so on. Thus,
infants born before 30 weeks gestation will be subject to many physiological stresses.
Cortisol secretion in response to these illnesses may simply override and distort any
circadian rhythm. This is in keeping with data showing that sick adults in ITU with high
Cortisol levels lack circadian rhythm (Reincke et al., 1995). In some cases in the present
study, clinical events could be related to changes in Cortisol levels. For example, Infant 2
(Figure 6-2) developed a respiratory tract infection at 15 postnatal weeks. At this point, the
salivary Cortisol suddenly jumped from <0.5 and 1.24 to 32.9 and 31.9 nmol L"1 during the
week of the illness.
6.5.3 'Reverse' Circadian Rhythm:
Interestingly, although there appeared to be no sustained adult type classical circadian
rhythm, a different and unexpected trend became apparent. A sustained pattern of evening >
morning levels ('reverse circadian rhythm') was noted over consecutive weeks in 4 of the
infants (Table 6-2).
Table 6-2 Details of the salivary Cortisol patterns in infants who displayed a trend towards a 'reverse'
circadian rhythm.
Subject Post natal age (weeks,
inclusive)
% drop from morning to evening
Infant 1 3-7 69%, 69%, 15%, 86%, 84%
Infant 3 6-9 61%, 33%, 73%, 61%
Infant 2 4-7 78%, 30%, 21%, 60%
Infant 5 9-14 57%, 20%, 57%, 15%, 5%, 95%
While not every percentage difference fulfils the 40% definition, the trend is sustained, the
majority of the differences marked and most would be regarded as significant by Santiago,
Kreiger and Antonini (Antonini et al., 2000; Krieger et al., 1971; Santiago et al., 1996). The
significance of this pattern is unclear. Kiess et al noted (Kiess et al., 1995) that term infants
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under the age of 9 months sometimes had evening levels of salivary Cortisol 5 times higher
than morning levels. It has also been suggested that a reversed rhythm may be associated
with chronic stress (Krieger et al., 1971). A similar finding has been reported by Economou,
who studied sick preterm infants with respiratory distress syndrome and sick term infants
with birth asphyxia or meconium aspiration in the first week of life. His grouped data
showed means that were significantly higher at 2000 hours when compared to levels at 0800
hours and 1400 hours (Economou et al., 1993). Preterm infants are frequently exposed to a
variety of noxious stimuli, and may become hypersensitive to physical stimuli (Fitzgerald et
al., 1989). As the day proceeds, infants may find handling, investigations and environmental
stimuli increasingly stressful, and so respond by increasing their Cortisol secretion. The
concept of 'wind-up', where infants perceive non-noxious stimuli as 'pain' is now widely
accepted (Whitfield and Grunau, 2000). This may contribute to 'inappropriate' secretion of
high levels of Cortisol over the course of the day. A trend towards a 'reverse' circadian
rhythm was more prevalent than a true circadian pattern in the subjects in this study.
In this type of study, numbers are inevitably small and sample frequency less than ideal,
which can make data analysis and interpretation difficult. For a longitudinal study, however,
the numbers are comparable to previous studies and the weekly sampling more frequent. It
may be that the 'reverse' findings occurred by chance, but this trend was seen in four infants,
and sustained over several weeks in each case. It was a more predominant pattern than the
classical adult circadian rhythm. This, along with the collective findings of evening higher
than morning values, suggests that further investigation into stress and 'reverse' Cortisol
rhythm would be warranted.
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6.6 CONCLUSIONS
1. There was no adult-type circadian rhythm in any of the 11 infants. All were born at < 30
weeks gestation and 5 were studied to term.
2. A trend towards a 'reverse' circadian rhythm may have been detected with evening
values statistically significantly higher than morning values in collective data, and 4 out
of 11 infants having periods of consistently higher evening than morning values.
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7 SALIVARY CORTISOL LEVELS IN 'WELL' INFANTS
7.1 OVERVIEW
Background: In order to evaluate salivary Cortisol as a potential tool for assessing distress
in preterm and sick newborn infants, control values are required for comparison.
Objective: To generate normal data for salivary Cortisol levels in infants with no or minor
physical illness and no apparent cause for distress or pain.
Design: Combination of cross-sectional and longitudinal data.
Subjects: Preterm controls: Gestational age < 32 weeks. 2 samples each day.
Day 3 (n=10), Day 7-12 (n=10), Day 13-23 (n=10), Day 24-52 (n=10)
Term controls: Gestational age 37-41 weeks. Single samples. Day 3 (n=20)
Follow-up controls: Term and preterm. Infants who had been ill then recovered. 2
samples each day. Day 7-23 (n=15)
Results
1) For all controls, median : 19.9 nmol L"1, range: 2.5-102 nmol L"1, interquartile range
12.0-31.5 nmol L"1
2) There was no significant change in salivary Cortisol levels taken from preterm controls
across the first 7 weeks of life p=0.17.
3) There was no significant difference between the salivary Cortisol levels of term and
preterm infants on day 3 of life p=0.7.
4) When they were well, the salivary Cortisol levels of infants who had experienced distress
earlier in life were not significantly different from the levels of controls with no earlier
experience of distress p=0.49.
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7.2 BACKGROUND
In order to evaluate salivary Cortisol as a potential tool for assessing distress in preterm and
sick newborn infants, control values are required for comparison. The aim of this part of the
study was to generate normal data for salivary Cortisol levels in infants with no or minor
physical illness and no apparent cause for distress or pain. Few data exist for saliva levels for
the preterm population (Calixto et al., 2000; Antonini et al., 2000; Azcarate et al., 1997;
Bettendorf et al., 1998), and plasma levels in the literature for comparison are not from
clearly defined groups of infants.
7.3 METHODS
7.3.1 Study design
Combination of cross-sectional and longitudinal observational study.
7.3.2 Sample collection and analysis
Samples of saliva were collected using the method described in chapter 4, and analysed as
described in chapter 3. Timing of samples was opportunistic, determined largely by the
clinical needs and care-giving procedures being received by the infant. A 'no-handling'
period of 1 hour was required prior to each collection of saliva. For preterm infants, and
follow-up controls, 3-4 samples were collected from each infant between 6am and midnight
on the same study day. The minimum period between collections was 1 hour, and the
maximum, 15 hours. 2 saliva samples that yielded results were required for inclusion in
analysis. Term infants had a single sample collected.
7.3.2.1 PNA on day of study
Infants were recruited where possible on day 3 of life, (ie >48 hours old). Subsequent
samples were taken during the second, third and following weeks of life, to enable a profile
of Cortisol levels over the neonatal period to be developed. Some infants who fulfilled
inclusion criteria but whose parents declined consent initially, were recruited during the
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second, third or subsequent weeks of life. 'Follow-up' controls were infants who had been in
a 'distress' group, but who had recovered for >48 hours and had no discernible reason to be
distressed.
7.3.3 Illness severity scores
CRIB and SNAP scores were carried out retrospectively by chart review as described in
chapter 2.6, for the time spanning the two samples yielding results on the study day, the
eight-hour period prior to this, and the day of birth. Because clinical charts and
investigations were not carried out for term controls on the postnatal wards, their scores were
presumed to be zero.
7.3.4 Subjects
Preterm infants;
a. Day 3 (n=10)
b. Day 7-12 (n=10)
c. Day 13-23 (n=10)








Gestational age < 32 weeks for preterm controls or 37-41 weeks for term controls.
Term infants, and day 3 preterm controls: 48-72 hours old
Apgar score at 5 mins >7
BW between 3rd and 97th centiles
No evidence of, or clinical suspicion of a condition likely to cause distress at time of
sampling.
No evidence of, or clinical suspicion of a condition likely to cause distress prior to
sampling period, since birth.
No requirement for interventions likely to cause distress, eg mechanical ventilation,
CPAP, Lumbar puncture, etc.
No overt signs of behavioural distress as reported by nursing staff, parent or
researcher for 1 hour prior to or at time of sampling.
7.3.6 Exclusion criteriae
Requirement of incubator 02 >30% in preterm infants
Hypoglycaemia < 2.2 mmol L"1
Hypotension (<10th centile for BW) (Weindling A.M., 1989)
Treatment with inotropes or postnatal corticosteroid therapy
pH < 7.2 at or in 12 hours prior to time of sampling
IVH
Maternal substance abuse
History of birth asphyxia or Umbilical cord ph<7
Instrumental delivery or evidence of birth trauma, eg bruising,
fracture.
Infants of mothers with significant co-existing medical illness such








Salivary Cortisol values were obtained from 130 samples from 56 infants in the various
control groups.
Where two samples were taken within the study period, the mean of the two was used to
represent that infant's 'study-day' result for all analysis.
The distribution of salivary Cortisol was skewed to the right so all values were transformed to
log 10 for further analysis.
Figure 7-1 Histogram of mean salivary Cortisol levels (nmol L"1)
Mean salivary Cortisol (nmolL-1)
Figure 7-2 Histogram of Iog10 mean salivary Cortisol levels (nmol L"1)
.38 .63 .88 1.13 1.38 1.63 1.88
.50 .75 1.00 1.25 1.50 1.75 2.00
Log 10 of mean salivary or salivary Cortisol (nmolL-1)
196
7.4.2 Subjects and demographics
Preterm control values were obtained from 21 infants and each post-natal time period studied
contained results from 10 of the infants.







Table 7-2 Continuous characterisics of the 21 preterm controls
Characteristic Mean Median Range SD
GA 30 31 26-32 1.7
BW 1431 1457 705-1955 346
BW centile 44 50 3-90 25
5min apgar 8.4 9 7-10 1.1
Is1 day SNAP 10.5 11 2-26 6.7
Study day SNAP 2.3 2.0 0-6 1.6
1st day CRIB 1.3 0. 0-7 2.3
Study day CRIB 0.8 0. 0-5 1.4
Figure 7-3 Maternal steroid exposure
Total 21
Multiple maternal steroids 3
Full course maternal steroids 10
Partial course maternal steroids 5
No maternal steroids 3
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Table7-3 Pattern of sampling for individual infants over time
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Follow-up CPAP infants: n=5
Follow-up Ventilated infants: n=4
Follow-up NEC infants n=4
Follow-up meningitis infants n=2
7.4.4 Comparison of characteristics of infants in each post-natal time period
In order to detect systematic bias in the characteristics of the infants in the different postnatal
time period preterm control groups:
1. A new variable that was the 'mean day of sampling' for each subject was created.
2. For continuous characteristics, a Spearman's correlation between the mean day and
the characteristic was sought.
3. For the categorical characteristics, those with were compared to those without a
certain characteristic, within each group separately to see if there was a difference in
'mean day of sampling', using Mann Whitney-U.
Only one of the 15 characteristics (BW, BW Centile, GA, 5 min apgar score, SNAP score for
first day of life, SNAP score for study period, CRIB score for first day of life, CRIB score
for study period, maternal illness, antenatal steroid exposure, sex, twin pregnancy, labour,
foetal illness, caesarean-section) was significantly different between the groups (p<0.05).
This would be expected to occur by chance because of multiple analyses and so will be
disregarded. (The name of factor was therefore not supplied by statastician who carried out
this part of the analysis).
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7.4.5 Salivary Cortisol levels in control sub-groups
Table 7-4 Salivary Cortisol in the control subgroups
nmol L"' Median Range
Preterm Day 3 25.2 7.5-102.0
Preterm Day 7-12 18.8 6.9-45.0
Preterm Day 13-23 31.1 11.0-49.0
Preterm Day 24-52 14.0 7.6-58.5
Term Day 3 20.4 2.5-97.9
Follow-up Day 7-23 18.8 6.7-49.5
Figure 7-4 Log 10 salivary Cortisol in the control subgroups (nmol L")
N- 10 10 10 10 20 15
day3 dayl 3-23 term controls
day7-12 day23-52 All FU controls
Control group
Figure 7-5 Salivary Cortisol in the control subgroups (nmol L~)
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N- 10 10 10 10 20 15
day3 dayl 3-23 term controls
day7-12 day23-52 All FU controls
Control group
7.4.6 Statistics: Comparison of salivary Cortisol levels in control sub-groups
There was no difference in salivary Cortisol between preterm groups across 4 postnatal ages.
Mixed model analysis was used because there was a mixture of longitudinal and cross-
sectional data, and it was necessary to weight subjects' results appropriately (p=0.17).
There was similarly no significant correlation between study day and salivary Cortisol result,
Spearman's rho correlation, p=0.35.
There was no difference in salivary Cortisol comparing preterm groups to 'follow-up'
controls (mixed model analysis p=0.49).
There was no difference in salivary Cortisol of preterm (day3) compared to term (day3)
controls (unpaired t-test on log 10 values p=0.7).
7.4.7 Analysis of factors determining/ influencing salivary Cortisol level
Correlation (Spearman's rho) was examined for each continuous characteristic at each age
group separately. Of the 40 correlations carried out (BW, BW Centile, GA, 5 min apgar
score, SNAP score on day of birth, SNAP score on study day, CRIB score on day of birth,
CRIB score on study day, maternal illness, antenatal steroid exposure), only antenatal steroid
exposure was significant
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For analysis, antenatal steroid exposure was quantified in a graded fashion, such that;
0= no antenatal steroids, 1= partial course of steroids, 2= full course, 3= multiple courses.
Table 7-5 Correlation coefficients and p values for Spearman's correlation between antenatal steroid
exposure and salivary Cortisol
Age group Spearman's Rho correlation coefficient P value
Day 3 (n=10) -0.03 0.93
Day7-12 (n=10) 0.31 0.37
Dayl 3-23 (n=10) 0.52 0.13
Day 24-52 (n=10) 0.84 0.02
Figure 7-6Mean salivary Cortisol for PNA 24-52 days in relation to antenatal steroid exposure (nmolL-1)
Maternal steroid exposure
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Chi-squared and Mann-Whitney-U tests were carried out for each categorical characteristic
at each age group separately. Of the 20 tests (examining sex, twin pregnancy, labour, fetal
illness, caesarean section) only one (twin pregnancy) was found to be significant, which
would be expected to occur by chance, so will be disregarded.
In conclusion, no significant relationship was found between salivary Cortisol level and any
perinatal or infant factor, except antenatal steroid exposure in age group 24-52 days, which is
examined further in the 'discussion' section of this chapter.
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7.4.8 Variation between the two samples taken within each study day
Figure 7-7 Scatterplot of same-day first and second sample salivary Cortisol results (nmol L"1)
4 8 20 60 100
Earlier sample salivary Cortisol result (nmolL-1)
Paired sample t-test showed no difference between the logs of earlier and later in the day
salivary Cortisol results p=0.07. Correlation between earlier and later salivary Cortisol results
significant p<0.01, Spearmans on cortisol(r=0.52), Pearsons on log 10 cortisols(r=0.48)
There was no relationship between the time between samples and the variation of Cortisol
levels in those samples: Pearsons correlation of:
1. time between samples




Figure 7-8 Histogram of number of hours between samples
0 1 2 3 4 5 0 7 8 9 10 11 12 13 14 15
Time between samples (hours)
Study period ranged from I-15 hours, mean 7.7, median 7.8, SD 5.3
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7.5 DISCUSSION
7.5.1 Salivary Cortisol values in controls
7.5.1.1 General
While it is relatively easy to define a 'normal' or 'control' term new-born infant, the concept
of a control preterm infant is more difficult. Premature births are not normal, whether the
premature birth has occurred for maternal or infant related reasons. Without medical
intervention and support, many premature infants would die or be profoundly damaged. The
premature infant's physiology is designed to function within the closely controlled in-utero
environment. Respiration, digestion, energy homeostasis, waste-product-removal,
biochemical equilibrium and temperature regulation are all controlled by maternal/placental
function. The preterm infant's physiology may not yet be ready to take on these functions
alone. Thus, without medical intervention each one of these realms of physiology becomes
abnormal and stressful. Even with medical support and intervention, that their physiology is
being forced to function before it is mature is abnormal. Thus, the preterm infant control, is
really a 'relative' control, or 'relatively normal' preterm infant. It is a compromise; the
nearest to a subject group with whom 'more abnormal' characteristics of sick premature
infants can be compared.
7.5.1.2 Distribution
The distribution of salivary Cortisol results in this study was skewed to the right with near
normal distribution following log 10 transformatiion. This is in agreement with several other
authors studying total plasma Cortisol in similar populations (Heckmann et al., 1999;
Stevens, 1970; Watterberg and Scott, 1995).
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7.5.1.3 Timing of samples and variation
It would have been ideal to have samples collected, at a standardised time of, for example, 2
hours apart. However, the constraints of nursing and medical treatments and interventions,
along with some samples failing to yield results made this impractical. All samples were
collected after a minimum of a 1 hour no-handling period. It was speculated that the effect of
handling (Davis and Emory, 1995a) and minor procedures such as venepuncture (Mantagos
et al., 1991)would have more of an effect on Cortisol levels than the time between samples
and the detection of normal hour to hour variation. Only one author in the literature has
incorporated a no-handling period into their study on infants in ITU (Heckmann et al., 1999).
In the present study, the initial intention was to measure Cortisol 4 times in a 24 hour period,
but viscosity and volume problems with the samples meant that many samples were
unusable. Therefore, the first 2 samples with a single study day that yielded results were used
in analysis.
The non-standard sampling regime does not appear to have affected the results. As shown in
the 'variation' section of the results, there was no significant difference between salivary
Cortisol in samples taken at different times of the day from the same infant on the same day.
The length of time between samples was not related to the degree of variation between the
results.
In acutely ill adults, a single total plasma Cortisol value is thought to be sufficient to make a
(presumptive) diagnosis of adrenal insufficiency (Grinspoon and Biller, 1994). Jett et al also
suggest that a single sample of plasma for Cortisol levels in preterm infants is adequate to
determine adrenocortical function (Jett et al., 1997).
In the term infants, 2 samples would have been ideal. The practicalities of identifying
eligible infants, gaining consent from parents, sampling from infants, both following no-
handling or feeding times on the postnatal wards made this extremely difficult. The majority
of 'normal' infants and mothers are discharged from hospital before or about 48 hours post-
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partum. Therefore, twice the number of subjects as the preterm controls were recruited and
sampled once only.
In this study there is no preterm control group bom at gestational ages 33-36 weeks. At the
beginning of the study, some infants in this group were recruited. It soon became evident that
they were going to be a difficult group to follow over time, as many infants were discharged
home after 1-2 weeks, or transferred to outlying hospitals. Most of the 'distress' group
infants were <32 weeks or term. Thus the decision was made to concentrate on gathering
more detailed data from these equivalent control groups to allow more meaningful
comparisons.
7.5.1.4 Salivary levels discussed in relation to literature
Term infants
The median level of 20.4 nmol L"1 and range of 2.5-97.9 nmol L"1 from this study for term,
healthy controls sampled on day 3 of life are in keeping with the levels published in the
literature. See chapter 2-4 and table 2-3.
Preterm infants
There are 3 papers and 1 abstract with values for salivary Cortisol in preterm infants. The
levels are comparable to the median of 23.2 nmol L"1 and range of 6.9-102 nmol L"1 from this
study.
Calixto found a salivary Cortisol mean of 27.6 nmol L" and plasma mean of 372
nmol L"1 in a group of 48 infants, 3-7 days old, bom at 26-33 weeks GA (Calixto et
al., 2002).
Antonini et al showed salivary Cortisol levels of approximately 2-14 nmol L"'on a
graph from a group of infants bom at 31-34 weeks GA, sampled between 2 and 24
post-natal weeks (Antonini et al., 2000).
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Azcarate et al found similar levels in sick and well preterm and term infants varying
from 1.1-172 nmol L"1 (Azcarate et al., 1997).
Bettendorph et al found control preterm infants born at gestational age 26-31 weeks,
post natal age >2 weeks to have median salivary Cortisol levels of 5.5 nmol L"1.
Term controls at 2 days post-natal age had median level 6.5 nmol L"1. These levels
are lower than those of the present study, and the other published studies with
salivary Cortisol levels in the literature for preterm infants (Bettendorf et al., 1998).
Estimating total plasma Cortisol values from salivary levels for comparison
with literature
The data described in chapter 5 generated a scattergram and regression line and equation
which enables the estimation of an equivalent total plasma value for the salivary Cortisol
levels obtained in this study. Applying the regression equation, equivalent total plasma
values were generated for comparison with plasma values in the literature.
Overall regression equation:
Salivary Cortisol = 0.87 x plasma Cortisol - 186.4
Therefore, Plasma Cortisol = (186.4+Salivary Cortisol) / 0.87
Table 7-6 Estimated equivalent total plasma Cortisol values for controls















All preterm controls 23.2 241 6.9 222 102 331
Day3 preterm
controls
25.2 243 7.5 223 102 331
Day 3 Term controls 20.4 237 2.5 217 97.9 326
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Well infants: plasma levels
The minimum estimated equivalent plasma Cortisol for the control infants in this study is 222
nmol L"1, which is above the level at which adrenocortical insufficiency would be implied,
suggesting that none of the controls infants in the present study displayed 'insufficiency'.
See chapter 2-5.
Plasma Cortisol levels from studies with comparable, well preterm infants.
The infants studied by Heckman et al are an appropriate comparison group for the control
infants in this study. As well as the levels described, the distribution, with the normalisation
following log 10 transformation and the clinical characteristics of the infants excluded, are
similar. The authors describe a study aiming to establish a reference range for serum Cortisol
concentrations in preterm infants with a gestational age of less than 30 weeks during the first
two weeks of life. Infants were prospectively classified by the following exclusion criteria:
surfactant administration, arterial hypotension, acute or uncontrolled infection, ventricular
haemorrhage II degrees or above, blood glucose < 2.2 mmol L"1, exchange transfusion, stress
as a result of any kind of examination or nursing for at least 4 hours before blood sampling.
In appropriate for gestational age infants (n = 37, median gestational age 27.7 weeks, median
birthweight 1030 g) a reference range was generated: 73-562 nmol L"1 with a median of 199
nmol L"1 (Heckmann et al., 1999). This agrees well with the estimated equivalent total
plasma Cortisol median of 240 nmol L"1 in preterm controls in the present study.
The estimated median levels of 240 nmol L"1 in controls from the present study are also
similar to the following reports:
1. Thomas et al found basal levels on day 3-4 in 15 preterm well infants of 306 nmol L
1
(Thomas et al., 1986).
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2. Hindmarsh et al found a mean of 294 nmol L"1 in a group of 10 'unstressed' preterm
infants at approximately 3 post natal days (Hindmarsh et al., 1989).
3. In a further study of a group of well preterm infants where SNAP-PE and NTISS
scores were used to define illness severity, median total plasma Cortisol was found to
be 240 nmol L"1, <2 weeks PNA, n = 46 (Heckmann et al., 2000).
4. Stevens found a median/ mean (estimated from graph in paper) of 275 nmol L"1 after
the first 24 hours in healthy term infants <1 week old (Stevens, 1970).
Some authors, however, have described lower levels in well preterm infants comparable to
the control group in the present study:
1. Arnold et al who found a median Cortisol in clinically stable infants born at 25-33
weeks and <9 days old of 176 nmol L"1 (Arnold et al., 1998).
2. Al Saedi defined reference ranges based on 39 well preterm infants mean 29 weeks,
>5 days old. Range 20-680 nmol L'1, mean 125+/-107 nmol L"1 but includes infants
up to 8 weeks old (al Saedi et al., 1995).
3. Mean Cortisol was described as being 193 nmol L"'in premature infants (<38 weeks)
in the first month of life (Fujitaka et al., 1997). This is lower than our levels for both
term and preterm infants, but does include infants >32 weeks and up to 1 month,
which could bring the mean down.
7.5.2 Factors potentially influencing salivary Cortisol in controls
7.5.2.1 Gestational age
The literature referred to is reviewed in detail in appendix 6. In the present study, there was
no significant relationship between salivary Cortisol and gestational age. This is in agreement
with several studies (Huysman et al., 2000; Arnold et al., 1998; Kauppila et al., 1978; Lee et
al., 1989; Metzger et al., 1993; Midgley et al., 2001).
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When examining the effect of gestational age on Cortisol levels, it is logical to account for
the potential effect of illness stress on Cortisol levels as preterm infants tend to be sicker than
more mature infants. In addressing the question of gestational age or commenting on this
relationship, many authors do not differentiate between sick and well infants, or do not
perform appropriate analysis to account for degree of illness. This may well be the reason
that there are several studies describing higher Cortisol levels associated with lower GA
(Economou et al., 1993; Ng et al., 2000; Nomura, 1997; Rokicki et al., 1990; Scott and
Watterberg, 1995).
However, in a group of well infants (clearly defined in paper) studied in the first 2 weeks of
life, born at <30 weeks gestation, gestational age was found to be significantly associated
with Cortisol values (log(10)) so that higher values were obtained in infants bom at earlier
gestation (Heckmann et al., 1999).
Results from the present study demonstrated no difference in salivary Cortisol levels between
preterm controls(n=10) and term controls(n=20). Both groups were sampled on day 3. The
results are in keeping with findings from 2 other studies making similar comparisons
(Azcarate et al., 1997; Kraiem et al., 1985).
Bettendorf, however, found significantly higher salivary Cortisol levels in a group of 10 term
controls when compared to a group of 10 preterm (26-31 weeks) controls (Bettendorf et al.,
1998). The term infants were sampled on day 2, while the preterm infants were 15+ days old.
It is quite possible that the term infants' higher Cortisol reflected response to delivery.
Economou studied infants over the first month of life and found higher control Cortisol levels
in the preterm 'well' group (GA 33.5 weeks) on day 3 than the term 'well' group. However,
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it is not made clear in the paper the criteria for being 'well' in the preterm infants
(Economou etal., 1993).
The reason that no relationship between GA and Cortisol was detected in the present study
may be that the group was too homogenous (GA 26-32 weeks), and did not extend back to
24 weeks GA.
The absence of a detectable difference between salivary Cortisol in term and preterm control
groups may also be due to type 2 error. If this were the case, it would be likely to be
secondary to the relatively small sample size of n=10 in each group.
7.5.2.2 Postnatal age
This study was designed originally so that a cohort of 10 infants would be followed
sequentially from day 3 over 4-6 weeks, with a result from each infant in each of 4 time
periods. Several problems arose with this design:
1. Infants who were recruited initially became unwell, eg with sepsis, necrotising
enterocolitis, etc. so were no longer termed 'controls'.
2. Infants who were recruited initially were transferred to outlying hospitals when they
were considered to be well enough and so were lost to follow up.
3. Some infants were recruited initially, but the first saliva samples taken were of
insufficient volume or too viscous to yield a result.
4. Some infants who fulfilled criteria for recruitment were not entered initially as their
parents declined consent until they felt that the infant was 'settled and doing well'.
These infants were therefore recruited 'late'.
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For these reasons, and described in detail in the 'results' section (Table 7.3), a mixture of
cross sectional and longitudinal data was generated, forming 40 'infant study days' from 21
infants. The characteristics of the groups from each postnatal time period did not differ
significantly. No significant change in Cortisol levels over the first 4-6 weeks of life was
found.
Several authors have described a decline in Cortisol levels over the first 2 weeks of life in
preterm infants (Metzger et al., 1993; Banks et al., 2001a; Kanarek et al., 1988; Kauppila et
al., 1978).
In general, most studies do not separate sick from well infants in their analysis of trend in
Cortisol levels over time and well-defined, reproducible measures of illness are seldom used.
Preterm infants are usually sickest during the first days of life. This is likely to make earlier
values higher compared to later weeks.
In keeping with this suggestion, Economou found a general decrease in Cortisol levels over
15 days. In preterm infants, Cortisol levels were higher in the first 5 days than for the rest of
first month, with this difference being more pronounced in the sick infants. (Economou et
al., 1993). Scott and Watterberg found that the postnatal pattern in Cortisol values depended
on gestational age. Ill infants more than 27 wk gestational age increased their Cortisol values
from day 2 to day 6 although Cortisol values decreased in well infants. These patterns
resulted in a non-significant change over time for these age groups. In contrast, Cortisol
values significantly decreased from day 2 to day 6 in both well and ill infants that were born
at <27 weeks GA (Scott and Watterberg, 1995).
There are probably 2 main reasons why there was no decrease in Cortisol levels in controls
over postnatal age in this study. Firstly, no samples were taken prior to day 3, so Cortisol
levels did not detect the effect of the stress of delivery and labour. Secondly, analysis of the
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effect of postnatal age was only performed in controls, so stressed infants with higher levels
due to illness that occurred earlier in life were excluded. SNAP and CRIB scores are
available as clear indicators of illness severity.
In agreement with findings in this study are:
1. Watterberg, Scott, et al. who found no change in Cortisol levels in preterm
infants over the first week of life, following the first 48 hours (Watterberg et al.,
2000).
2. Bettendorf, Albers, et al who found no significant relationship between salivary
Cortisol levels and postnatal age in preterm infants, who were well and stable
(Bettendorf et al., 1998).
3. Arnold et al who found that in infants <9 days old, that there was no association
between mean Cortisol over 6 hours and post natal age (Arnold et al., 1998).
4. Lee et al who found that following a fall immediately after birth, levels in
preterm infants 31-35 weeks GA appeared to be stable over the first week of life.
(Lee et al., 1989)
5. Kraiem, who found a rapid fall in Cortisol levels after the first few hours
following birth, to levels that remained stable for samples taken at 3 and 10
days. This was the pattern for both term and preterm (32+/-2 weeks GA) infants
(Kraiem et al., 1985)
6. Ng et al who found no difference in response to hCRH in a group of 14 infants
<32 weeks gestation tested on days 7 and 14 (Ng et al., 1997b).
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7.5.2.3 Antenatal steroids
The data from this study suggest that antenatal steroid exposure does not significantly
suppress salivary Cortisol levels from day 3 of life onwards, table 7.5. There was no
significant relationship for age groups spanning days 3-23. The significant correlation for
day 24-52 of life was one of 40 correlations with salivary Cortisol, and the direction of the
relationship was opposite to that expected, see fig 7.6, ie. not suppression. It was the advice
of the statistician that this result occurred by chance and so should be disregarded. These
results are in keeping with the literature on the effect of antenatal steroid therapy on the HPA
axis in the newborn period It suggests that, overall, if suppression occurs, it would seem that
it is transient, resolving within the first few days of life. There is no literature describing
higher Cortisol associated with increasing maternal steroid exposure. See appendix 5.
7.5.2.4 BW
Infants < 3rd centile were excluded from any group of the study, as infants with IUGR are
known to have different adrenocortical metabolism (Heckmann et al., 1999). In this study,
neither birth weight nor birth-weight centile correlated significantly with salivary Cortisol
values.
7.5.2.5 Sex
It has been suggested that sex (Davis and Emory, 1995b) might contribute to Cortisol levels.
It is unlikely that the magnitude of influence on Cortisol levels would be significant relative
to the marked differences between controls and sick infants.
216
7.5.2.6 Behavioural State
It has been suggested that behavioural state might influence Cortisol levels (Anders et al.,
1970). In a study of well, stable term and preterm infants, no significant relationship was
found between sleep-state or state of arousal and salivary Cortisol levels (Bettendorf et al.,
1998).
7.5.2.7 Apgar score/ fetal illness
Infants in poor condition at birth or with apgar score less than or equal to 7 at 5 minutes were
excluded from the study. This excludes infants with significant asphyxia and/or fetal illness,
that might induce a prolonged adrenocortical response lasting into the first week of life that
would confound the interpretation of Cortisol values related to postnatal distress of
identifiable cause. Fetal illness was defined as the presence of any of the following: poor
CTG, poor biophysical profile or cord prolapse. Neither apgar score nor fetal illness was
related to salivary Cortisol levels.
7.5.2.8 Maternal obstetric illness
Maternal obstetric illness was defined as the presence of high blood pressure, ante-partum
haemorrage, or infection. Infants of mothers with significant pre-existing or chronic medical
illness such as diabetes, epilepsy, or substance abuse were excluded from all groups of the
study. There was no difference between the Cortisol levels in those infants born to mothers
with, compared to those without obstetric maternal illness.
7.5.2.9 Delivery
The effects of delivery on Cortisol levels are thought to have subsided by 48 hours PNA
(Kauppila et al., 1978). In this study, the presence or absence of labour, and Caesarian
section were unrelated to Cortisol levels.
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7.5.2.10 Twin
Those infants born of a twin pregnancy did not have significantly different Cortisol levels
from those born of singleton pregnancies.
7.5.2.11 Illness severity
There was no correlation between illness severity scores (SNAP or CRIB) from birth or the
time of sampling and salivary Cortisol levels. This topic is discussed in more detail in the
following chapter.
7.5.2.12 Previous pain experience
It is possible that the early pain experience might be associated with a sustained Cortisol
response, detectable several days or weeks later. This pattern has been observed in patients
with burns who have sustained hypercortisolaemia for several weeks following discharge
from hospital (Lephart et al., 1987).
Increased neurological plasticity in the neonatal period may mean that exposure to repetitive
pain causes permanent or longterm changes. Decreased pain thresholds and altered gene
expression in the somatosensory cortex were noted in adult rats that were exposed to
repetitive pain in the neonatal period when compared to those that were not. Of particular
relevance to the present study, however, no difference was found in corticosterone and
ACTH levels following air-puff startle or in pain thresholds in adult rats between those
exposed and those not exposed to noxious stimuli in the neonatal period (Anand et al., 1999;
Anand, 2000b). Similarly, in this study, 'follow-up control' salivary Cortisol levels are not
higher than those in 'non-pain exposed' (control) infants.
7.5.3 SUMMARY
1) For the control group as a whole (preterm, term and follow-up) salivary Cortisol levels
were: median : 19.9 nmolL"1, Range: 2.5-102 nmolL"1. The salivary levels and estimated
equivalent total plasma Cortisol levels are in keeping with the available literature.
218
2) There was no significant change in salivary Cortisol levels taken from preterm controls
across the first 7 weeks of life p=0.17.
3) There was no significant difference between the salivary Cortisol levels from term and
preterm infants on day 3 of life p=0.7.
4) When they were well, the salivary Cortisol levels of infants who had experienced distress
earlier in life were not significantly different from the levels of controls with no earlier
experience of distress p=0.49.
5) Salivary Cortisol levels in well infants from day 3 onwards are not related to gestational
age, post-natal age, exposure to antenatal steroids, sex, birth-weight, birth-weight centile,
apgar score at 5 minutes, the presence of maternal obstetric or fetal illness, twin
pregnancy, the presence or absence of labour or c-section, or illness severity scored by
CRIB and SNAP scores at birth or at the time of saliva sampling.
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8 Does Salivary Cortisol Reflect Distress in Sick and Preterm New¬
born Infants?
8.1 OVERVIEW
Background Salivary Cortisol may be raised in sick or pre-term infants subjected to
sustained distress.
Objective To examine salivary Cortisol levels in infants grouped by potentially distressing
clinical condition, compared to controls.
Method Cortisol was measured in saliva samples from 30 infants with presumably
distressing conditions:
1) Requiring nasal continuous positive airways pressure (n=10).
2) Requiring endotracheal intubation and intermittent positive airways pressure
ventilation (n=10).
3) With inflammatory conditions; necrotising enterocolitis (n=8) and
meningitis (n=2).
Half of the infants (n= 15) had follow-up samples taken on a day when they were well, to
allow for intra-subject comparison.
Results
1. Salivary Cortisol levels for distressed group as a whole: median: 163.3 nmol L"1,
range: 22.7-3462 nmol L"1 interquartile range 107-314.9 nmol L"1
2. Each distress group taken separately had salivary Cortisol levels higher than the control
group (p<0.01). The infants with meningitis had levels higher than all the other groups
taken separately (p=0.01) but there was no difference amongst the other groups.
3. Salivary Cortisol levels of infants when 'distressed' were higher than when they were
'well' (follow-up controls) p<0.01.
4. Illness severity assessed by SNAP and CRIB scores at birth or time of Cortisol
measurement did not account for the differences between the groups.
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8.2 BACKGROUND
In order to test the hypothesis that salivary Cortisol mirrors distress in sick and preterm
newborn infants, subjects were grouped according to condition. It was presumed that each
condition studied was associated with a certain degree of distress, based on the probable
distress that an adult would feel should they be subjected to a similar clinical situation to the
infants. The distress groups were graded as follows:
0= no distress (controls)
1= nasal CPAP
2= conventional mechanical ventilation
3= necrotising enterocolitis
4= meningitis
In order to distinguish physiological stress from the presumed distress associated with the
diagnosis, illness severity scores were carried out for use in the statistical analysis.
8.3 METHODS
8.3.1 Sample collection and analysis
Methods as described in chapters 3 and 4
8.3.1.1 Timing of samples
Sampling was the same as in the preterm control group described in the previous




Infants were recruited as soon after diagnosis as possible, usually on the same day as
diagnosis.
FU controls: When infants who had been studied as part of a 'distress' group
recovered, and were clinically stable >48 hours, with no other apparent cause for
distress, saliva was collected on a 'follow-up control' study day.
8.3.2 Illness severity scores
CRIB and SNAP scores were carried out retrospectively on all the subjects as measures of
illness severity. Scores were derived using the tables displayed in chapter 2-6;
For the first 12 (for CRIB) and 24 (for SNAP) hours after birth
For the 8 hour period prior to saliva sampling
For the saliva sampling period
8.3.3 Inclusion criteria
Minimum age: 48 hours
Apgar score at 5 mins >7
BW between 3rd and 97th centiles
One main diagnosis/clinical problem/intervention:
1) CPAP. Continuous positive airways pressure via nasal device for RDS/pulmonary
immaturity/apnoea ofprematurity.
2) Ventilation. Conventional mechanical ventilation via an endotracheal tube for
RDS/pulmonary immaturity; mandatory ventilation or patient triggered ventilation
depending on the decision of the infant's clinician. The use of opiate sedation was at the
discretion of the clinical team caring for the infant.
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3) NEC. The presence of a combination of abdominal distension, bilious gastric aspirates,
suggestive x-ray changes, and clinical deterioration such that the infant was placed on a
'NEC regime' (triple antibiotics, no milk feeds, total parenteral nutrition, gastric
drainage and close clinical monitoring for signs of bowel perforation.)
4) Meningitis. Clinical picture leading to lumber puncture with cerebrospinal fluid changes
consistent with acute bacterial meningitis and positive culture of likely organism (group
B Streptococcus).
8.3.4 Exclusion criteria
Multiple major problems, eg sepsis + ventilation for RDS, pulmonary haemorrhage +
ventilation, NEC + IVH
Hypoglycaemia < 2.2 mmol L"1




History of birth asphyxia
Umbilical cord ph<7.0
Instrumental delivery or evidence of birth trauma, eg bruising, clavicle or other fracture.
Infants of mothers with significant co-existing chronic medical illness such as diabetes,




Salivary Cortisol values were obtained from 60 samples, two samples within each study day
from each of the 30 infants in the 'distress' group as a whole. 30 further 'follow-up' results
were obtained, two samples from each of 15 of these infants. The mean of the two samples
was used to represent that infant's 'study-day' result for all analysis. The distribution of
salivary Cortisol was skewed to the right, so all mean values were transformed to log 10 for
further analysis.
Figure 8-1 Histogram of mean salivary Cortisol (nmol L"1)
Mean Salivary Cortisol (nmolL-1)
Figure 8-2 Histogram of Iog10 mean salivary Cortisol (nmol L"1)
1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50
log 10 mean Salivary Cortisol (nmolL-1)
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8.4.2 Subjects and demographics (+ compared to controls)














Controls (day 3) 31(30.9) 29-32 1605(1554) 1040-1850
CPAP 28(28.7) 26-32 1112.5(1163.5) 730-2030
Ventilated 30(29.2) 24-32 1270(1224.7) 593-2035
NEC 28(28.8) 26-34 1065(1222) 595-2131
Meningitis 37(37) 36-38 2990(2990) 2190-3790
All distress 29(28.4) 24-38 1225(1321) 595-3790




28.5(28.9) 24-34 1192(1192) 595-2131
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4:6 5 0 8 5 0 0
CPAP
(n=10)
4:6 4 4 4 8 0 2
Ventilated
(n=10)
5:5 7 3 5 8 2 8
NEC
(n=8)
4:4 2 3 5 5 3 6
Meningitis
(n=2)
1:1 0 0 2 0 0 0
All distress 14:16 13 10 16 21 5 16








Controls (n=10) 6 2 1 1
CPAP (n=10) 4 4 2 0
Ventilated (n=10) 6 2 1 1
NEC (n=8) 4 1 1 2
Meningitis (n=2) 0 0 0 2
8.4.3 Statistics for subject characteristics
Kruskall-Wallis test for multiple comparisons of non-normal data in unrelated groups
showed no significant differences between preterm groups:




for gestational age p=0.06 and BW p=0.12.
The meningitis infants (who were term) were, as expected, significantly more mature and
heavy than the above groups, p=0.015 and p=0.026 for GA and BW respectively.
There were no significant differences for the degree of obstetric maternal illness(p=0.5),
administration of antenatal steroid (p=0.2), 5 minute apgar score (p=0.4) or BW centile
(p=0.74).
Chi squared test showed no difference between the groups for the categorical data; Sex, twin,
labour or c-section. Presence of fetal illness was equivalent between the distress groups, but
absent in the controls. Fetal illness is defined in section 7.5.2.7.
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8.4.4 Salivary Cortisol levels in 'distress' groups compared to controls
For comparison to controls, the preterm control group day 3 were used, as their Cortisol
levels were equivalent to all the other control groups (see previous chapter) and the day of
sampling was similar to the day of sampling for most of the 'distress' groups.
Table 8-5 Salivary Cortisol levels (mean of two samples from one study day) (nmol L"1) in subject
subgroups
Salivary Cortisol (nmol L1) Median Range
Preterm controls Day 3(n=10) 25.2 7.5-102.0
CPAP (n=10) 121.65 22.7-303.6
Ventilated (n=10) 163.1 57.0-416.5
Necrotising enterocolitis (n=8) 218.1 98.2-2469.6
Meningitis (n=2) 2892.1 2322.3-3462.0
Distress group as a whole (n=30) 163.3 22.7-3462.0
Figure 8-3 Log 10 mean salivary Cortisol levels in the distress subgroups and control group (nmol L"1)
cpap ventilated meningitis
'Presumed distress' group
One way ANOVA with Post-Hoc (Turkey HSD) analysis showed that each distress group
taken separately had salivary Cortisol levels higher than the control group (p<0.0l). The
infants with meningitis had levels higher than all the other groups taken separately (p<0.0l).
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There was no difference between the CPAP and ventilated groups(p=0.7), the ventilated and
NEC groups(p=0.7), or the CPAP and NEC groups(p=0.1).
8.4.5 Intra-subject comparison of salivary Cortisol levels: 'distressed' vs 'well'
Paired sample t-test comparing log 10 mean salivary Cortisol of infants when 'distressed' to
the same infants when they became 'well' (follow-up controls) p<0.01.
Figure 8-4 Box plot of Iog10 salivary Cortisol in infants initially in a 'distress' group compared to when
clinically well (nmol L"1)
4.0
o 10.
a ■ . m
N = 15 15
'distressed' follow-up: well
Infant group
Distressed: median: 124.8 nmol L"1 range: 22.7-3462 nmol L"1
Well: median: 18.8 nmol L"1 range: 6.7-49.5 nmol L"1
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8.4.6 Analysis of factors influencing salivary Cortisol levels
The General Linear Model (GLM) was used to analyse the effect that potential confounding
factors had on the mean salivary Cortisol levels. Of particular interest were the illness
severity scores. Analysis showed that SNAP and CRIB scores at birth, in the 8 hours prior to
or during the study period did not contribute significantly to the Cortisol result.
Dependent Variable: LOG 10 Mean Salivary Cortisol. Fixed factor: 'Distress group'







5 minute apgar score 0.63
SNAP score 1st 24 hours 0.36
SNAP score 8 hours prior to study 0.90
SNAP score during study period 0.53
CRIB score for 1st 12 hours 0.22
CRIB score 8 hours prior to study 0.06
CRIB score during study period 0.24






Morphine during study 0.46
Morphine prior to study 0.78
PNA (study day) 0.25
'Distress group' 0.02 *
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8.4.7 Variation between the two samples taken within each study period
Figure 8-5 Scatterplot of first and second samples taken with study period (nmol L"1)
40 100 300 500 2000 4000
Earlier sample salivary Cortisol result (nmolL-1)
Correlation between earlier and later salivary Cortisol results significant (p<0.01) using
Pearson's correlation on loglO mean salivary Cortisol level: r=0.85.
Paired sample t-test showed no difference between loglO means of earlier and later in the
day salivary Cortisol results (p=0.07)
There was no difference in the degree of variation present in the distress group compared to
the control groups. Independent samples t-test on loglO difference between the earlier and
later Cortisol levels in controls compared to pain groups p=0.57. (Each control infant was
represented only once.)
The time between samples was not significantly related to the Cortisol level: correlation
between time difference between samples and the degree ofvariation between those samples
([difference between values / mean of the 2 samples] X 100) is not significant, (Pearson's
correlation on loglO values: r=-0.1, p=0.58).
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8.4.8 Illness severity scores
There were significant differences between both of the scores at all of the times measured
between the groups, p<0.01 Kruskall-Wallis test.
Table 8-7 Illness severity scores for 'distress' and control groups
Median (range) Controls
(day 3)
CPAP Ventilated NEC Meningitis
Birth SNAP 6.5(2-16) 14.5(7-25) 15(8-22) 18.5(5-22) 0
Study day SNAP 2.0(0-6) 8(3-15) 14(5-24) 7.0(1-23) 0.5(0-1)
Birth CRIB 0.5(0-3) 2.5(1-6) 3(1-14) 4(0-8) 0
Study day CRIB 0(0-1) 2.5(0-6) 1(0-15) 3(0-8) 0
As both parameters had skewed distributions, Spearman's rank correlation was carried out to
explore the relationship between mean salivary Cortisol and illness severity scores.
Salivary Cortisol from the study period correlated significantly with both scores (CRIB and
SNAP) at all times except SNAP score in the 1st 24 hours.




















Mean Cortisol 0.2 0.4 0.3 0.3 0.4 0.3
P= 0.24 0.03 0.05 0.03 0.01 0.05
The CRIB and SNAP scores correlated with each other at all times, all p<0.01, using
Spearman's correlation. Scores from different times correlated with each other, all p<0.01,
using Spearman's correlation.
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Mean salivary Cortisol (nmol/l)
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8.5 DISCUSSION
8.5.1 Simplification of clinical scenarios for interpretation of results
It is nearly impossible to study intensive care patients in standardised conditions. Most
patients requiring intensive care do not have single organ or single system pathology. There
are generally many variables at play, both in terms of disease processes and subject
responses to those processes. Their interactions are extremely complex and currently poorly
understood. In order to simplify the interpretation of results in this study, an attempt was
made to standardise patient groups. Patients with more than one main problem were
excluded. In addition to this, infants displaying physiological parameters that are known
stimuli for Cortisol release in themselves, or that might be manifestations of adrenal
insufficiency, eg hypotension and hypoglycaemia, were excluded.
While aiding interpretation of results, the drawback of such a design was that patient
numbers recruited were reduced. Also, conclusions about the applicability of the results to
the neonatal population in general must be to some extent guarded; most infants in neonatal
ITU have multisystem pathology, and many suffer hypotension or hypoglycaemia at some
stage in their early postnatal course.
8.5.2 Timing of samples
As with controls, it would have been ideal to have samples collected at a standardised time
of, for example, 2 hrs apart. The constraints described in the controls section were even more
restricting in the distressed group as the infants required more intervention on the whole.
Hence, sampling was opportunistic. The 'non-standard' sampling regime does not appear to
have affected the results. As shown in the 'variation' section of the results, there was no
significant difference between salivary Cortisol in samples taken at different times of the day
from the same infant on the same day. The length of time between samples was not related to
the degree of variation between the results.
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8.5.3 Day of study
There was a significant difference in PNA at sampling time between the distress groups and
controls p<0.01. An attempt was made to standardise all collections to day 3,7, etc to allow
comparison to controls and to avoid the effect of labour on Cortisol levels. Unfortunately, the
development of illness was not predictable in this way so it was not always possible to do
this. However, salivary Cortisol in controls on different postnatal days did not vary.
Therefore the decision was made, following consultation with a clinical statistician, to
compare all of the 'distress' groups, no matter what day of life their samples were collected,
to the day 3 control levels. A substantial number of the 'distress' infants had samples
collected on day 3; all 10 CPAP infants, both meningitis infants and 2 NEC infants. All
ventilated infants were collected on day 3-5. Study day was also entered as a potential
confounder in the GLM analysis. It's contribution was not significant, p=0.25. Thus this
difference in study day between the groups was not considered to be of importance.
8.5.4 Distribution
As with controls, the distribution of salivary Cortisol values was highly skewed to the right,
and brought to 'normal' by log 10 transformation.
While this is in keeping with the results ofmany studies, some studies have found 'bimodal'
distribution, with a group of infants with low levels of Cortisol, consistent with adrenal
insufficiency. This is discussed further below.
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8.5.5 Demographics
The only differences in demographics between the distress groups compared to controls
were:
1. GA. P=0.02, which was due to the presence of the 2 term meningitis babies. When
the preterm groups were compared ie, the controls, CPAP, ventilated and NEC
infants, there were no differences between the groups p=0.06.
2. BW. P=0.03 which was also due to the presence of the 2 term meningitis babies.
When the controls, CPAP, ventilated and NEC infants were compared, there was no
difference between the groups p=0.1.
The control infants tended to be more mature and heavier than the distress infants. This
reflects the tendency of more immature and lower BW infants to suffer more complications
of prematurity. All other population characteristics of the distress infants compared to the
control infants were similar.
8.5.6 Salivary Cortisol papers
There appear to be only two publications with salivary Cortisol levels for sick infants:
1) Azcarate et al found a maximum level of salivary Cortisol in sick preterm
infants of 172 nmol L"1, which is lower than the upper range of 300-3000 nmol
L"1 found in the present study (Azcarate et al., 1997). However, only seven sick
infants were included in that study.
2) Vaughn et al found a salivary Cortisol mean of approx 190 nmol L"1 in term
infants in the post-operative period (Vaughn et al., 1996). This level is between
the medians found in the present study for ventilated and NEC infants.(163 nmol
L"1 and 218 nmol L"1)
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8.5.7 Comparison with levels in the literature
As previously discussed, there are few data on salivary Cortisol levels in sick or preterm
infants. For the comparison of the results from this study with the literature, estimated
equivalent total plasma Cortisol values were calculated as described in the 'controls' chapter
(section 7.5.1.4).




















23.2 241 6.9 222 102 331
Day3 preterm
controls
25.2 243 7.5 223 102 331
Term controls 20.4 237 2.5 217 97.9 326
Cpap infants 121.7 354 22.7 240 303.8 563
Ventilated infants 163.1 401 57 279 416.5 692
NEC 218.1 465 98.2 327 2469.6 3053
Meningitis 2892 3586 2322 2883 3462 4193
Above 4 combined 163.3 401 22.7 240 3462 4193
8.5.7.7 Infants with meningitis
Each distress group taken separately had salivary Cortisol levels significantly higher than
controls. The only subgroup of the distress infants that had levels significantly higher than
the other subgroups was the meningitis group.
The salivary Cortisol levels of the 2 infants with meningitis were extremely high; higher than
reported elsewhere in the literature for saliva. Paired plasma samples were also available,
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and these samples comprise some of the highest values discussed in chapter 5. These infants
had a serious bacterial infection of a major organ, with a possible generalised or septic
component. Neither infant however was physiologically unstable, both having low SNAP
and CRIB scores. Neither infant required supplementary 02, circulatory support or treatment
for hypoglycaemia. As described in the literature review of neuroendocrinology and HPAA
activation, sepsis, IL1, IL6, and TNF are potent stimuli for Cortisol production, with several
reports of Cortisol levels in septic patients in the many thousands. Ng noted extremely high
levels of ACTH and Cortisol (1438 nmol L"1 post CRH) occurred in an infant with bacterial
endocarditis (Ng et al., 1997b). In a study of 13 newborn infants (GA 28-40 weeks) with
septic shock, endotoxin was recovered from eight infants. Serum Cortisol concentration from
infants with endotoxemia (2500 nmol L"1 +/- 1644 nmol L"1) was significantly higher than
that from infants without endotoxemia (1097 nmol L"1 +/- 659 nmol If1) The highest single
value noted was 6350 nmol L"1 (Togari et al., 1986). One other infant, who had NEC, in the
present study, had salivary Cortisol levels in the 1000s. This infant went on to die. It is likely,
and in fitting with the clinical picture for the infant, that bacterial sepsis was a contributing
factor to the infant's illness.
Thus, the salivary Cortisol levels in the infants with meningitis were in keeping with the
magnitude of plasma Cortisol levels described in serious bacterial infection in the literature,
but neither of these infants was shocked, had multi-organ failure or was clinically unstable.
Each would presumably have suffered severe pain from meningeal inflammation. Each
infant would also have had presumably high levels of circulating IL1, IL6, and TNF. Thus
either the pain or the inflammatory mediators could be responsible for the massive Cortisol
production. With limited data on inflammatory mediators +/- Cortisol interactions available
for the neonatal population, it seems reasonable to assume that high levels of inflammatory
mediators and pain will co-exist in the clinical setting. Thus Cortisol released due to
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inflammatory mediators would be in keeping with the hypothesis that Cortisol levels may
mirror pain in this population.
8.5.7.2 Infants receiving nasal CPAP
There do not appear to be any papers that discuss infants requiring nasal CPAP as a distinct
group in relation to Cortisol levels. Infants in this group would generally have respiratory
disease less severe than those requiring intubation and conventional mechanical ventilation.
Although the infants do not have a potentially uncomfortable endotracheal tube in situ, they
do require nasal prongs and a fixation device to keep the prongs in situ. There is also the
potential for discomfort from having pressurised gas forced into the nose, mucosal irritation
or damage from this or the pressure of prongs, and the general restriction of movement and
position associated with the treatment. It is conventional not to treat infants who require
nasal CPAP with morphine for sedation. This is because it is generally thought that these
infants are relatively close to being weaned from all respiratory support, and that morphine
may slow down the weaning process. Anecdotally, it has been widely observed that infants
receiving nasal CPAP are agitated and may be as distressed as infants receiving conventional
ventilation via an endotracheal tube with no sedation. Other researchers have also identified
this group of infants as 'potentially distressed' (Debillon et al., 2001).
Results from the present study showed a median salivary Cortisol that was significantly
higher than controls and lower but not statistically significantly so, than the conventional
ventilation group. In contrast, the SNAP scores of the CPAP group were significantly lower
than the ventilated group (p=0.02 Kuskall-Wallis test). This is in keeping with the suggestion




Infants who received HFOV were not studied. This is because these infants tended to be less
mature, more sick and have multi-system pathology. Hypotension was frequently apparent
and required treatment with dopamine, and morphine sedation was routine. It was felt that
these infants had so many complicated factors potentially influencing Cortisol levels that
interpretation of their salivary Cortisol levels in relation to distress would be extremely
difficult. Infants receiving conventional (IPPV) ventilation via an endotracheal tube may
suffer distress as a result of the same factors mentioned for the CPAP group, and as listed in
the introductory chapter 2-2. Several studies of plasma Cortisol in preterm infants separate
ventilated infants from other clinical groups. The following studies describe levels in
keeping with the estimated equivalent total plasma Cortisol median of 401 nmol L"1 from this
study.
Studies with similar Cortisol levels for ventilated infants:
1) Reynolds found in 13 infants with non-fatal RDS on day 3 mean levels of 402nmol L"1
(Reynolds, 1973).
2) Pokela found a median total plasma Cortisol of 420 nmol L"1 in ventilated preterm
infants < 1 week old (Pokela, 1994b).
3) Ng et al studied 23 preterm infants who were ventilator dependant at 28 days, and found
mean levels of 427 nmol L"1 (Ng et al., 1997a).
4) Barker and Rutter studied 47 ventilated preterm infants GA median 28 weeks, at median
15 hours PNA. Prior to diamorphine, the median was 364 nmol L"1 (Barker and Rutter,
1996).
5) Alkalay et al found basal am mean of 400 nmol L"1 prior to metyrapone in non-adrenal
suppressed ventilated infants treated with dexamethasone for CLD (Alkalay et al., 1990).
6) In a study of 61 preterm (< 32 gestational weeks) infants, serum Cortisol concentrations
on day 14 were found to be significantly higher in infants requiring mechanical
ventilation than those not ventilated (P = 0.014) (Ng et al., 1997c).
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In contrast, one group of researchers have found lower levels of Cortisol in ventilated infants:
Scott & Watterberg found that illness had a significant negative effect on Cortisol levels such
that the cofactors ventilatory support pattern or "use of surfactant" defined a pattern where
Cortisol values were lower in infants that had the highest ventilatory requirements or that
received surfactant or inotropic support compared with values from those infants who did not
have these requirements. Illness severity was assessed by a score based on ventilatory
respiratory illness (Scott and Watterberg, 1995). The authors did not discuss the use or
effects of sedation in this sicker group with lower Cortisol levels. Also, they did not address
the potential direct effects of the inotropes or surfactant on Cortisol release. Because illness
severity was measured in one system only, this may have been a relatively poor measure of
illness severity to attempt to relate to Cortisol.
The same researchers have consistently described adrenal insufficiency in preterm infants
and attempted to relate early Cortisol levels with the development of chronic lung disease. In
one study, newborns <1500 g birth weight had serum Cortisol measured 3 times during days
2 to 7 of life. 'Geometric means' of 125 nmol L"1 in those who developed CLD and 168
nmolL"1 in those who did not were found (Watterberg et al., 2000). These levels are lower
than those found in this study. In another study, ventilated infants born 24-33 weeks GA, on
day 5-7 of life means were in the region of 140 nmol L"1 (Watterberg and Scott, 1995). This,
again is low compared with the ventilated group in the present study.
Some researchers have found no difference in Cortisol levels between ventilated and non-
ventilated infants. In a study of 21 preterm infants <30 weeks GA, ventilated infants had
equivalent basal Cortisol levels to non-ventilated infants, and less response to ACTH. The
ventilated infants had significantly higher SNAP scores than non-ventilated infants
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(Huysman et al., 2000). Ng noted that mechanical ventilation did not seem to influence
adrenocortical function (Ng et al., 1997b).
8.5.7.4 Infants with NEC and 'distressed' group as a whole
There appears to be no data directly relating NEC to Cortisol levels in the literature. For the
sake of comparison of the Cortisol levels to the literature, NEC infants in this study are
presumed to be equivalent to non-specifically 'sick' infants referred to in many studies of
Cortisol values in the neonatal population. In the present study the levels in NEC infants were
higher but not significantly so than those of the infants in the CPAP or ventilation groups,
but significantly higher than controls. Data from this study produce an estimated equivalent
total plasma Cortisol median for the group as a whole of 401 nmol L"1 (see table above).
An underlying process in NEC is serious inflammation of the bowel wall. In a proportion of
cases, this proceeds to perforation of the bowel wall, and if this is not detected and treated, to
peritonitis. An equivalent adult illness with inflammation of the bowel wall and similar
potential progression or complications would be appendicitis. The relative area of
inflammation is much smaller in appendicitis, but the abdominal pain is notoriously severe.
It was therefore presumed that infants with NEC would suffer significant distress. The
infants in the NEC group had a wide range of illness severity, from one infant who did not
require any ventilatory support, and minimal general intervention, to one who progressed
from requiring nasal CPAP to ventilation to collapse and who subsequently died.
Several studies describe Cortisol levels in 'sick' infants in keeping with those found in this
study:
1. Thomas et al found values from day 3-4 of life, in sick preterm infants, mean basal
value, 536 nmol L"1 (Thomas et al., 1986).
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2. Hindmarsh et al found a mean of 448 nmol L"1 in a group of 10 'stressed' preterm
infants at about 3 postnatal days. This is comparable to the levels in the present study
of 401 nmol L"1 and 465 nmol L"1 medians in ventilated and NEC infants
respectively (Hindmarsh et al., 1989).
3. Day 3 Cortisol mean (360 nmol L"1) in preterm 'sick' infants was at the lower end of
our estimated plasma total medians for CPAP (354 nmol L~'), ventilated (401 nmol
L"1), and NEC (465 nmol L"1) infants (Economou et al., 1993).
4. Hughs et al studied 10 infants <10 days old who were sick and bom 24-32 weeks
GA. The mean level was 2000 nmol L"1 on day 3 and maximum was 4000 nmol L"1,
with wide variation. These levels are in fitting with the meningitis and sickest NEC
infants in this study (Hughes et al., 1987).
5. Banks et al found levels at 24 hours to be mean 535 nmol L ', in 314 infants bom 24-
32 weeks GA (Banks et al., 2001a).
6. Ng et al found basal mean Cortisol levels of 396 nmol L"1 at 7 days PNA in infants
<32 weeks (Ng et al., 1997b).
7. Midgley et al found in 22 infants of varying clinical condition, bom at 24-31 weeks
GA on day 7 median levels of 279 nmol L"1 (Midgley et al., 2001)s.
8. Merz et al found a basal mean of 346 nmol L"1 in 34 preterm infants on day 4-7 of
life (Merz et al., 1998).
Lower levels in sick infants described in the literature
Despite the finding that all the groups of infants who were ill, and the sickest infants in this
study had higher median Cortisol levels than controls, and the extensive literature with
similar findings, some studies have described sick preterm infants with low basal Cortisol
concentrations. The authors of the various studies have suggested a reduced ability in some
preterm sick infants to respond adequately to stress during intensive care (Hanna et al., 1997;
Kari et al., 1996; Scott and Watterberg, 1995; Arnold et al., 1997; Hingre et al., 1994;
Huysman et al., 2000; Korte et al., 1996; Lee et al., 1989; Rokicki et al., 1990; Wittekind et
al., 1993). See also appendix 3.
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There are many potential reasons for lower levels in the above studies compared with the
present study, not least the difficulty in defining standardised groups of infants for
comparison. For this study, infants were specifically selected and recruited in order to aid
interpretation of the Cortisol levels, excluding infants with hypoglycaemia, hypotension or
other phenomena that might either induce a large Cortisol response, or result from Cortisol
insufficiency. If such infants had been included, they might have had Tow' levels of Cortisol.
It was not a primary aim to investigate the presence or absence of Cortisol insufficiency in
preterm and sick infants. Any subsequent study attempting to relate distress directly to
Cortisol levels, should include infants with hypotension and hypoglycaemia to examine the
extent to which these factors influence the final Cortisol level.
The levels in this study may also be higher because there were few infants born at 24 or 25
weeks GA. This is largely as a result of the exclusion criteria regarding multi-pathology.
These infants are the population most likely to suffer from adrenal insufficiency. Scott and
Watterberg suggest that infants bom <27 weeks GA were unable to mount a sufficient
Cortisol response to illness (Scott and Watterberg, 1995).
Reasons for the disparity between papers on findings of adrenal insufficiency/ response to
illness are not obviously attributable to differences in laboratory technique. Reviewing the
literature (table 2-4), there are no consistent differences in, for example, use of prior
extraction procedure. It also seems unlikely that differences in clinical management in
different centres would result in marked differences in Cortisol levels in infants eg antenatal
steroid dose regimes are standardised.
As discussed in chapter 2.4.3.2, Gunnar proposed that a total plasma Cortisol level of 440
nmol L"1 indicated significant distress in the newborn infant. From the correlation data
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described in chapter 5, this plasma level would be equivelent to a salivary Cortisol level of
approximately 200 nmol L"1. However, Gunnar's theory was based on the assumption that
Cortisol binding capacity in infants was the same as in adults. As detailed in chapter 2.5.8,
Cortisol binding capacity in newborn, preterm and sick infants is lower; in the region of 200-
260 nmol L'1. Taking into account the reduced binding capacity of the population, the
findings from this study of the lower median of 160 nmol L"1 for salivary, and estimated
equivelent of 400 nmol L~' for plasma Cortisol in 'distressed' infants are entirely in keeping
with Gunnar's theory; the levels from the 'distressed' infants in the present study would be
consistant with Gunnar's definition of 'significant distress'.
8.5.7.5 FU values
The salivary Cortisol levels of infants at the time when they were likely to be distressed was
significantly higher than several days later when they were well (FU controls). We have
shown that in well infants, there is no such significant decrease in levels that can be
attributed to postnatal age alone. Thus, this difference is presumably due to a feature of their
illness. Whether this is pain/distress or the physiological stress of illness severity is discussed
below (SNAP scores etc). The FU control values are not higher than salivary Cortisol levels
from infants who have not experienced previous distress of a similar magnitude. As
discussed previously (chapter 7.5.2), it is possible that the earlier experience of pain would
be associated with a sustained Cortisol response, detectable several days or weeks later. This
study did not confirm this hypothesis.
8.5.8 Factors determining salivary Cortisol
The general linear model was used to assess the contribution of various factors to the final
salivary Cortisol result. 'Distress' group was graded 0=controls, 1=CPAP, 2=ventilated,
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3=NEC, 4=meningitis. 21 factors were analysed: 'distress' group, post-natal age, sex, BW,
GA, 5 minute apgar score, BW centile, maternal obstetric illness, maternal steroids, twin,
fetal illness, labour, caesarian-section, morphine received prior to study period, morphine
received during study period, birth SNAP score, birth CRIB score, actual study SNAP score,
actual study CRIB score, SNAP score for 8 hours prior to study, CRIB score for 8 hours
prior to study. The only factor that had a significant contribution to the salivary Cortisol was
'presumed distress' group p=0.02.
8.5.8.1 Influence of gestational age in pain infants
There was no relationship between GA and Cortisol levels in the 'sick' infants in this study,
taken as a group (CPAP+Ventilated+NEC+meningitis) (general linear model, p>0.5). This
implies that immature infants have adequate capacity to mount a Cortisol response to stress.
In one study, sick preterm infants had higher Cortisol levels than sick term infants
(Economou et al., 1993). Several authors have described more premature infants as having
higher Cortisol values than more mature (Ng et al., 2000; Nomura, 1997; Rokicki et al.,
1990; Scott and Watterberg, 1995). This is probably because preterm infants tend to be
sicker than more mature infants. As discussed in the 'controls' chapter, and appendix 6, there
are as many or more authors who have failed to describe a clear relationship between GA
and Cortisol level.
8.5.8.2 Influence ofMorphine on Cortisol levels.
Several authors have shown that opiates can decrease plasma Cortisol levels (Barker and
Rutter, 1996; Pokela, 1993; Vaughn PR, 1996b). None of the control group received
morphine. Morphine received during the study period by 5 of the 30 'distress' infants did not
influence the final salivary Cortisol result. Prior exposure to opiates did not influence Cortisol
246
levels either. It may be that within an individual, the use of opiate will induce a significant
reduction in Cortisol level, but with the spread of values in the various clinical groups, this
effect is statistically lost.
The other factors, BW, PNA, BW centile, apgar score at 5 mins, etc that did not have a
significant effect on the Cortisol levels in distressed infants are discussed in detail in the
'controls' chapter (7).
8.5.9 Illness severity
There were significant, if relatively weak, correlations between salivary Cortisol and all of
the scores performed with the exception of SNAP score for the first 24 hours after birth
(p=0.24). These correlations were stronger when all of the control infants (not just day 3
preterm controls) were included in the analysis. GLM showed that 'presumed distress group'
was more closely related to salivary Cortisol (p=0.02) with illness severity having an
insignificant contribution (p>0.05).
Adult ITU patients have higher total plasma Cortisol than controls, and there is a correlation
between the levels, severity of illness and mortality (Jurney et al., 1987; Reincke et al.,
1995). Two other studies in the neonatal population have found a positive relationship
between illness severity score and Cortisol level:
1. In a study of 314 infants born at gestational ages 24-32, CRIB scores were positively
associated with Cortisol level on days 1 and 3 through 7 (Banks et al., 2001b).
2. Barker and Rutter studied Cortisol and adrenaline responses in 47 ventilated preterm
infants who were judged clinically to require sedation. Stress hormone concentrations
were significantly correlated with severity of illness prior to and after sedation, assessed
using the arterial: alveolar oxygen partial pressure ratio. Noradrenaline showed the
strongest correlation, but the correlation coefficient between Cortisol and arterial:
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alveolar oxygen partial pressure ratio was significant at p<0.05, r=0.33 (Barker and
Rutter, 1996). These figures are very similar to the correlation data between both SNAP
and CRIB scores at the time of sampling in the present study, and salivary Cortisol.
Several studies of the newborn population relating illness severity scores to Cortisol levels
failed to demonstrate a similar positive relationship (Arnold et al., 1998; Hanna et al., 1997;
Heckmann et al., 2000; Huysman et al., 2000; Jett et al., 1997; Scott and Watterberg, 1995).
See appendix 1 for details of these studies. The present study measured salivary Cortisol,
which may be a more biologically relevant measure than plasma Cortisol. This may have
enabled a positive correlation with illness severity to emerge that would not had total plasma
Cortisol been measured.
This study may also have been able to demonstrate a significant relationship between illness
severity and Cortisol because of the recruitment protocol. This excluded infants with overt
signs of Cortisol insufficiency/stimuli for Cortisol release in order to simplify interpretation of
results. Thus, some sick infants with low Cortisol may have been excluded. The debate about
the existence of adrenocortical insufficiency in preterm and sick infants, its magnitude and
significance remains unresolved. Whether this is actually important regarding the present
study is not clear; most studies attempting to relate adrenocortical function to hypotension,
one of the most significant and dramatic signs of adrenocortical insufficiency, have failed to
identify a direct relationship. The possibility of a subgroup of infants with adrenocortical
insufficiency remains, but further research is required to characterise and identify it.
In summary, illness severity, assessed by deviation from normal physiology, in the form of
the SNAP and CRIB scores, does not appear to be related to Cortisol as closely as 'presumed
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distress group'. This holds true even when the extremely high Cortisol values of the infants
with meningitis (and low SNAP scores) are removed from the GLM.
This may be because either;
1. While they are good measures, SNAP and CRIB scores are not ideal measures of
physiological stress. Scoring may become more predictive of Cortisol levels if the
contribution of inflammatory mediators is somehow incorporated into or partnered with
existing scores or
2. Because distress is a significant entity distinct from physiological stress and is a potent
stimulus for Cortisol release.
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8.6 SUMMARY AND CONCLUSIONS
The results from this study suggest that the degree of distress that an infant is presumed to
suffer, based on his or her diagnosis, is more closely related to salivary Cortisol level than
any other factor analysed, including scored illness severity. There are data relating
distressing stimuli such as circumcision and venepuncture to raised Cortisol levels in
newborn infants, and a substantial literature confirming the relationship between
psychological 'distress' and Cortisol levels in medically well adults. Despite this evidence,
researchers working with medically sick infants have not generally reported or discussed the
effects of pain or distress on Cortisol levels in their patients.
In this study, 'sustained distress' has been identified and examined as an important
contributory factor to the level of salivary Cortisol in preterm and sick newborn infants. Since
this study was carried out, a recent publication has described a behavioural tool for the
assessment of sustained distress in the newborn infant (Debillon et al., 2001). The use of
such a tool, in conjunction with physiological stress measures such as the SNAP score, the
measurement of inflammatory mediators, and an indicator of free, biologically active Cortisol
may further tease out the nature of the relationship between physiological and psychological
distress and Cortisol in the sick newborn infant. It seems sensible that this next stage of
research should include infants with possible signs of adrenal insufficiency, and with
multiple pathology, so including more infants with gestational ages in the 24-26 week range.
Investigation into the effect that distress-alleviating measures have on salivary Cortisol in
sick and preterm infants with continuing pain or distress would also be helpful.
The simple findings from this study remain, however, that salivary Cortisol levels were raised
in infants with physiological illness that is almost certainly associated with sustained
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distress. This is consistent with the hypothesis that salivary Cortisol is a potential mirror of
sustained distress in the preterm and sick newborn infant. Salivary Cortisol thus has potential
as an important component in the assessment of sustained distress, and as a tool for
monitoring the effects of distress-alleviating measures.
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9 APPENDICES
These appendices are intended to pull together as much information as possible on specific
areas of interest. They refer to subjects that are covered in the literature review chapters and
the discussion sections of the later chapters.
9.1 Appendix 1 Studies with data on the relationship between Cortisol and
degree of illness
Studies finding no difference in Cortisol levels between well and sick infants or no correlation
between clinical features and Cortisol
In a study of term infants in the first 3 days of life, Gutai found no difference between control Cortisol
levels and those from sick infants (suffering from asphyxia, RDS, tortion of testis and sepsis) (Gutai et
al., 1972)
In a study of 13 well and 9 sick preterm infants, Cortisol values were not different between the sick
and healthy infants and were similar to full-term values. The authors did, however describe higher
steroid precursors (17 OH-P and 11-deoxycortisol) in the sicker infants. The infants were 31-35 weeks
GA, and the 'sick' infants had 'moderate to severe RDS' (Lee et al., 1989).
Ng noted that mechanical ventilation did not seem to influence adrenocortical function, but that
extremely high levels of ACTH and Cortisol (1438 nmol L"1 post CRH) occurred in an infant with
bacterial endocarditis (Ng et al., 1997b).
In a study of 26 infants bom at 25-30 weeks GA, over 16 weeks (total 95 samples), Arnold et al found
that plasma Cortisol was not influenced by the clinical state. 'Unwell' was defined as requiring 25% or
more 02, IV fluids or mechanical ventilation, however, implying that the 'unwell' infants may not
have been particularly 'sick' (Arnold et al., 1997).
In a prospective study, serum total Cortisol and CBG were measured in single blood samples from 31
ELBW infants, with GA < 28 weeks, in the first 8 days of life. Severity of illness was assessed using
the Score for Neonatal Acute Physiology Perinatal Extension (SNAP-PE). There was no significant
correlation between serum total Cortisol and severity of illness. Cortisol was not significantly different
in the 7 of 31 infants who died. However, the samples were taken at varying post natal ages, the
samples were random, and numbered only 31 in total, details of the laboratory methodology are not
given, and illness scores were at birth and not at the time of sampling (Hanna et al., 1997).
Thomas et al found that there was no significant difference in basal plasma Cortisol concentrations on
day 3-4 PNA between sick preterm infants (mean 536 nmol L"') and healthy preterm infants (mean
306 nmol L"1), although they were highest in preterm ill infants (Thomas et al., 1986). The group of
sick infants included sepsis, asphyxia, RDS, post-op.
Arnold et al performed SNAP scores on the day of Cortisol measurement in 26 infants. All infants
were < 9 days old, one 24 hours, 5 on day 2. There was no correlation between the SNAP score and
mean Cortisol over the 6 hr study period. 21 of the 26 infants had mild illness, with scores 0-9. The
remaining 5 had moderate illness with scores of 10-19 (Arnold et al., 1998). Thus, this group did not
include a wide spectrum of illness severity, and had only a small number of the more moderately sick
infants. This may account for the failure to find a relationship between illness severity and Cortisol
levels.
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In a study of 25 infants, mean GA 28 weeks, over the first 8 weeks of life, at none of the postnatal
ages studied was plasma Cortisol found to be influenced by the degree of illness. (Wittekind et ah,
1993).
A study of 12 ventilated premature infants on day 2 found no relationship between plasma Cortisol or
urinary noradrenaline and degree of respiratory disease severity (Wahlig et al., 1994). This may be
due to the confounding effects of the continuing influence of labour +/- delivery on Cortisol on day 2.
In a study of salivary Cortisol levels, no difference was found between levels in sick vs well infants
(Azcarate et al., 1997). There were, however only 7 infants in each group, and no definition of well or
sick was given.
Jett et al performed multiple sampling over a 6 hour period in 14 infants <28 weeks GA on day 4—6
of life, and SNAP-PE scores for the first 24 hours and on day of sampling. No relationship was found
between mean Cortisol levels or the presence of Cortisol pulses and SNAP-PE scores. The primary aim
of the study was to describe pulsitility, and in order to be included in the study, an indwelling
umbilical arterial catheter had to be in situ. This immediately selected a subgroup of infants who were
possibly more unwell that those who had had their catheters removed and had BW < 1000 gr. Many of
the infants were receiving dopamine, insulin, indomethacin etc, which implies that the infants were a
'sick' subgroup, and the mean SNAP-PE score was high (27). Therefore the relationship between
Cortisol levels and illness severity was not sought across the range of degrees of illness severity and
may account for the lack of relationship demonstrated (Jett et al., 1997).
Heckmann et al studied Cortisol levels in preterm infants <30 weeks GA, some of whom were
hypotensive and treated with catecholamines. SNAP-PE and NTISS scores were performed at birth
and on the day of Cortisol measurement. Of the ill, normotensive infants, 15/25 had infection
associated with CRP > 10 mg dL"1, but the group did not have statistically higher Cortisol than the
controls. This is not in keeping with the possibility that very high Cortisol levels may be due to
bacterial infection. Hypotensive infants had a double peak of Cortisol levels, higher and lower than
controls. The incidence of proven or likely infection in the hypotensive infants with extremely high
Cortisol values (median 1200 nmol L"1) is not given, nor is an explanation offered for the extremely
high values found in this sub-group. The authors found no difference in Cortisol levels between those
responsive and those unresponsive to hydrocortisone for the treatment of hypotension. Despite the
finding of severity of illness scores being significantly different between the groups, controls < ill
normotensive < ill hypotensive, no difference in illness severity was found between those with high
and those with low Cortisol levels and ill normotensive infants did not have statistically different
Cortisol levels from controls (Heckmann et al., 2000).
Studies finding a difference in Cortisol between well and sick infants or a positive correlation
between clinical features and Cortisol
Serum Cortisol concentrations on day 14 were found to be significantly higher in infants requiring
mechanical ventilation compared to non-ventilated infants (P = 0.014) (Ng et al., 1997c).
a:A ratio was found to correlate negatively with Cortisol levels, 0.05, r = -0.3, in ventilated infants.
This was not such a strong correlation as with plasma catecholamines (Barker and Rutter, 1996).
Reynolds found significantly higher Cortisol in infants with fatal RDS both at 3 and 7 days when
compared with non-fatal RDS affected infants. Both well and sick infants responded to ACTH. He
concluded that an inadequate adrenal response did not contribute to the pathogenesis of RDS. He
found no infants with 'inadequate' adrenal function (Reynolds, 1973).
92 neonates were investigated at 8:00 AM and PM on the second, fourth, and sixth days of life.
Respiratory distress syndrome, especially in fatal cases, was found to be associated with an elevation
in neonatal Cortisol levels (Kauppila et al., 1978).
In a study of 314 infants born at GA 24-32 weeks, the Clinical Risk Index for Babies (CRIB) was
positively associated with Cortisol level on days 1 and 3 through 7 (Banks et ah, 2001b).
Economou et al found that Cortisol levels were higher in first 5 days than the rest of first month, with
this difference more pronounced in the sick infants. They suggested that the higher Cortisol levels (p <
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0.001) he and co-workers observed in sick preterm and full-term neonates, when compared to their
respective controls, suggested an appropriate response to stress (Economou et al., 1993).
The adrenocortical response to stress was studied longitudinally in 10 ill preterm infants using
measurements of Cortisol and 17 OH-P concentrations in filter paper blood spots. Mean Cortisol and 17
OH-P concentrations reached a peak of 2200 nmol L"1 and 65 nmol L"1, respectively, between the third
and fifth days of life. These concentrations far exceeded those observed in older children and adults
subjected to stress as a result of surgery. Further pulses of endogenous Cortisol production of 4000
nmol L" or more occurred in association with clinical complications such as intraventricular
haemorrhage (Hughes et al., 1987).
Sick infants >27 weeks GA increased their Cortisol values from day 2 to day 6 although Cortisol values
decreased in well infants. In contrast, Cortisol values significantly decreased from day 2 to day 6 in
both well and ill infants that were < 27 weeks GA (Scott and Watterberg, 1995).
Clearly defined groups of infants, standardised tools for assessing illness severity and
standardised postnatal ages and gestational ages may have facilitated the direct relationship
becoming evident in these studies.
Studies finding an inverse relationship between Cortisol and degree of illness
Scott & Watterberg found lower Cortisol values in infants that had the highest ventilatory
requirements, that received surfactant or ionotropic support compared with values from infants
without these requirements. Illness severity was assessed by RAS score, which is based on ventilatory
respiratory illness (Scott and Watterberg, 1995). The reason that higher Cortisol associated with more
severe illness was not found in this study may be that only indicators of respiratory illness were used,
rather than a more comprehensive score such as SNAP, that would include infective, biochemical and
other sources of 'illness stress'. Also 'requirement' for interventions, such as ionotropes, surfactant,
and ventilatory support are non-standard measures: there may be considerable intra and inter clinician
or unit variation in threshold for intervention. It might also be that more infants of GA 24-27 weeks
were included in the study, and these infants constitute a subgroup more likely to suffer from adrenal
insufficiency.
In a study of 21 preterm infants, ventilated infants were found to have lower levels of baseline Cortisol
than non-ventilated infants. The ventilated infants had significantly higher SNAP scores than non-
ventilated infants (Huysman et al., 2000). This study found no relationship between SNAP scores and
baseline Cortisol, and a negative correlation between ACTH stimulated Cortisol levels and SNAP
scores. This second finding is in keeping with the fact that a blunted response to ACTH is observed in
adult ITU patients who have high basal Cortisol levels (Jurney et al., 1987).
254
9 2
Appendix 2 Studies with total plasma Cortisol values > 1000 nmol L"1
Economou describes 2 infants who subsequently died who had plasma Cortisol levels consistently >
1600 nmol L"1. Mean levels are quoted, although the distribution is visibly skewed. Mean levels of
preterm sick infants were 360 nmol L'1, and term sick infants were 268 nmol L' , although no
standardised description or gradation of degree of sickness was given. 13 levels from samples from 60
infants were >1000 nmol L"1 (Economou et al., 1993).
The adrenocortical response to stress was studied longitudinally in 10 ill preterm infants using
measurements of Cortisol and 17 OH-P concentrations in filter paper blood spots. Mean Cortisol and
17 OH-P concentrations reached a peak of 2200 nmol L"1 and 65 nmol L"1, respectively, between the
third and fifth days of life. These concentrations far exceeded those observed in older children and
adults subjected to stress as a result of surgery. Further pulses of endogenous Cortisol production of
4000 nmol L"1 or more occurred in association with clinical complications such as intraventricular
haemorrhage (Hughes et al., 1987).
Heckmann et al found 2 outlying levels of Cortisol of 1233 nmol L"1 and 2050 nmol L"1 in well infants
(Heckmann et al., 1999).
Mantagos et al found one level of plasma Cortisol as high as 1377 nmol L"1 in a well term infant
following venepuncture (Mantagos et al., 1991).
Barker et al found a range of Cortisol levels of 26-7799 nmol L"1 in 47 ventilated preterm infants GA
median 28 weeks, at median 15 hrs PNA (Barker and Rutter, 1996).
Jett et al found the upper end of the range for infants <28 weeks GA , 4-6 days PNA to be 1503 nmol
L"1 (Jett et al., 1997).
Heckmann et al found the median plasma Cortisol of a group of preterm hypotensive infants to be
1200 nmol L"1 (range 764-1482 nmol L"1) (Heckmann et al., 2000).
Thomas et al quotes levels in the 1000 nmol L"1 s and Reynolds quotes some post ACTH Cortisol
values >1000 nmol L"1 (Reynolds, 1973;Thomas et al., 1986).
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9.3 Appendix 3 Studies finding low total plasma Cortisol levels in sick
infants
Thomas et al found 5 of 23 stressed preterm infants had undetectable basal Cortisol levels. They did
however produce adequate Cortisol response to high dose ACTH (Thomas et al., 1986).
The majority of ill infants of mean GA 26 weeks in first week of life were found to have total plasma
Cortisol <200 nmol L"') (Kari et al., 1996).
Hingre suggested that considering the degree of stress and degree of illness, preterm (<30 weeks GA)
newborns had low basal Cortisol levels (mean 207 nmol L"1), comparable to term infants, but
considerably higher precursors (17 OH-P and 11-deoxycortisol). This suggested that 11 (3 hydroxylase
activity was reduced. 5 of 23 infants were also found to have a sub-optimal response to ACTH.
Economou identified 4 of 15 sick term infants with total plasma Cortisol values 90-190 nmol L"1 and 6
of 15 sick preterm infants with values 100-220 nmol L"1 who were termed 'poor responders'. The
definition was based on levels being less than 2 SD ofmean of controls (Economou et al., 1993).
In a study of 31 ELBW infants, GA < 28 weeks, in the first 8 days of life, five of the infants, having a
mean SNAP-PE score of 41 (ie sick infants), had serum total Cortisol levels < 83 nmol L"1. Five
infants had levels <136 nmol L" . Estimated mean serum free Cortisol concentrations in these infants
(21 nmol L"') were comparable to estimated free Cortisol levels diagnostic of adrenal insufficiency in
sick adult patients (Hanna et al., 1997).
Lee et al found that half of infants studied (n=7) had Cortisol <140 nmol L*1, and maximum of 410
nmol L", and suggested an enzyme level block to adequate stress levels of Cortisol (Lee et al., 1989).
In another study, 60% of infants had basal Cortisol < 138 nmol L', 30% had basal Cortisol < 83 nmol
L"1. The authors suggested that delayed maturation of adrenal response may result in physiologically
inadequate Cortisol concentrations in stressed very low birth weight infants (Korte et al., 1996).
At the end of the first week of life, infants who subsequently developed BPD and prolonged oxygen
dependence had significantly lower Cortisol secretion in response to ACTH than infants who
recovered without BPD. There was no difference in basal Cortisol levels between the groups. The
authors speculated that these babies may be unable to secrete adequate amounts of Cortisol in a setting
of increased stress, leaving them vulnerable to continuing lung injury (Watterberg and Scott, 1995).
Scott and Watterberg suggested that some infants with severe illness, ie with higher requirements for
ventilatory support and requirement of surfactant, had inappropriately low Cortisol levels (Scott and
Watterberg, 1995).
An ACTH test was performed on day 4 in 21 infants, GA 25.6-29.6 weeks. The SNAP score was used
to measure illness severity. Patients with an adverse outcome had significantly lower baseline
cortisol/17 OH-P ratios and 60-minute Cortisol levels during ACTH testing The authors suggest an
insufficient adrenal response to stress in sick ventilated very preterm infants with GA < 30 weeks
compared with non-ventilated less sick infants (Huysman et al., 2000).
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9.4 Appendix 4 Studies suggesting reduced enzyme activity as cause for
Cortisol insufficiency in sick or preterm neonates.
17 OH-P, 11-deoxycortisol, and aldosterone values have been found to be higher in sick preterm
infants than in healthy preterm infants. In one study, compared to healthy full-term infants, the
premature infants had significantly higher 17-hydroxypregnenolone, 17 OH-P, and DHEAS
concentrations. The authors suggest that elevated steroid precursors in preterm infants and low Cortisol
levels in stressed sick preterm infants may indicate a relative immaturity of adrenal enzyme activity
(specifically, 11 /3-hydroxylase) and inadequate adrenal reserve for stress (Lee et al., 1989). Korte also
postulated that an elevated mean 11-deoxycortisol/cortisol ratio indicated that decreased 11 /3-
hydroxylase activity may limit Cortisol production in some infants (Korte et al., 1996).
Hingre et al have also found that the mean basal substrate/product ratio of 11-deoxycortisol has been
found to be markedly elevated in preterm infants compared to that in full-term infants. These findings
are consistent with decreased activity of 11 (3-hydroxylase in preterm infants born at < 30 weeks GA.
Decreased 11 /3-hydroxylase activity appears to be more prominent than the deficiency of 3 /3-
hydroxysteroid dehydrogenase that has been found in infants with lesser degrees of prematurity,
suggesting that 11 ^-hydroxylase activity may be regulated during fetal development to increase
during the latter part of gestation. ACTH appeared to induce an increase in the activity of 11 /3-
hydroxylase activity. The authors suggest that despite generally reduced activity of this enzyme in
preterm newborns, the rate-limiting step in the production of Cortisol might well be 3 /3-
hydroxysteroid dehydrogenase (Hingre et al., 1994).
Fujitaka however argues that the findings of raised steroid precursors may be due to antibody cross
reactivity and so falsely elevated levels (Fujitaka et al., 1997). Using HPLC, he did not reproduce the
findings.
In contrast, in a study using HPLC on spot plasma samples, 17 OH-P was detectable in 8 of 33
preterm infants < 32 weeks GA. Levels were undetectable by 22 days PNA. None of these infants had
'low' levels of Cortisol or cortisone. 17 OH-P was not detected in infants > 32 weeks GA (Nomura,
1997). A similar pattern was found with 11-deoxycortisol, with detection in 11/33, disappearance by
21 days PNA, absence in infants > 32 weeks GA and no association with low Cortisol or cortisone.
Raised 17-OHP in sick and preterm infants
Higher baseline levels of 17 OH-P in preterm sick infants compared to term infants have been found
by several authors (al Saedi et al., 1995; Murphy et al., 1983; Wallace et al., 1987). High levels of the
precursor 17 OH-P appear to be produced in response to ACTH, but lower Cortisol in sick compared
with well ventilated preterm infants, suggesting an inability to convert the precursor to Cortisol
(Huysman et al., 2000). These findings are in agreement with the earlier results published by Thomas
et al. Basal plasma 17 OH-P concentrations were significantly increased in sick and well preterm
infants compared to term infants and the peak plasma 17 OH-P response to ACTH was significantly
higher in preterm ill infants (Thomas et al., 1986). Murphy et al also found mean plasma 17 OH-P
values were appreciably higher in ill term and healthy preterm infants compared with healthy term
infants, but the highest values were found in ill preterm infants. None of the infants had adrenal
disease but some very ill infants had plasma 17 OH-P values approaching those seen in untreated
infants with congenital adrenal hyperplasia (Murphy et al., 1983).
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9.5 Appendix 5 Studies with data on changes in Cortisol levels with
postnatal age
Term infants
In an early (1978) study of 12 term healthy new-borns, delivered by SVD, with chromatography
followed by specific RIA (Sippell et al., 1978a), Cortisol remained elevated in comparison with later
infancy, with the exception of a marked "glucocorticoid dip" in Cortisol and corticosterone levels
between 2 and 12 hours after birth (Sippell et al., 1978b).
Kojima found day one Cortisol levels in (presumably) normal term infants to be significantly lower
than cord levels. Cortisol then rose over the first 5 days of life before decreasing again towards 10
days PNA (Kojima et al., 1981).
The absolute free Cortisol values in full-term infants were highest immediately after birth then they
fell to the lowest level observed between the third and fifth days of life (Rokicki et al., 1990).
Preterm infants
Several authors have described a decline in Cortisol levels over the first 2 weeks of life (Metzger et al.,
1993; Kanarek et al., 1988; Kauppila et al., 1978).
Similarly, Economou found a general decrease in Cortisol level over 15 days PNA. In preterm infants,
Cortisol levels were higher in first 5 days than the rest of thefirst month, with this difference more
pronounced in the sick infants (Economou et al., 1993).
ACTH stimulation tests were performed in 15 relatively well premature infants bom at 28-34 weeks
GA. The mean basal levels of Cortisol were significantly higher at 5-10 days PNA than at 27-31 days
PNA (Noguchi and Reynolds, 1978).
In a study of 314 infants, 24 to 32 weeks GA, mean Cortisol was 85.5 nmol L"1 at birth, reached
maximal levels at 24 hours PNA (535.2 nmol L'", and decreased to 162.8 nmol L"1 at 14 to 28 days
PNA (Banks et al., 2001a).
In infants bom after 30 weeks GA, Cortisol levels rose after birth and remain elevated for 24-48 hours
(Kraiem et al., 1985).
Cortisol values obtained in the first 3 days of life were found to be higher on day 2 than on days 3-7.
Values on day 3-4 were similar to those on day 5-7 PNA (Watterberg et al., 2000).
Scott and Watterberg found that the postnatal pattern in Cortisol values depended on GA. Ill infants
more than 27 weeks GA increased their Cortisol values from day 2 to day 6 although Cortisol values
decreased in well infants. These patterns resulted in a non-significant change over time for these age
groups. In contrast, Cortisol values significantly decreased from day 2 to day 6 in both well and ill
infants that were < 27 weeks PNA (Scott and Watterberg, 1995).
Long-term changes with postnatal age
There appears to be a fall in total Cortisol levels over the first 2 months of life in preterm infants
(Arnold et al., 1997; Noguchi and Reynolds, 1978; Wittekind et al., 1993).
A systematic decrease in the free Cortisol value was observed in infants over 3 months in preterm and
term infants (Rokicki et al., 1990).
Studies with no changes in Cortisol with postnatal age demonstrated
In infants <9 days old, Arnold et al found that there was no association between mean Cortisol over 6
hours and postnatal age (Arnold et al., 1998).
In only 'mildly ill' infants, 38-94 days old, PNA had no effect on mean plasma levels (Metzger et al.,
1993).
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Following a fall immediately after birth, levels in preterm infants 31-35 weeks GA appeared to be
stable over the first week of life (Lee et al., 1989).
Kraiem found a rapid fall in Cortisol levels after the first few hours following birth, to levels that
remained stable for samples taken at 3 and 10 days PNA. This was the pattern for both term and
preterm (32+/- 2 weeks GA) infants (Kraiem et al., 1985).
Ng et al found no difference in response to hCRH in a group of 14 infants < 32 weeks GA tested on
days 7 and 14 (Ng et al., 1997b).
Watterberg, Scott, et al. found no difference in Cortisol levels in preterm infants over the first week of
life, following the first 48 hours (Watterberg et al., 2000).
Bettendorf, Albers, et al found no significant relationship between salivary Cortisol levels and
postnatal age in preterm infants aged 15-39 days, who were well and stable (Bettendorf et al., 1998).
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9.6 Appendix 6 Studies with data on changes in Cortisol levels with
gestational age
Studies describing 'lower gestation: higher Cortisol'
In a group of well infants (clearly defined in paper) studied in the first 2 weeks of life, born at < 30
weeks GA, lower GA was associated with higher values (log(10) (Heckmann et al., 1999).
In a group of infants GA 24-36 weeks, during the first week of life, Scott and Waterberg described an
inverse relationship between GA and Cortisol concentrations, with the least mature infants having the
highest random Cortisol values (Scott and Watterberg, 1995).
Higher levels of Cortisol were found in preterm (32 weeks GA) compared to term infants, aged 4-31
days PNA, in a study of 'spot' plasma samples (Nomura, 1997).
In a study of total and free plasma Cortisol, the absolute free Cortisol values in premature newborns at
3-5 days of life exceeded the values observed in full-term subjects (Rokicki et al., 1990).
Economou studied infants over the first month of life and found higher control Cortisol levels in the
preterm group (GA 33.5 weeks GA) than the term group. Sick preterm infants had higher Cortisol
levels than sick term infants (Economou et al., 1993).
Ng et al studied total of 140 preterm (mean GA 29.6 weeks) and term infants. Blood samples were
taken at 24 hours (day 1), and on day 4-5 of life. On day 4-5, but not day 1, preterm infants' mean
Cortisol levels were higher than term infants' (Ng et al., 2000).
No changes in Cortisol with gestational age demonstrated
In a study of salivary Cortisol on day 3 of life, Azcarate found no difference between healthy term and
healthy preterm (mean BW 1420gr) infants' levels (Azcarate et al., 1997).
Kraiem compared term to preterm infants (32+/- 2 weeks GA) up to 10 days old and found no
difference in mean Cortisol levels. No details of the degree of clinical compromise of the preterm
infants was given in the paper (Kraiem et al., 1985).
In a group of infants bom at 25-29 weeks GA, sampled on day 4, there was no relationship between
baseline Cortisol and GA in a study relating Cortisol to illness severity (Huysman et al., 2000).
In infants bom at 31-35 weeks GA, sampled at 2-5 days PNA, baseline Cortisol was not found to be
related to GA by Lee et al (Lee et al., 1989).
There was no association between mean Cortisol over 6 hours and GA in a group of infants born at 25-
33 weeks GA (Arnold et al., 1998).
Cortisol levels at PNA 1 week were not related to GA in infants bom 24-31 weeks GA (Midgley et
al., 2001).
Prematurity was found not to affect neonatal Cortisol levels over the first week of life (Kauppila et al.,
1978).
In a recent study of 314 infants, 24 to 32 weeks GA, levels during the first week were not found to be
associated with gestational age, but levels on days 14-18 were inversely related to GA (Banks et al.,
2001a).
In a study of preterm well, preterm ill (GA > 30 weeks), and term ill infants, basal plasma 17 OH-P
concentrations were significantly increased in both groups of preterm infants but there was no
significant difference in basal plasma Cortisol concentrations, between the groups although they were
highest in preterm ill infants (Thomas et al., 1986).
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In infants born 24- 34 weeks GA, GA had no effect on mean plasma levels but the highest mean
Cortisol levels and the highest production rates were noted to be in the 2 most premature infants
(Metzger et al., 1993).
'Ill' preterm infants at 21 days PNA, mean GA 26 weeks were found to have similar Cortisol levels to
healthy term infants during the first week of life (Kari et al., 1996).
Hingre et al studied 25 infants < 30 weeks GA who were moderately sick on day 4 and found levels
similar to well term infants, but with raised steroid precursors (Hingre et al., 1994).
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9.7 Appendix 7 Studies with data on the effect of antenatal steroids on neonatal Cortisol levels
No or little difference found in neonatal Cortisol levels after antenatal steroid therapy
Ng et al have published 3 studies of the CRH test in various groups of infants. In a hCRH study of 61
infants < 32 weeks GA and < 1500gr, on days 7 and 14 PNA, the baseline and post-stimulation
plasma ACTH and Cortisol did not differ significantly between infants whose mothers received no
antenatal corticosteroids, and those whose mothers received 1-2 doses or > 2 doses (mean 7.2 doses)
of antenatal dexamethasone (Ng et al., 1997c).
Similarly, carrying out the CRH test prior to dexamethasone therapy at mean 28 days PNA, on infants
<1500g, Ng found no difference between those who did and those who did not receive antenatal
steroids (Ng et al., 1997a).
The authors also examined the effect of multiple (8) courses of antenatal steroids on the preterm
infant's adrenal response to hCRH. The absence of a significant difference in post-stimulation
hormone concentrations between days 7 and 14, and the similarity of their hormone responses with
those of older children and adults, suggested that no severe pituitary-adrenal suppression had
occurred. Nonetheless, there was evidence of mild adrenal suppression in some of the treated infants
(Ng et al., 1999).
In a study of Cortisol levels over the first week of life in 92 infants, after maternal dexamethasone
therapy, neonatal Cortisol concentration was found to be lower 30-60 minutes after delivery, but from
the second day on it was at the same level as in infants without maternal therapy (Kauppila et al.,
1978).
In a study of well preterm infants, 28-34 weeks GA, 5-31 days PNA, there were 4 of 15 infants whose
mothers had antenatal steroids. Their baseline and post ACTH stimulation values were similar to those
not exposed to antenatal steroids (Noguchi and Reynolds, 1978).
A study of infants 25-28 weeks GA, comparing 8 infants treated with antenatal steroids with 18 who
were not, found that the median amplitude of the cotisol secretory burst of the steroid-exposed infants
was significantly less than that of the controls but there was no difference in the mean Cortisol levels
between the groups (Arnold et al., 1998).
In a DBPCRT of 74 patients, the responsiveness of the adrenal cortex of the newborn infants,
evaluated by a 2-hr ACTH test at the age of 24 hrs, did not differ between infants whose mothers had
received either betamethasone or placebo (Teramo et al., 1980). Two further studies have examined
the Cortisol response to ACTH in infants exposed and not exposed to antenatal steroids. Neither found
a significant difference (Ohrlander et al., 1977; Wilson et al., 1988).
Early (<lst week) difference found in neonatal Cortisol levels after antenatal steroid therapy
In a study of 136 infants treated with antenatal steroid, compared with controls, umbilical cord levels
of DHEAS and Cortisol were significantly reduced within the first 24 hours after initial treatment and
remained significantly lower than in control infants through 4 days after initial treatment (Parker, Jr. et
al., 1996).
In a study of 215 betamethasone-treated infants and 117 untreated infants of 26-36 weeks GA, Cortisol
levels were suppressed within 6 hours of betamethasone treatment, decreased to 45% of the
concentration in untreated infants and returned to normal by 7 days PNA. The authors, however,
concluded that the suppression of fetal Cortisol did not interfere with the pituitary-adrenocortical
response to stress after birth (Ballard et al., 1980).
Wittekind studied 25 infants bom at 24-33 weeks GA and found that plasma Cortisol was significantly
decreased 1 week after birth in infants whose mothers had received antenatal steroid, but at no other
time in the 2 month study period (Wittekind et al., 1993).
Sustained difference found in neonatal Cortisol levels after antenatal steroid therapy
In a study of 33 infants < 32 weeks GA, levels of Cortisol and cortisone were markedly decreased in 4
of 16 infants whose mothers had received multiple courses of antenatal steroids. Low levels lasted for
3-4 weeks (Nomura, 1997).
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